[  1] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-17)/Hikal Limited has informed the Exchange about Transcript
[  2] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-17)/Hikal Limited has informed the Exchange about Transcript
[  3] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-17)/Hikal Limited has informed the Exchange about Transcript
[  4] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-17)/Hikal Limited has informed the Exchange about Transcript
[  5] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-17)/Hikal Limited has informed the Exchange about Transcript
[  6] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-17)/Hikal Limited has informed the Exchange about Transcript
[  7] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-17)/Hikal Limited has informed the Exchange about Transcript
[  8] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-17)/Hikal Limited has informed the Exchange about Transcript
[  9] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-17)/Hikal Limited has informed the Exchange about Transcript
[ 10] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-10)/Solara Active Pharma Sciences Limited has informed the Exchange about Transcript of earnings call pertaining to unaudited financial results of the Company for the quarter and nine months ended December 31, 2025.
[ 11] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-10)/Solara Active Pharma Sciences Limited has informed the Exchange about Transcript of earnings call pertaining to unaudited financial results of the Company for the quarter and nine months ended December 31, 2025.
[ 12] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-17)/Hikal Limited has informed the Exchange about Transcript
[ 13] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-17)/Hikal Limited has informed the Exchange about Transcript
[ 14] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-17)/Hikal Limited has informed the Exchange about Transcript
[ 15] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-17)/Hikal Limited has informed the Exchange about Transcript
[ 16] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-10)/Solara Active Pharma Sciences Limited has informed the Exchange about Transcript of earnings call pertaining to unaudited financial results of the Company for the quarter and nine months ended December 31, 2025.
[ 17] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-10)/Solara Active Pharma Sciences Limited has informed the Exchange about Transcript of earnings call pertaining to unaudited financial results of the Company for the quarter and nine months ended December 31, 2025.
[ 18] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-10)/Solara Active Pharma Sciences Limited has informed the Exchange about Transcript of earnings call pertaining to unaudited financial results of the Company for the quarter and nine months ended December 31, 2025.
[ 19] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-16)/Orchid Pharma Limited has informed the Exchange about Transcript
[ 20] Press Release (2026-02-06)/Solara Active Pharma Sciences Limited has informed the exchange regarding the press release dated February 06, 2026, titled "Solara Q3'26 Performance."
[ 21] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-17)/Hikal Limited has informed the Exchange about Transcript
[ 22] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-17)/Hikal Limited has informed the Exchange about Transcript
[ 23] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-17)/Hikal Limited has informed the Exchange about Transcript
[ 24] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-17)/Hikal Limited has informed the Exchange about Transcript
[ 25] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-10)/Solara Active Pharma Sciences Limited has informed the Exchange about Transcript of earnings call pertaining to unaudited financial results of the Company for the quarter and nine months ended December 31, 2025.
[ 26] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-10)/Solara Active Pharma Sciences Limited has informed the Exchange about Transcript of earnings call pertaining to unaudited financial results of the Company for the quarter and nine months ended December 31, 2025.
[ 27] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-10)/Solara Active Pharma Sciences Limited has informed the Exchange about Transcript of earnings call pertaining to unaudited financial results of the Company for the quarter and nine months ended December 31, 2025.
[ 28] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-16)/Orchid Pharma Limited has informed the Exchange about Transcript
[ 29] Press Release (2026-02-06)/Solara Active Pharma Sciences Limited has informed the exchange regarding the press release dated February 06, 2026, titled "Solara Q3'26 Performance."
[ 30] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-17)/Hikal Limited has informed the Exchange about Transcript
[ 31] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-17)/Hikal Limited has informed the Exchange about Transcript
[ 32] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-17)/Hikal Limited has informed the Exchange about Transcript
[ 33] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-17)/Hikal Limited has informed the Exchange about Transcript
[ 34] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-10)/Solara Active Pharma Sciences Limited has informed the Exchange about Transcript of earnings call pertaining to unaudited financial results of the Company for the quarter and nine months ended December 31, 2025.
[ 35] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-10)/Solara Active Pharma Sciences Limited has informed the Exchange about Transcript of earnings call pertaining to unaudited financial results of the Company for the quarter and nine months ended December 31, 2025.
[ 36] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-10)/Solara Active Pharma Sciences Limited has informed the Exchange about Transcript of earnings call pertaining to unaudited financial results of the Company for the quarter and nine months ended December 31, 2025.
[ 37] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-16)/Orchid Pharma Limited has informed the Exchange about Transcript
[ 38] Press Release (2026-02-06)/Solara Active Pharma Sciences Limited has informed the exchange regarding the press release dated February 06, 2026, titled "Solara Q3'26 Performance."
[ 39] Analysts/Institutional Investor Meet/Con. Call Updates (2025-11-19)/Natural Capsules Limited has informed the Exchange about Transcript
[ 40] Analysts/Institutional Investor Meet/Con. Call Updates (2025-11-19)/Natural Capsules Limited has informed the Exchange about Transcript
[ 41] Analysts/Institutional Investor Meet/Con. Call Updates (2025-11-19)/Natural Capsules Limited has informed the Exchange about Transcript
[ 42] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-17)/Hikal Limited has informed the Exchange about Transcript
[ 43] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-17)/Hikal Limited has informed the Exchange about Transcript
[ 44] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-17)/Hikal Limited has informed the Exchange about Transcript
[ 45] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-17)/Hikal Limited has informed the Exchange about Transcript
[ 46] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-10)/Solara Active Pharma Sciences Limited has informed the Exchange about Transcript of earnings call pertaining to unaudited financial results of the Company for the quarter and nine months ended December 31, 2025.
[ 47] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-10)/Solara Active Pharma Sciences Limited has informed the Exchange about Transcript of earnings call pertaining to unaudited financial results of the Company for the quarter and nine months ended December 31, 2025.
[ 48] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-10)/Solara Active Pharma Sciences Limited has informed the Exchange about Transcript of earnings call pertaining to unaudited financial results of the Company for the quarter and nine months ended December 31, 2025.
[ 49] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-16)/Orchid Pharma Limited has informed the Exchange about Transcript
[ 50] Press Release (2026-02-06)/Solara Active Pharma Sciences Limited has informed the exchange regarding the press release dated February 06, 2026, titled "Solara Q3'26 Performance."
[ 51] Analysts/Institutional Investor Meet/Con. Call Updates (2025-11-19)/Natural Capsules Limited has informed the Exchange about Transcript
[ 52] Analysts/Institutional Investor Meet/Con. Call Updates (2025-11-19)/Natural Capsules Limited has informed the Exchange about Transcript
[ 53] Analysts/Institutional Investor Meet/Con. Call Updates (2025-11-19)/Natural Capsules Limited has informed the Exchange about Transcript
[ 54] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-17)/Hikal Limited has informed the Exchange about Transcript
[ 55] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-17)/Hikal Limited has informed the Exchange about Transcript
[ 56] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-17)/Hikal Limited has informed the Exchange about Transcript
[ 57] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-17)/Hikal Limited has informed the Exchange about Transcript
[ 58] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-10)/Solara Active Pharma Sciences Limited has informed the Exchange about Transcript of earnings call pertaining to unaudited financial results of the Company for the quarter and nine months ended December 31, 2025.
[ 59] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-10)/Solara Active Pharma Sciences Limited has informed the Exchange about Transcript of earnings call pertaining to unaudited financial results of the Company for the quarter and nine months ended December 31, 2025.
[ 60] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-10)/Solara Active Pharma Sciences Limited has informed the Exchange about Transcript of earnings call pertaining to unaudited financial results of the Company for the quarter and nine months ended December 31, 2025.
[ 61] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-16)/Orchid Pharma Limited has informed the Exchange about Transcript
[ 62] Press Release (2026-02-06)/Solara Active Pharma Sciences Limited has informed the exchange regarding the press release dated February 06, 2026, titled "Solara Q3'26 Performance."
[ 63] Analysts/Institutional Investor Meet/Con. Call Updates (2025-11-19)/Natural Capsules Limited has informed the Exchange about Transcript
[ 64] Analysts/Institutional Investor Meet/Con. Call Updates (2025-11-19)/Natural Capsules Limited has informed the Exchange about Transcript
[ 65] Analysts/Institutional Investor Meet/Con. Call Updates (2025-11-19)/Natural Capsules Limited has informed the Exchange about Transcript
[ 66] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-12)/Marksans Pharma Limited transcript of Investors/Analyst meet on Q3 9M FY 26 Unaudited Financial Results held on February 06, 2026
[ 67] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-17)/Hikal Limited has informed the Exchange about Transcript
[ 68] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-17)/Hikal Limited has informed the Exchange about Transcript
[ 69] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-17)/Hikal Limited has informed the Exchange about Transcript
[ 70] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-17)/Hikal Limited has informed the Exchange about Transcript
[ 71] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-10)/Solara Active Pharma Sciences Limited has informed the Exchange about Transcript of earnings call pertaining to unaudited financial results of the Company for the quarter and nine months ended December 31, 2025.
[ 72] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-10)/Solara Active Pharma Sciences Limited has informed the Exchange about Transcript of earnings call pertaining to unaudited financial results of the Company for the quarter and nine months ended December 31, 2025.
[ 73] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-10)/Solara Active Pharma Sciences Limited has informed the Exchange about Transcript of earnings call pertaining to unaudited financial results of the Company for the quarter and nine months ended December 31, 2025.
[ 74] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-16)/Orchid Pharma Limited has informed the Exchange about Transcript
[ 75] Press Release (2026-02-06)/Solara Active Pharma Sciences Limited has informed the exchange regarding the press release dated February 06, 2026, titled "Solara Q3'26 Performance."
[ 76] Analysts/Institutional Investor Meet/Con. Call Updates (2025-11-19)/Natural Capsules Limited has informed the Exchange about Transcript
[ 77] Analysts/Institutional Investor Meet/Con. Call Updates (2025-11-19)/Natural Capsules Limited has informed the Exchange about Transcript
[ 78] Analysts/Institutional Investor Meet/Con. Call Updates (2025-11-19)/Natural Capsules Limited has informed the Exchange about Transcript
[ 79] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-12)/Marksans Pharma Limited transcript of Investors/Analyst meet on Q3 9M FY 26 Unaudited Financial Results held on February 06, 2026
[ 80] Analysts/Institutional Investor Meet/Con. Call Updates (2025-11-19)/Natural Capsules Limited has informed the Exchange about Transcript
[ 81] Analysts/Institutional Investor Meet/Con. Call Updates (2025-11-19)/Natural Capsules Limited has informed the Exchange about Transcript
[ 82] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-17)/Hikal Limited has informed the Exchange about Transcript
[ 83] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-17)/Hikal Limited has informed the Exchange about Transcript
[ 84] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-17)/Hikal Limited has informed the Exchange about Transcript
[ 85] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-17)/Hikal Limited has informed the Exchange about Transcript
[ 86] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-10)/Solara Active Pharma Sciences Limited has informed the Exchange about Transcript of earnings call pertaining to unaudited financial results of the Company for the quarter and nine months ended December 31, 2025.
[ 87] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-10)/Solara Active Pharma Sciences Limited has informed the Exchange about Transcript of earnings call pertaining to unaudited financial results of the Company for the quarter and nine months ended December 31, 2025.
[ 88] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-10)/Solara Active Pharma Sciences Limited has informed the Exchange about Transcript of earnings call pertaining to unaudited financial results of the Company for the quarter and nine months ended December 31, 2025.
[ 89] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-16)/Orchid Pharma Limited has informed the Exchange about Transcript
[ 90] Press Release (2026-02-06)/Solara Active Pharma Sciences Limited has informed the exchange regarding the press release dated February 06, 2026, titled "Solara Q3'26 Performance."
[ 91] Analysts/Institutional Investor Meet/Con. Call Updates (2025-11-19)/Natural Capsules Limited has informed the Exchange about Transcript
[ 92] Analysts/Institutional Investor Meet/Con. Call Updates (2025-11-19)/Natural Capsules Limited has informed the Exchange about Transcript
[ 93] Analysts/Institutional Investor Meet/Con. Call Updates (2025-11-19)/Natural Capsules Limited has informed the Exchange about Transcript
[ 94] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-12)/Marksans Pharma Limited transcript of Investors/Analyst meet on Q3 9M FY 26 Unaudited Financial Results held on February 06, 2026
[ 95] Analysts/Institutional Investor Meet/Con. Call Updates (2025-11-19)/Natural Capsules Limited has informed the Exchange about Transcript
[ 96] Analysts/Institutional Investor Meet/Con. Call Updates (2025-11-19)/Natural Capsules Limited has informed the Exchange about Transcript
[ 97] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-17)/Hikal Limited has informed the Exchange about Transcript
[ 98] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-17)/Hikal Limited has informed the Exchange about Transcript
[ 99] Investor Presentation (2026-02-13)/Natural Capsules Limited has informed the Exchange about Investor Presentation
[100] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-17)/Hikal Limited has informed the Exchange about Transcript
[101] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-17)/Hikal Limited has informed the Exchange about Transcript
[102] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-17)/Hikal Limited has informed the Exchange about Transcript
[103] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-17)/Hikal Limited has informed the Exchange about Transcript
[104] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-10)/Solara Active Pharma Sciences Limited has informed the Exchange about Transcript of earnings call pertaining to unaudited financial results of the Company for the quarter and nine months ended December 31, 2025.
[105] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-10)/Solara Active Pharma Sciences Limited has informed the Exchange about Transcript of earnings call pertaining to unaudited financial results of the Company for the quarter and nine months ended December 31, 2025.
[106] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-10)/Solara Active Pharma Sciences Limited has informed the Exchange about Transcript of earnings call pertaining to unaudited financial results of the Company for the quarter and nine months ended December 31, 2025.
[107] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-16)/Orchid Pharma Limited has informed the Exchange about Transcript
[108] Press Release (2026-02-06)/Solara Active Pharma Sciences Limited has informed the exchange regarding the press release dated February 06, 2026, titled "Solara Q3'26 Performance."
[109] Analysts/Institutional Investor Meet/Con. Call Updates (2025-11-19)/Natural Capsules Limited has informed the Exchange about Transcript
[110] Analysts/Institutional Investor Meet/Con. Call Updates (2025-11-19)/Natural Capsules Limited has informed the Exchange about Transcript
[111] Analysts/Institutional Investor Meet/Con. Call Updates (2025-11-19)/Natural Capsules Limited has informed the Exchange about Transcript
[112] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-12)/Marksans Pharma Limited transcript of Investors/Analyst meet on Q3 9M FY 26 Unaudited Financial Results held on February 06, 2026
[113] Analysts/Institutional Investor Meet/Con. Call Updates (2025-11-19)/Natural Capsules Limited has informed the Exchange about Transcript
[114] Analysts/Institutional Investor Meet/Con. Call Updates (2025-11-19)/Natural Capsules Limited has informed the Exchange about Transcript
[115] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-17)/Hikal Limited has informed the Exchange about Transcript
[116] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-17)/Hikal Limited has informed the Exchange about Transcript
[117] Investor Presentation (2026-02-13)/Natural Capsules Limited has informed the Exchange about Investor Presentation
[118] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-17)/Hikal Limited has informed the Exchange about Transcript
[119] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-17)/Hikal Limited has informed the Exchange about Transcript
[120] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-17)/Hikal Limited has informed the Exchange about Transcript
[121] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-17)/Hikal Limited has informed the Exchange about Transcript
[122] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-10)/Solara Active Pharma Sciences Limited has informed the Exchange about Transcript of earnings call pertaining to unaudited financial results of the Company for the quarter and nine months ended December 31, 2025.
[123] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-10)/Solara Active Pharma Sciences Limited has informed the Exchange about Transcript of earnings call pertaining to unaudited financial results of the Company for the quarter and nine months ended December 31, 2025.
[124] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-10)/Solara Active Pharma Sciences Limited has informed the Exchange about Transcript of earnings call pertaining to unaudited financial results of the Company for the quarter and nine months ended December 31, 2025.
[125] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-16)/Orchid Pharma Limited has informed the Exchange about Transcript
[126] Press Release (2026-02-06)/Solara Active Pharma Sciences Limited has informed the exchange regarding the press release dated February 06, 2026, titled "Solara Q3'26 Performance."
[127] Analysts/Institutional Investor Meet/Con. Call Updates (2025-11-19)/Natural Capsules Limited has informed the Exchange about Transcript
[128] Analysts/Institutional Investor Meet/Con. Call Updates (2025-11-19)/Natural Capsules Limited has informed the Exchange about Transcript
[129] Analysts/Institutional Investor Meet/Con. Call Updates (2025-11-19)/Natural Capsules Limited has informed the Exchange about Transcript
[130] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-12)/Marksans Pharma Limited transcript of Investors/Analyst meet on Q3 9M FY 26 Unaudited Financial Results held on February 06, 2026
[131] Analysts/Institutional Investor Meet/Con. Call Updates (2025-11-19)/Natural Capsules Limited has informed the Exchange about Transcript
[132] Analysts/Institutional Investor Meet/Con. Call Updates (2025-11-19)/Natural Capsules Limited has informed the Exchange about Transcript
[133] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-17)/Hikal Limited has informed the Exchange about Transcript
[134] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-17)/Hikal Limited has informed the Exchange about Transcript
[135] Investor Presentation (2026-02-13)/Natural Capsules Limited has informed the Exchange about Investor Presentation
[136] Analysts/Institutional Investor Meet/Con. Call Updates (2025-11-19)/Natural Capsules Limited has informed the Exchange about Transcript
[137] Analysts/Institutional Investor Meet/Con. Call Updates (2025-11-19)/Natural Capsules Limited has informed the Exchange about Transcript
[138] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-14)/Divi's Laboratories Limited has informed the Exchange about Transcript
[139] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-14)/Divi's Laboratories Limited has informed the Exchange about Transcript
[140] Investor Presentation (2026-01-22)/Kopran Limited has informed the Exchange about Investor Presentation
[141] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-17)/Hikal Limited has informed the Exchange about Transcript
[142] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-17)/Hikal Limited has informed the Exchange about Transcript
[143] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-17)/Hikal Limited has informed the Exchange about Transcript
[144] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-17)/Hikal Limited has informed the Exchange about Transcript
[145] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-10)/Solara Active Pharma Sciences Limited has informed the Exchange about Transcript of earnings call pertaining to unaudited financial results of the Company for the quarter and nine months ended December 31, 2025.
[146] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-10)/Solara Active Pharma Sciences Limited has informed the Exchange about Transcript of earnings call pertaining to unaudited financial results of the Company for the quarter and nine months ended December 31, 2025.
[147] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-10)/Solara Active Pharma Sciences Limited has informed the Exchange about Transcript of earnings call pertaining to unaudited financial results of the Company for the quarter and nine months ended December 31, 2025.
[148] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-16)/Orchid Pharma Limited has informed the Exchange about Transcript
[149] Press Release (2026-02-06)/Solara Active Pharma Sciences Limited has informed the exchange regarding the press release dated February 06, 2026, titled "Solara Q3'26 Performance."
[150] Analysts/Institutional Investor Meet/Con. Call Updates (2025-11-19)/Natural Capsules Limited has informed the Exchange about Transcript
[151] Analysts/Institutional Investor Meet/Con. Call Updates (2025-11-19)/Natural Capsules Limited has informed the Exchange about Transcript
[152] Analysts/Institutional Investor Meet/Con. Call Updates (2025-11-19)/Natural Capsules Limited has informed the Exchange about Transcript
[153] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-12)/Marksans Pharma Limited transcript of Investors/Analyst meet on Q3 9M FY 26 Unaudited Financial Results held on February 06, 2026
[154] Analysts/Institutional Investor Meet/Con. Call Updates (2025-11-19)/Natural Capsules Limited has informed the Exchange about Transcript
[155] Analysts/Institutional Investor Meet/Con. Call Updates (2025-11-19)/Natural Capsules Limited has informed the Exchange about Transcript
[156] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-17)/Hikal Limited has informed the Exchange about Transcript
[157] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-17)/Hikal Limited has informed the Exchange about Transcript
[158] Investor Presentation (2026-02-13)/Natural Capsules Limited has informed the Exchange about Investor Presentation
[159] Analysts/Institutional Investor Meet/Con. Call Updates (2025-11-19)/Natural Capsules Limited has informed the Exchange about Transcript
[160] Analysts/Institutional Investor Meet/Con. Call Updates (2025-11-19)/Natural Capsules Limited has informed the Exchange about Transcript
[161] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-14)/Divi's Laboratories Limited has informed the Exchange about Transcript
[162] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-14)/Divi's Laboratories Limited has informed the Exchange about Transcript
[163] Investor Presentation (2026-01-22)/Kopran Limited has informed the Exchange about Investor Presentation
[164] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-17)/Hikal Limited has informed the Exchange about Transcript
[165] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-17)/Hikal Limited has informed the Exchange about Transcript
[166] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-17)/Hikal Limited has informed the Exchange about Transcript
[167] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-17)/Hikal Limited has informed the Exchange about Transcript
[168] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-10)/Solara Active Pharma Sciences Limited has informed the Exchange about Transcript of earnings call pertaining to unaudited financial results of the Company for the quarter and nine months ended December 31, 2025.
[169] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-10)/Solara Active Pharma Sciences Limited has informed the Exchange about Transcript of earnings call pertaining to unaudited financial results of the Company for the quarter and nine months ended December 31, 2025.
[170] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-10)/Solara Active Pharma Sciences Limited has informed the Exchange about Transcript of earnings call pertaining to unaudited financial results of the Company for the quarter and nine months ended December 31, 2025.
[171] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-16)/Orchid Pharma Limited has informed the Exchange about Transcript
[172] Press Release (2026-02-06)/Solara Active Pharma Sciences Limited has informed the exchange regarding the press release dated February 06, 2026, titled "Solara Q3'26 Performance."
[173] Analysts/Institutional Investor Meet/Con. Call Updates (2025-11-19)/Natural Capsules Limited has informed the Exchange about Transcript
[174] Analysts/Institutional Investor Meet/Con. Call Updates (2025-11-19)/Natural Capsules Limited has informed the Exchange about Transcript
[175] Analysts/Institutional Investor Meet/Con. Call Updates (2025-11-19)/Natural Capsules Limited has informed the Exchange about Transcript
[176] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-12)/Marksans Pharma Limited transcript of Investors/Analyst meet on Q3 9M FY 26 Unaudited Financial Results held on February 06, 2026
[177] Analysts/Institutional Investor Meet/Con. Call Updates (2025-11-19)/Natural Capsules Limited has informed the Exchange about Transcript
[178] Analysts/Institutional Investor Meet/Con. Call Updates (2025-11-19)/Natural Capsules Limited has informed the Exchange about Transcript
[179] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-17)/Hikal Limited has informed the Exchange about Transcript
[180] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-17)/Hikal Limited has informed the Exchange about Transcript
[181] Investor Presentation (2026-02-13)/Natural Capsules Limited has informed the Exchange about Investor Presentation
[182] Analysts/Institutional Investor Meet/Con. Call Updates (2025-11-19)/Natural Capsules Limited has informed the Exchange about Transcript
[183] Analysts/Institutional Investor Meet/Con. Call Updates (2025-11-19)/Natural Capsules Limited has informed the Exchange about Transcript
[184] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-14)/Divi's Laboratories Limited has informed the Exchange about Transcript
[185] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-14)/Divi's Laboratories Limited has informed the Exchange about Transcript
[186] Investor Presentation (2026-01-22)/Kopran Limited has informed the Exchange about Investor Presentation
[187] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-17)/Hikal Limited has informed the Exchange about Transcript
[188] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-17)/Hikal Limited has informed the Exchange about Transcript
[189] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-17)/Hikal Limited has informed the Exchange about Transcript
[190] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-17)/Hikal Limited has informed the Exchange about Transcript
[191] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-10)/Solara Active Pharma Sciences Limited has informed the Exchange about Transcript of earnings call pertaining to unaudited financial results of the Company for the quarter and nine months ended December 31, 2025.
[192] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-10)/Solara Active Pharma Sciences Limited has informed the Exchange about Transcript of earnings call pertaining to unaudited financial results of the Company for the quarter and nine months ended December 31, 2025.
[193] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-10)/Solara Active Pharma Sciences Limited has informed the Exchange about Transcript of earnings call pertaining to unaudited financial results of the Company for the quarter and nine months ended December 31, 2025.
[194] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-16)/Orchid Pharma Limited has informed the Exchange about Transcript
[195] Press Release (2026-02-06)/Solara Active Pharma Sciences Limited has informed the exchange regarding the press release dated February 06, 2026, titled "Solara Q3'26 Performance."
[196] Analysts/Institutional Investor Meet/Con. Call Updates (2025-11-19)/Natural Capsules Limited has informed the Exchange about Transcript
[197] Analysts/Institutional Investor Meet/Con. Call Updates (2025-11-19)/Natural Capsules Limited has informed the Exchange about Transcript
[198] Analysts/Institutional Investor Meet/Con. Call Updates (2025-11-19)/Natural Capsules Limited has informed the Exchange about Transcript
[199] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-12)/Marksans Pharma Limited transcript of Investors/Analyst meet on Q3 9M FY 26 Unaudited Financial Results held on February 06, 2026
[200] Analysts/Institutional Investor Meet/Con. Call Updates (2025-11-19)/Natural Capsules Limited has informed the Exchange about Transcript
[201] Analysts/Institutional Investor Meet/Con. Call Updates (2025-11-19)/Natural Capsules Limited has informed the Exchange about Transcript
[202] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-17)/Hikal Limited has informed the Exchange about Transcript
[203] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-17)/Hikal Limited has informed the Exchange about Transcript
[204] Investor Presentation (2026-02-13)/Natural Capsules Limited has informed the Exchange about Investor Presentation
[205] Analysts/Institutional Investor Meet/Con. Call Updates (2025-11-19)/Natural Capsules Limited has informed the Exchange about Transcript
[206] Analysts/Institutional Investor Meet/Con. Call Updates (2025-11-19)/Natural Capsules Limited has informed the Exchange about Transcript
[207] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-14)/Divi's Laboratories Limited has informed the Exchange about Transcript
[208] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-14)/Divi's Laboratories Limited has informed the Exchange about Transcript
[209] Investor Presentation (2026-01-22)/Kopran Limited has informed the Exchange about Investor Presentation
[210] Analysts/Institutional Investor Meet/Con. Call Updates (2025-11-19)/Natural Capsules Limited has informed the Exchange about Transcript
[211] Analysts/Institutional Investor Meet/Con. Call Updates (2025-11-19)/Natural Capsules Limited has informed the Exchange about Transcript
[212] Analysts/Institutional Investor Meet/Con. Call Updates (2025-11-19)/Natural Capsules Limited has informed the Exchange about Transcript
[213] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-17)/Hikal Limited has informed the Exchange about Transcript
[214] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-17)/Hikal Limited has informed the Exchange about Transcript
[215] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-17)/Hikal Limited has informed the Exchange about Transcript
[216] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-17)/Hikal Limited has informed the Exchange about Transcript
[217] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-10)/Solara Active Pharma Sciences Limited has informed the Exchange about Transcript of earnings call pertaining to unaudited financial results of the Company for the quarter and nine months ended December 31, 2025.
[218] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-10)/Solara Active Pharma Sciences Limited has informed the Exchange about Transcript of earnings call pertaining to unaudited financial results of the Company for the quarter and nine months ended December 31, 2025.
[219] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-10)/Solara Active Pharma Sciences Limited has informed the Exchange about Transcript of earnings call pertaining to unaudited financial results of the Company for the quarter and nine months ended December 31, 2025.
[220] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-16)/Orchid Pharma Limited has informed the Exchange about Transcript
[221] Press Release (2026-02-06)/Solara Active Pharma Sciences Limited has informed the exchange regarding the press release dated February 06, 2026, titled "Solara Q3'26 Performance."
[222] Analysts/Institutional Investor Meet/Con. Call Updates (2025-11-19)/Natural Capsules Limited has informed the Exchange about Transcript
[223] Analysts/Institutional Investor Meet/Con. Call Updates (2025-11-19)/Natural Capsules Limited has informed the Exchange about Transcript
[224] Analysts/Institutional Investor Meet/Con. Call Updates (2025-11-19)/Natural Capsules Limited has informed the Exchange about Transcript
[225] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-12)/Marksans Pharma Limited transcript of Investors/Analyst meet on Q3 9M FY 26 Unaudited Financial Results held on February 06, 2026
[226] Analysts/Institutional Investor Meet/Con. Call Updates (2025-11-19)/Natural Capsules Limited has informed the Exchange about Transcript
[227] Analysts/Institutional Investor Meet/Con. Call Updates (2025-11-19)/Natural Capsules Limited has informed the Exchange about Transcript
[228] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-17)/Hikal Limited has informed the Exchange about Transcript
[229] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-17)/Hikal Limited has informed the Exchange about Transcript
[230] Investor Presentation (2026-02-13)/Natural Capsules Limited has informed the Exchange about Investor Presentation
[231] Analysts/Institutional Investor Meet/Con. Call Updates (2025-11-19)/Natural Capsules Limited has informed the Exchange about Transcript
[232] Analysts/Institutional Investor Meet/Con. Call Updates (2025-11-19)/Natural Capsules Limited has informed the Exchange about Transcript
[233] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-14)/Divi's Laboratories Limited has informed the Exchange about Transcript
[234] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-14)/Divi's Laboratories Limited has informed the Exchange about Transcript
[235] Investor Presentation (2026-01-22)/Kopran Limited has informed the Exchange about Investor Presentation
[236] Analysts/Institutional Investor Meet/Con. Call Updates (2025-11-19)/Natural Capsules Limited has informed the Exchange about Transcript
[237] Analysts/Institutional Investor Meet/Con. Call Updates (2025-11-19)/Natural Capsules Limited has informed the Exchange about Transcript
[238] Analysts/Institutional Investor Meet/Con. Call Updates (2025-11-19)/Natural Capsules Limited has informed the Exchange about Transcript
[239] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-17)/Hikal Limited has informed the Exchange about Transcript
[240] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-17)/Hikal Limited has informed the Exchange about Transcript
[241] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-17)/Hikal Limited has informed the Exchange about Transcript
[242] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-17)/Hikal Limited has informed the Exchange about Transcript
[243] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-10)/Solara Active Pharma Sciences Limited has informed the Exchange about Transcript of earnings call pertaining to unaudited financial results of the Company for the quarter and nine months ended December 31, 2025.
[244] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-10)/Solara Active Pharma Sciences Limited has informed the Exchange about Transcript of earnings call pertaining to unaudited financial results of the Company for the quarter and nine months ended December 31, 2025.
[245] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-10)/Solara Active Pharma Sciences Limited has informed the Exchange about Transcript of earnings call pertaining to unaudited financial results of the Company for the quarter and nine months ended December 31, 2025.
[246] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-16)/Orchid Pharma Limited has informed the Exchange about Transcript
[247] Press Release (2026-02-06)/Solara Active Pharma Sciences Limited has informed the exchange regarding the press release dated February 06, 2026, titled "Solara Q3'26 Performance."
[248] Analysts/Institutional Investor Meet/Con. Call Updates (2025-11-19)/Natural Capsules Limited has informed the Exchange about Transcript
[249] Analysts/Institutional Investor Meet/Con. Call Updates (2025-11-19)/Natural Capsules Limited has informed the Exchange about Transcript
[250] Analysts/Institutional Investor Meet/Con. Call Updates (2025-11-19)/Natural Capsules Limited has informed the Exchange about Transcript
[251] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-12)/Marksans Pharma Limited transcript of Investors/Analyst meet on Q3 9M FY 26 Unaudited Financial Results held on February 06, 2026
[252] Analysts/Institutional Investor Meet/Con. Call Updates (2025-11-19)/Natural Capsules Limited has informed the Exchange about Transcript
[253] Analysts/Institutional Investor Meet/Con. Call Updates (2025-11-19)/Natural Capsules Limited has informed the Exchange about Transcript
[254] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-17)/Hikal Limited has informed the Exchange about Transcript
[255] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-17)/Hikal Limited has informed the Exchange about Transcript
[256] Investor Presentation (2026-02-13)/Natural Capsules Limited has informed the Exchange about Investor Presentation
[257] Analysts/Institutional Investor Meet/Con. Call Updates (2025-11-19)/Natural Capsules Limited has informed the Exchange about Transcript
[258] Analysts/Institutional Investor Meet/Con. Call Updates (2025-11-19)/Natural Capsules Limited has informed the Exchange about Transcript
[259] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-14)/Divi's Laboratories Limited has informed the Exchange about Transcript
[260] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-14)/Divi's Laboratories Limited has informed the Exchange about Transcript
[261] Investor Presentation (2026-01-22)/Kopran Limited has informed the Exchange about Investor Presentation
[262] Analysts/Institutional Investor Meet/Con. Call Updates (2025-11-19)/Natural Capsules Limited has informed the Exchange about Transcript
[263] Analysts/Institutional Investor Meet/Con. Call Updates (2025-11-19)/Natural Capsules Limited has informed the Exchange about Transcript
[264] Analysts/Institutional Investor Meet/Con. Call Updates (2025-11-19)/Natural Capsules Limited has informed the Exchange about Transcript
[265] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-17)/Hikal Limited has informed the Exchange about Transcript
[266] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-17)/Hikal Limited has informed the Exchange about Transcript
[267] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-17)/Hikal Limited has informed the Exchange about Transcript
[268] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-17)/Hikal Limited has informed the Exchange about Transcript
[269] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-10)/Solara Active Pharma Sciences Limited has informed the Exchange about Transcript of earnings call pertaining to unaudited financial results of the Company for the quarter and nine months ended December 31, 2025.
[270] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-10)/Solara Active Pharma Sciences Limited has informed the Exchange about Transcript of earnings call pertaining to unaudited financial results of the Company for the quarter and nine months ended December 31, 2025.
[271] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-10)/Solara Active Pharma Sciences Limited has informed the Exchange about Transcript of earnings call pertaining to unaudited financial results of the Company for the quarter and nine months ended December 31, 2025.
[272] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-16)/Orchid Pharma Limited has informed the Exchange about Transcript
[273] Press Release (2026-02-06)/Solara Active Pharma Sciences Limited has informed the exchange regarding the press release dated February 06, 2026, titled "Solara Q3'26 Performance."
[274] Analysts/Institutional Investor Meet/Con. Call Updates (2025-11-19)/Natural Capsules Limited has informed the Exchange about Transcript
[275] Analysts/Institutional Investor Meet/Con. Call Updates (2025-11-19)/Natural Capsules Limited has informed the Exchange about Transcript
[276] Analysts/Institutional Investor Meet/Con. Call Updates (2025-11-19)/Natural Capsules Limited has informed the Exchange about Transcript
[277] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-12)/Marksans Pharma Limited transcript of Investors/Analyst meet on Q3 9M FY 26 Unaudited Financial Results held on February 06, 2026
[278] Analysts/Institutional Investor Meet/Con. Call Updates (2025-11-19)/Natural Capsules Limited has informed the Exchange about Transcript
[279] Analysts/Institutional Investor Meet/Con. Call Updates (2025-11-19)/Natural Capsules Limited has informed the Exchange about Transcript
[280] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-17)/Hikal Limited has informed the Exchange about Transcript
[281] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-17)/Hikal Limited has informed the Exchange about Transcript
[282] Investor Presentation (2026-02-13)/Natural Capsules Limited has informed the Exchange about Investor Presentation
[283] Analysts/Institutional Investor Meet/Con. Call Updates (2025-11-19)/Natural Capsules Limited has informed the Exchange about Transcript
[284] Analysts/Institutional Investor Meet/Con. Call Updates (2025-11-19)/Natural Capsules Limited has informed the Exchange about Transcript
[285] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-14)/Divi's Laboratories Limited has informed the Exchange about Transcript
[286] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-14)/Divi's Laboratories Limited has informed the Exchange about Transcript
[287] Investor Presentation (2026-01-22)/Kopran Limited has informed the Exchange about Investor Presentation
[288] Analysts/Institutional Investor Meet/Con. Call Updates (2025-11-19)/Natural Capsules Limited has informed the Exchange about Transcript
[289] Analysts/Institutional Investor Meet/Con. Call Updates (2025-11-19)/Natural Capsules Limited has informed the Exchange about Transcript
[290] Analysts/Institutional Investor Meet/Con. Call Updates (2025-11-19)/Natural Capsules Limited has informed the Exchange about Transcript
[291] Press Release (2026-02-06)/Jubilant Pharmova Limited has informed the Exchange regarding a press release dated February 06, 2026, titled "Press Release alongwith Earnings Presentation on the financials and operational performance of the Company for the quarter and nine months ended December 31, 2025".
[292] Press Release (2026-02-06)/Jubilant Pharmova Limited has informed the Exchange regarding a press release dated February 06, 2026, titled "Press Release alongwith Earnings Presentation on the financials and operational performance of the Company for the quarter and nine months ended December 31, 2025".
[293] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-17)/Hikal Limited has informed the Exchange about Transcript
[294] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-17)/Hikal Limited has informed the Exchange about Transcript
[295] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-17)/Hikal Limited has informed the Exchange about Transcript
[296] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-17)/Hikal Limited has informed the Exchange about Transcript
[297] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-17)/Hikal Limited has informed the Exchange about Transcript
[298] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-17)/Hikal Limited has informed the Exchange about Transcript
[299] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-10)/Solara Active Pharma Sciences Limited has informed the Exchange about Transcript of earnings call pertaining to unaudited financial results of the Company for the quarter and nine months ended December 31, 2025.
[300] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-10)/Solara Active Pharma Sciences Limited has informed the Exchange about Transcript of earnings call pertaining to unaudited financial results of the Company for the quarter and nine months ended December 31, 2025.
[301] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-10)/Solara Active Pharma Sciences Limited has informed the Exchange about Transcript of earnings call pertaining to unaudited financial results of the Company for the quarter and nine months ended December 31, 2025.
[302] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-16)/Orchid Pharma Limited has informed the Exchange about Transcript
[303] Press Release (2026-02-06)/Solara Active Pharma Sciences Limited has informed the exchange regarding the press release dated February 06, 2026, titled "Solara Q3'26 Performance."
[304] Analysts/Institutional Investor Meet/Con. Call Updates (2025-11-19)/Natural Capsules Limited has informed the Exchange about Transcript
[305] Analysts/Institutional Investor Meet/Con. Call Updates (2025-11-19)/Natural Capsules Limited has informed the Exchange about Transcript
[306] Analysts/Institutional Investor Meet/Con. Call Updates (2025-11-19)/Natural Capsules Limited has informed the Exchange about Transcript
[307] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-12)/Marksans Pharma Limited transcript of Investors/Analyst meet on Q3 9M FY 26 Unaudited Financial Results held on February 06, 2026
[308] Analysts/Institutional Investor Meet/Con. Call Updates (2025-11-19)/Natural Capsules Limited has informed the Exchange about Transcript
[309] Analysts/Institutional Investor Meet/Con. Call Updates (2025-11-19)/Natural Capsules Limited has informed the Exchange about Transcript
[310] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-17)/Hikal Limited has informed the Exchange about Transcript
[311] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-17)/Hikal Limited has informed the Exchange about Transcript
[312] Investor Presentation (2026-02-13)/Natural Capsules Limited has informed the Exchange about Investor Presentation
[313] Analysts/Institutional Investor Meet/Con. Call Updates (2025-11-19)/Natural Capsules Limited has informed the Exchange about Transcript
[314] Analysts/Institutional Investor Meet/Con. Call Updates (2025-11-19)/Natural Capsules Limited has informed the Exchange about Transcript
[315] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-14)/Divi's Laboratories Limited has informed the Exchange about Transcript
[316] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-14)/Divi's Laboratories Limited has informed the Exchange about Transcript
[317] Investor Presentation (2026-01-22)/Kopran Limited has informed the Exchange about Investor Presentation
[318] Analysts/Institutional Investor Meet/Con. Call Updates (2025-11-19)/Natural Capsules Limited has informed the Exchange about Transcript
[319] Analysts/Institutional Investor Meet/Con. Call Updates (2025-11-19)/Natural Capsules Limited has informed the Exchange about Transcript
[320] Analysts/Institutional Investor Meet/Con. Call Updates (2025-11-19)/Natural Capsules Limited has informed the Exchange about Transcript
[321] Press Release (2026-02-06)/Jubilant Pharmova Limited has informed the Exchange regarding a press release dated February 06, 2026, titled "Press Release alongwith Earnings Presentation on the financials and operational performance of the Company for the quarter and nine months ended December 31, 2025".
[322] Press Release (2026-02-06)/Jubilant Pharmova Limited has informed the Exchange regarding a press release dated February 06, 2026, titled "Press Release alongwith Earnings Presentation on the financials and operational performance of the Company for the quarter and nine months ended December 31, 2025".
[323] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-17)/Hikal Limited has informed the Exchange about Transcript
[324] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-17)/Hikal Limited has informed the Exchange about Transcript
[325] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-17)/Hikal Limited has informed the Exchange about Transcript
[326] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-17)/Hikal Limited has informed the Exchange about Transcript
[327] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-17)/Hikal Limited has informed the Exchange about Transcript
[328] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-17)/Hikal Limited has informed the Exchange about Transcript
[329] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-10)/Solara Active Pharma Sciences Limited has informed the Exchange about Transcript of earnings call pertaining to unaudited financial results of the Company for the quarter and nine months ended December 31, 2025.
[330] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-10)/Solara Active Pharma Sciences Limited has informed the Exchange about Transcript of earnings call pertaining to unaudited financial results of the Company for the quarter and nine months ended December 31, 2025.
[331] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-10)/Solara Active Pharma Sciences Limited has informed the Exchange about Transcript of earnings call pertaining to unaudited financial results of the Company for the quarter and nine months ended December 31, 2025.
[332] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-16)/Orchid Pharma Limited has informed the Exchange about Transcript
[333] Press Release (2026-02-06)/Solara Active Pharma Sciences Limited has informed the exchange regarding the press release dated February 06, 2026, titled "Solara Q3'26 Performance."
[334] Analysts/Institutional Investor Meet/Con. Call Updates (2025-11-19)/Natural Capsules Limited has informed the Exchange about Transcript
[335] Analysts/Institutional Investor Meet/Con. Call Updates (2025-11-19)/Natural Capsules Limited has informed the Exchange about Transcript
[336] Analysts/Institutional Investor Meet/Con. Call Updates (2025-11-19)/Natural Capsules Limited has informed the Exchange about Transcript
[337] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-12)/Marksans Pharma Limited transcript of Investors/Analyst meet on Q3 9M FY 26 Unaudited Financial Results held on February 06, 2026
[338] Analysts/Institutional Investor Meet/Con. Call Updates (2025-11-19)/Natural Capsules Limited has informed the Exchange about Transcript
[339] Analysts/Institutional Investor Meet/Con. Call Updates (2025-11-19)/Natural Capsules Limited has informed the Exchange about Transcript
[340] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-17)/Hikal Limited has informed the Exchange about Transcript
[341] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-17)/Hikal Limited has informed the Exchange about Transcript
[342] Investor Presentation (2026-02-13)/Natural Capsules Limited has informed the Exchange about Investor Presentation
[343] Analysts/Institutional Investor Meet/Con. Call Updates (2025-11-19)/Natural Capsules Limited has informed the Exchange about Transcript
[344] Analysts/Institutional Investor Meet/Con. Call Updates (2025-11-19)/Natural Capsules Limited has informed the Exchange about Transcript
[345] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-14)/Divi's Laboratories Limited has informed the Exchange about Transcript
[346] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-14)/Divi's Laboratories Limited has informed the Exchange about Transcript
[347] Investor Presentation (2026-01-22)/Kopran Limited has informed the Exchange about Investor Presentation
[348] Analysts/Institutional Investor Meet/Con. Call Updates (2025-11-19)/Natural Capsules Limited has informed the Exchange about Transcript
[349] Analysts/Institutional Investor Meet/Con. Call Updates (2025-11-19)/Natural Capsules Limited has informed the Exchange about Transcript
[350] Analysts/Institutional Investor Meet/Con. Call Updates (2025-11-19)/Natural Capsules Limited has informed the Exchange about Transcript
[351] Press Release (2026-02-06)/Jubilant Pharmova Limited has informed the Exchange regarding a press release dated February 06, 2026, titled "Press Release alongwith Earnings Presentation on the financials and operational performance of the Company for the quarter and nine months ended December 31, 2025".
[352] Press Release (2026-02-06)/Jubilant Pharmova Limited has informed the Exchange regarding a press release dated February 06, 2026, titled "Press Release alongwith Earnings Presentation on the financials and operational performance of the Company for the quarter and nine months ended December 31, 2025".
[353] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-17)/Hikal Limited has informed the Exchange about Transcript
[354] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-17)/Hikal Limited has informed the Exchange about Transcript
[355] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-17)/Hikal Limited has informed the Exchange about Transcript
[356] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-17)/Hikal Limited has informed the Exchange about Transcript
[357] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-17)/Hikal Limited has informed the Exchange about Transcript
[358] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-17)/Hikal Limited has informed the Exchange about Transcript
[359] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-17)/Hikal Limited has informed the Exchange about Transcript
[360] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-17)/Hikal Limited has informed the Exchange about Transcript
[361] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-17)/Hikal Limited has informed the Exchange about Transcript
[362] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-10)/Solara Active Pharma Sciences Limited has informed the Exchange about Transcript of earnings call pertaining to unaudited financial results of the Company for the quarter and nine months ended December 31, 2025.
[363] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-10)/Solara Active Pharma Sciences Limited has informed the Exchange about Transcript of earnings call pertaining to unaudited financial results of the Company for the quarter and nine months ended December 31, 2025.
[364] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-10)/Solara Active Pharma Sciences Limited has informed the Exchange about Transcript of earnings call pertaining to unaudited financial results of the Company for the quarter and nine months ended December 31, 2025.
[365] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-16)/Orchid Pharma Limited has informed the Exchange about Transcript
[366] Press Release (2026-02-06)/Solara Active Pharma Sciences Limited has informed the exchange regarding the press release dated February 06, 2026, titled "Solara Q3'26 Performance."
[367] Analysts/Institutional Investor Meet/Con. Call Updates (2025-11-19)/Natural Capsules Limited has informed the Exchange about Transcript
[368] Analysts/Institutional Investor Meet/Con. Call Updates (2025-11-19)/Natural Capsules Limited has informed the Exchange about Transcript
[369] Analysts/Institutional Investor Meet/Con. Call Updates (2025-11-19)/Natural Capsules Limited has informed the Exchange about Transcript
[370] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-12)/Marksans Pharma Limited transcript of Investors/Analyst meet on Q3 9M FY 26 Unaudited Financial Results held on February 06, 2026
[371] Analysts/Institutional Investor Meet/Con. Call Updates (2025-11-19)/Natural Capsules Limited has informed the Exchange about Transcript
[372] Analysts/Institutional Investor Meet/Con. Call Updates (2025-11-19)/Natural Capsules Limited has informed the Exchange about Transcript
[373] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-17)/Hikal Limited has informed the Exchange about Transcript
[374] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-17)/Hikal Limited has informed the Exchange about Transcript
[375] Investor Presentation (2026-02-13)/Natural Capsules Limited has informed the Exchange about Investor Presentation
[376] Analysts/Institutional Investor Meet/Con. Call Updates (2025-11-19)/Natural Capsules Limited has informed the Exchange about Transcript
[377] Analysts/Institutional Investor Meet/Con. Call Updates (2025-11-19)/Natural Capsules Limited has informed the Exchange about Transcript
[378] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-14)/Divi's Laboratories Limited has informed the Exchange about Transcript
[379] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-14)/Divi's Laboratories Limited has informed the Exchange about Transcript
[380] Investor Presentation (2026-01-22)/Kopran Limited has informed the Exchange about Investor Presentation
[381] Analysts/Institutional Investor Meet/Con. Call Updates (2025-11-19)/Natural Capsules Limited has informed the Exchange about Transcript
[382] Analysts/Institutional Investor Meet/Con. Call Updates (2025-11-19)/Natural Capsules Limited has informed the Exchange about Transcript
[383] Analysts/Institutional Investor Meet/Con. Call Updates (2025-11-19)/Natural Capsules Limited has informed the Exchange about Transcript
[384] Press Release (2026-02-06)/Jubilant Pharmova Limited has informed the Exchange regarding a press release dated February 06, 2026, titled "Press Release alongwith Earnings Presentation on the financials and operational performance of the Company for the quarter and nine months ended December 31, 2025".
[385] Press Release (2026-02-06)/Jubilant Pharmova Limited has informed the Exchange regarding a press release dated February 06, 2026, titled "Press Release alongwith Earnings Presentation on the financials and operational performance of the Company for the quarter and nine months ended December 31, 2025".
[386] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-17)/Hikal Limited has informed the Exchange about Transcript
[387] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-17)/Hikal Limited has informed the Exchange about Transcript
[388] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-17)/Hikal Limited has informed the Exchange about Transcript
[389] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-17)/Hikal Limited has informed the Exchange about Transcript
[390] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-17)/Hikal Limited has informed the Exchange about Transcript
[391] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-17)/Hikal Limited has informed the Exchange about Transcript
[392] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-17)/Hikal Limited has informed the Exchange about Transcript
[393] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-17)/Hikal Limited has informed the Exchange about Transcript
[394] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-17)/Hikal Limited has informed the Exchange about Transcript
[395] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-17)/Hikal Limited has informed the Exchange about Transcript
[396] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-10)/Solara Active Pharma Sciences Limited has informed the Exchange about Transcript of earnings call pertaining to unaudited financial results of the Company for the quarter and nine months ended December 31, 2025.
[397] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-10)/Solara Active Pharma Sciences Limited has informed the Exchange about Transcript of earnings call pertaining to unaudited financial results of the Company for the quarter and nine months ended December 31, 2025.
[398] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-10)/Solara Active Pharma Sciences Limited has informed the Exchange about Transcript of earnings call pertaining to unaudited financial results of the Company for the quarter and nine months ended December 31, 2025.
[399] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-16)/Orchid Pharma Limited has informed the Exchange about Transcript
[400] Press Release (2026-02-06)/Solara Active Pharma Sciences Limited has informed the exchange regarding the press release dated February 06, 2026, titled "Solara Q3'26 Performance."
[401] Analysts/Institutional Investor Meet/Con. Call Updates (2025-11-19)/Natural Capsules Limited has informed the Exchange about Transcript
[402] Analysts/Institutional Investor Meet/Con. Call Updates (2025-11-19)/Natural Capsules Limited has informed the Exchange about Transcript
[403] Analysts/Institutional Investor Meet/Con. Call Updates (2025-11-19)/Natural Capsules Limited has informed the Exchange about Transcript
[404] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-12)/Marksans Pharma Limited transcript of Investors/Analyst meet on Q3 9M FY 26 Unaudited Financial Results held on February 06, 2026
[405] Analysts/Institutional Investor Meet/Con. Call Updates (2025-11-19)/Natural Capsules Limited has informed the Exchange about Transcript
[406] Analysts/Institutional Investor Meet/Con. Call Updates (2025-11-19)/Natural Capsules Limited has informed the Exchange about Transcript
[407] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-17)/Hikal Limited has informed the Exchange about Transcript
[408] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-17)/Hikal Limited has informed the Exchange about Transcript
[409] Investor Presentation (2026-02-13)/Natural Capsules Limited has informed the Exchange about Investor Presentation
[410] Analysts/Institutional Investor Meet/Con. Call Updates (2025-11-19)/Natural Capsules Limited has informed the Exchange about Transcript
[411] Analysts/Institutional Investor Meet/Con. Call Updates (2025-11-19)/Natural Capsules Limited has informed the Exchange about Transcript
[412] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-14)/Divi's Laboratories Limited has informed the Exchange about Transcript
[413] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-14)/Divi's Laboratories Limited has informed the Exchange about Transcript
[414] Investor Presentation (2026-01-22)/Kopran Limited has informed the Exchange about Investor Presentation
[415] Analysts/Institutional Investor Meet/Con. Call Updates (2025-11-19)/Natural Capsules Limited has informed the Exchange about Transcript
[416] Analysts/Institutional Investor Meet/Con. Call Updates (2025-11-19)/Natural Capsules Limited has informed the Exchange about Transcript
[417] Analysts/Institutional Investor Meet/Con. Call Updates (2025-11-19)/Natural Capsules Limited has informed the Exchange about Transcript
[418] Press Release (2026-02-06)/Jubilant Pharmova Limited has informed the Exchange regarding a press release dated February 06, 2026, titled "Press Release alongwith Earnings Presentation on the financials and operational performance of the Company for the quarter and nine months ended December 31, 2025".
[419] Press Release (2026-02-06)/Jubilant Pharmova Limited has informed the Exchange regarding a press release dated February 06, 2026, titled "Press Release alongwith Earnings Presentation on the financials and operational performance of the Company for the quarter and nine months ended December 31, 2025".
[420] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-17)/Hikal Limited has informed the Exchange about Transcript
[421] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-17)/Hikal Limited has informed the Exchange about Transcript
[422] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-17)/Hikal Limited has informed the Exchange about Transcript
[423] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-17)/Hikal Limited has informed the Exchange about Transcript
[424] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-17)/Hikal Limited has informed the Exchange about Transcript
[425] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-17)/Hikal Limited has informed the Exchange about Transcript
[426] Press Release (2026-02-06)/Jubilant Pharmova Limited has informed the Exchange regarding a press release dated February 06, 2026, titled "Press Release alongwith Earnings Presentation on the financials and operational performance of the Company for the quarter and nine months ended December 31, 2025".
[427] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-10)/Solara Active Pharma Sciences Limited has informed the Exchange about Transcript of earnings call pertaining to unaudited financial results of the Company for the quarter and nine months ended December 31, 2025.
[428] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-17)/Hikal Limited has informed the Exchange about Transcript
[429] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-17)/Hikal Limited has informed the Exchange about Transcript
[430] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-17)/Hikal Limited has informed the Exchange about Transcript
[431] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-17)/Hikal Limited has informed the Exchange about Transcript
[432] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-10)/Solara Active Pharma Sciences Limited has informed the Exchange about Transcript of earnings call pertaining to unaudited financial results of the Company for the quarter and nine months ended December 31, 2025.
[433] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-10)/Solara Active Pharma Sciences Limited has informed the Exchange about Transcript of earnings call pertaining to unaudited financial results of the Company for the quarter and nine months ended December 31, 2025.
[434] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-10)/Solara Active Pharma Sciences Limited has informed the Exchange about Transcript of earnings call pertaining to unaudited financial results of the Company for the quarter and nine months ended December 31, 2025.
[435] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-16)/Orchid Pharma Limited has informed the Exchange about Transcript
[436] Press Release (2026-02-06)/Solara Active Pharma Sciences Limited has informed the exchange regarding the press release dated February 06, 2026, titled "Solara Q3'26 Performance."
[437] Analysts/Institutional Investor Meet/Con. Call Updates (2025-11-19)/Natural Capsules Limited has informed the Exchange about Transcript
[438] Analysts/Institutional Investor Meet/Con. Call Updates (2025-11-19)/Natural Capsules Limited has informed the Exchange about Transcript
[439] Analysts/Institutional Investor Meet/Con. Call Updates (2025-11-19)/Natural Capsules Limited has informed the Exchange about Transcript
[440] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-12)/Marksans Pharma Limited transcript of Investors/Analyst meet on Q3 9M FY 26 Unaudited Financial Results held on February 06, 2026
[441] Analysts/Institutional Investor Meet/Con. Call Updates (2025-11-19)/Natural Capsules Limited has informed the Exchange about Transcript
[442] Analysts/Institutional Investor Meet/Con. Call Updates (2025-11-19)/Natural Capsules Limited has informed the Exchange about Transcript
[443] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-17)/Hikal Limited has informed the Exchange about Transcript
[444] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-17)/Hikal Limited has informed the Exchange about Transcript
[445] Investor Presentation (2026-02-13)/Natural Capsules Limited has informed the Exchange about Investor Presentation
[446] Analysts/Institutional Investor Meet/Con. Call Updates (2025-11-19)/Natural Capsules Limited has informed the Exchange about Transcript
[447] Analysts/Institutional Investor Meet/Con. Call Updates (2025-11-19)/Natural Capsules Limited has informed the Exchange about Transcript
[448] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-14)/Divi's Laboratories Limited has informed the Exchange about Transcript
[449] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-14)/Divi's Laboratories Limited has informed the Exchange about Transcript
[450] Investor Presentation (2026-01-22)/Kopran Limited has informed the Exchange about Investor Presentation
[451] Analysts/Institutional Investor Meet/Con. Call Updates (2025-11-19)/Natural Capsules Limited has informed the Exchange about Transcript
[452] Analysts/Institutional Investor Meet/Con. Call Updates (2025-11-19)/Natural Capsules Limited has informed the Exchange about Transcript
[453] Analysts/Institutional Investor Meet/Con. Call Updates (2025-11-19)/Natural Capsules Limited has informed the Exchange about Transcript
[454] Press Release (2026-02-06)/Jubilant Pharmova Limited has informed the Exchange regarding a press release dated February 06, 2026, titled "Press Release alongwith Earnings Presentation on the financials and operational performance of the Company for the quarter and nine months ended December 31, 2025".
[455] Press Release (2026-02-06)/Jubilant Pharmova Limited has informed the Exchange regarding a press release dated February 06, 2026, titled "Press Release alongwith Earnings Presentation on the financials and operational performance of the Company for the quarter and nine months ended December 31, 2025".
[456] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-17)/Hikal Limited has informed the Exchange about Transcript
[457] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-17)/Hikal Limited has informed the Exchange about Transcript
[458] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-17)/Hikal Limited has informed the Exchange about Transcript
[459] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-17)/Hikal Limited has informed the Exchange about Transcript
[460] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-17)/Hikal Limited has informed the Exchange about Transcript
[461] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-17)/Hikal Limited has informed the Exchange about Transcript
[462] Press Release (2026-02-06)/Jubilant Pharmova Limited has informed the Exchange regarding a press release dated February 06, 2026, titled "Press Release alongwith Earnings Presentation on the financials and operational performance of the Company for the quarter and nine months ended December 31, 2025".
[463] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-10)/Solara Active Pharma Sciences Limited has informed the Exchange about Transcript of earnings call pertaining to unaudited financial results of the Company for the quarter and nine months ended December 31, 2025.
[464] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-10)/Solara Active Pharma Sciences Limited has informed the Exchange about Transcript of earnings call pertaining to unaudited financial results of the Company for the quarter and nine months ended December 31, 2025.
[465] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-17)/Hikal Limited has informed the Exchange about Transcript
[466] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-17)/Hikal Limited has informed the Exchange about Transcript
[467] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-17)/Hikal Limited has informed the Exchange about Transcript
[468] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-17)/Hikal Limited has informed the Exchange about Transcript
[469] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-10)/Solara Active Pharma Sciences Limited has informed the Exchange about Transcript of earnings call pertaining to unaudited financial results of the Company for the quarter and nine months ended December 31, 2025.
[470] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-10)/Solara Active Pharma Sciences Limited has informed the Exchange about Transcript of earnings call pertaining to unaudited financial results of the Company for the quarter and nine months ended December 31, 2025.
[471] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-10)/Solara Active Pharma Sciences Limited has informed the Exchange about Transcript of earnings call pertaining to unaudited financial results of the Company for the quarter and nine months ended December 31, 2025.
[472] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-16)/Orchid Pharma Limited has informed the Exchange about Transcript
[473] Press Release (2026-02-06)/Solara Active Pharma Sciences Limited has informed the exchange regarding the press release dated February 06, 2026, titled "Solara Q3'26 Performance."
[474] Analysts/Institutional Investor Meet/Con. Call Updates (2025-11-19)/Natural Capsules Limited has informed the Exchange about Transcript
[475] Analysts/Institutional Investor Meet/Con. Call Updates (2025-11-19)/Natural Capsules Limited has informed the Exchange about Transcript
[476] Analysts/Institutional Investor Meet/Con. Call Updates (2025-11-19)/Natural Capsules Limited has informed the Exchange about Transcript
[477] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-12)/Marksans Pharma Limited transcript of Investors/Analyst meet on Q3 9M FY 26 Unaudited Financial Results held on February 06, 2026
[478] Analysts/Institutional Investor Meet/Con. Call Updates (2025-11-19)/Natural Capsules Limited has informed the Exchange about Transcript
[479] Analysts/Institutional Investor Meet/Con. Call Updates (2025-11-19)/Natural Capsules Limited has informed the Exchange about Transcript
[480] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-17)/Hikal Limited has informed the Exchange about Transcript
[481] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-17)/Hikal Limited has informed the Exchange about Transcript
[482] Investor Presentation (2026-02-13)/Natural Capsules Limited has informed the Exchange about Investor Presentation
[483] Analysts/Institutional Investor Meet/Con. Call Updates (2025-11-19)/Natural Capsules Limited has informed the Exchange about Transcript
[484] Analysts/Institutional Investor Meet/Con. Call Updates (2025-11-19)/Natural Capsules Limited has informed the Exchange about Transcript
[485] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-14)/Divi's Laboratories Limited has informed the Exchange about Transcript
[486] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-14)/Divi's Laboratories Limited has informed the Exchange about Transcript
[487] Investor Presentation (2026-01-22)/Kopran Limited has informed the Exchange about Investor Presentation
[488] Analysts/Institutional Investor Meet/Con. Call Updates (2025-11-19)/Natural Capsules Limited has informed the Exchange about Transcript
[489] Analysts/Institutional Investor Meet/Con. Call Updates (2025-11-19)/Natural Capsules Limited has informed the Exchange about Transcript
[490] Analysts/Institutional Investor Meet/Con. Call Updates (2025-11-19)/Natural Capsules Limited has informed the Exchange about Transcript
[491] Press Release (2026-02-06)/Jubilant Pharmova Limited has informed the Exchange regarding a press release dated February 06, 2026, titled "Press Release alongwith Earnings Presentation on the financials and operational performance of the Company for the quarter and nine months ended December 31, 2025".
[492] Press Release (2026-02-06)/Jubilant Pharmova Limited has informed the Exchange regarding a press release dated February 06, 2026, titled "Press Release alongwith Earnings Presentation on the financials and operational performance of the Company for the quarter and nine months ended December 31, 2025".
[493] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-17)/Hikal Limited has informed the Exchange about Transcript
[494] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-17)/Hikal Limited has informed the Exchange about Transcript
[495] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-17)/Hikal Limited has informed the Exchange about Transcript
[496] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-17)/Hikal Limited has informed the Exchange about Transcript
[497] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-17)/Hikal Limited has informed the Exchange about Transcript
[498] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-17)/Hikal Limited has informed the Exchange about Transcript
[499] Press Release (2026-02-06)/Jubilant Pharmova Limited has informed the Exchange regarding a press release dated February 06, 2026, titled "Press Release alongwith Earnings Presentation on the financials and operational performance of the Company for the quarter and nine months ended December 31, 2025".
[500] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-10)/Solara Active Pharma Sciences Limited has informed the Exchange about Transcript of earnings call pertaining to unaudited financial results of the Company for the quarter and nine months ended December 31, 2025.
[501] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-10)/Solara Active Pharma Sciences Limited has informed the Exchange about Transcript of earnings call pertaining to unaudited financial results of the Company for the quarter and nine months ended December 31, 2025.
[502] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-17)/Hikal Limited has informed the Exchange about Transcript
[503] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-17)/Hikal Limited has informed the Exchange about Transcript
[504] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-17)/Hikal Limited has informed the Exchange about Transcript
[505] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-17)/Hikal Limited has informed the Exchange about Transcript
[506] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-10)/Solara Active Pharma Sciences Limited has informed the Exchange about Transcript of earnings call pertaining to unaudited financial results of the Company for the quarter and nine months ended December 31, 2025.
[507] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-10)/Solara Active Pharma Sciences Limited has informed the Exchange about Transcript of earnings call pertaining to unaudited financial results of the Company for the quarter and nine months ended December 31, 2025.
[508] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-10)/Solara Active Pharma Sciences Limited has informed the Exchange about Transcript of earnings call pertaining to unaudited financial results of the Company for the quarter and nine months ended December 31, 2025.
[509] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-16)/Orchid Pharma Limited has informed the Exchange about Transcript
[510] Press Release (2026-02-06)/Solara Active Pharma Sciences Limited has informed the exchange regarding the press release dated February 06, 2026, titled "Solara Q3'26 Performance."
[511] Analysts/Institutional Investor Meet/Con. Call Updates (2025-11-19)/Natural Capsules Limited has informed the Exchange about Transcript
[512] Analysts/Institutional Investor Meet/Con. Call Updates (2025-11-19)/Natural Capsules Limited has informed the Exchange about Transcript
[513] Analysts/Institutional Investor Meet/Con. Call Updates (2025-11-19)/Natural Capsules Limited has informed the Exchange about Transcript
[514] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-12)/Marksans Pharma Limited transcript of Investors/Analyst meet on Q3 9M FY 26 Unaudited Financial Results held on February 06, 2026
[515] Analysts/Institutional Investor Meet/Con. Call Updates (2025-11-19)/Natural Capsules Limited has informed the Exchange about Transcript
[516] Analysts/Institutional Investor Meet/Con. Call Updates (2025-11-19)/Natural Capsules Limited has informed the Exchange about Transcript
[517] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-17)/Hikal Limited has informed the Exchange about Transcript
[518] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-17)/Hikal Limited has informed the Exchange about Transcript
[519] Investor Presentation (2026-02-13)/Natural Capsules Limited has informed the Exchange about Investor Presentation
[520] Analysts/Institutional Investor Meet/Con. Call Updates (2025-11-19)/Natural Capsules Limited has informed the Exchange about Transcript
[521] Analysts/Institutional Investor Meet/Con. Call Updates (2025-11-19)/Natural Capsules Limited has informed the Exchange about Transcript
[522] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-14)/Divi's Laboratories Limited has informed the Exchange about Transcript
[523] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-14)/Divi's Laboratories Limited has informed the Exchange about Transcript
[524] Investor Presentation (2026-01-22)/Kopran Limited has informed the Exchange about Investor Presentation
[525] Analysts/Institutional Investor Meet/Con. Call Updates (2025-11-19)/Natural Capsules Limited has informed the Exchange about Transcript
[526] Analysts/Institutional Investor Meet/Con. Call Updates (2025-11-19)/Natural Capsules Limited has informed the Exchange about Transcript
[527] Analysts/Institutional Investor Meet/Con. Call Updates (2025-11-19)/Natural Capsules Limited has informed the Exchange about Transcript
[528] Press Release (2026-02-06)/Jubilant Pharmova Limited has informed the Exchange regarding a press release dated February 06, 2026, titled "Press Release alongwith Earnings Presentation on the financials and operational performance of the Company for the quarter and nine months ended December 31, 2025".
[529] Press Release (2026-02-06)/Jubilant Pharmova Limited has informed the Exchange regarding a press release dated February 06, 2026, titled "Press Release alongwith Earnings Presentation on the financials and operational performance of the Company for the quarter and nine months ended December 31, 2025".
[530] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-17)/Hikal Limited has informed the Exchange about Transcript
[531] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-17)/Hikal Limited has informed the Exchange about Transcript
[532] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-17)/Hikal Limited has informed the Exchange about Transcript
[533] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-17)/Hikal Limited has informed the Exchange about Transcript
[534] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-17)/Hikal Limited has informed the Exchange about Transcript
[535] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-17)/Hikal Limited has informed the Exchange about Transcript
[536] Press Release (2026-02-06)/Jubilant Pharmova Limited has informed the Exchange regarding a press release dated February 06, 2026, titled "Press Release alongwith Earnings Presentation on the financials and operational performance of the Company for the quarter and nine months ended December 31, 2025".
[537] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-10)/Solara Active Pharma Sciences Limited has informed the Exchange about Transcript of earnings call pertaining to unaudited financial results of the Company for the quarter and nine months ended December 31, 2025.
[538] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-10)/Solara Active Pharma Sciences Limited has informed the Exchange about Transcript of earnings call pertaining to unaudited financial results of the Company for the quarter and nine months ended December 31, 2025.
[539] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-17)/Hikal Limited has informed the Exchange about Transcript
[540] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-17)/Hikal Limited has informed the Exchange about Transcript
[541] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-17)/Hikal Limited has informed the Exchange about Transcript
[542] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-17)/Hikal Limited has informed the Exchange about Transcript
[543] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-17)/Hikal Limited has informed the Exchange about Transcript
[544] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-10)/Solara Active Pharma Sciences Limited has informed the Exchange about Transcript of earnings call pertaining to unaudited financial results of the Company for the quarter and nine months ended December 31, 2025.
[545] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-10)/Solara Active Pharma Sciences Limited has informed the Exchange about Transcript of earnings call pertaining to unaudited financial results of the Company for the quarter and nine months ended December 31, 2025.
[546] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-10)/Solara Active Pharma Sciences Limited has informed the Exchange about Transcript of earnings call pertaining to unaudited financial results of the Company for the quarter and nine months ended December 31, 2025.
[547] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-16)/Orchid Pharma Limited has informed the Exchange about Transcript
[548] Press Release (2026-02-06)/Solara Active Pharma Sciences Limited has informed the exchange regarding the press release dated February 06, 2026, titled "Solara Q3'26 Performance."
[549] Analysts/Institutional Investor Meet/Con. Call Updates (2025-11-19)/Natural Capsules Limited has informed the Exchange about Transcript
[550] Analysts/Institutional Investor Meet/Con. Call Updates (2025-11-19)/Natural Capsules Limited has informed the Exchange about Transcript
[551] Analysts/Institutional Investor Meet/Con. Call Updates (2025-11-19)/Natural Capsules Limited has informed the Exchange about Transcript
[552] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-12)/Marksans Pharma Limited transcript of Investors/Analyst meet on Q3 9M FY 26 Unaudited Financial Results held on February 06, 2026
[553] Analysts/Institutional Investor Meet/Con. Call Updates (2025-11-19)/Natural Capsules Limited has informed the Exchange about Transcript
[554] Analysts/Institutional Investor Meet/Con. Call Updates (2025-11-19)/Natural Capsules Limited has informed the Exchange about Transcript
[555] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-17)/Hikal Limited has informed the Exchange about Transcript
[556] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-17)/Hikal Limited has informed the Exchange about Transcript
[557] Investor Presentation (2026-02-13)/Natural Capsules Limited has informed the Exchange about Investor Presentation
[558] Analysts/Institutional Investor Meet/Con. Call Updates (2025-11-19)/Natural Capsules Limited has informed the Exchange about Transcript
[559] Analysts/Institutional Investor Meet/Con. Call Updates (2025-11-19)/Natural Capsules Limited has informed the Exchange about Transcript
[560] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-14)/Divi's Laboratories Limited has informed the Exchange about Transcript
[561] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-14)/Divi's Laboratories Limited has informed the Exchange about Transcript
[562] Investor Presentation (2026-01-22)/Kopran Limited has informed the Exchange about Investor Presentation
[563] Analysts/Institutional Investor Meet/Con. Call Updates (2025-11-19)/Natural Capsules Limited has informed the Exchange about Transcript
[564] Analysts/Institutional Investor Meet/Con. Call Updates (2025-11-19)/Natural Capsules Limited has informed the Exchange about Transcript
[565] Analysts/Institutional Investor Meet/Con. Call Updates (2025-11-19)/Natural Capsules Limited has informed the Exchange about Transcript
[566] Press Release (2026-02-06)/Jubilant Pharmova Limited has informed the Exchange regarding a press release dated February 06, 2026, titled "Press Release alongwith Earnings Presentation on the financials and operational performance of the Company for the quarter and nine months ended December 31, 2025".
[567] Press Release (2026-02-06)/Jubilant Pharmova Limited has informed the Exchange regarding a press release dated February 06, 2026, titled "Press Release alongwith Earnings Presentation on the financials and operational performance of the Company for the quarter and nine months ended December 31, 2025".
[568] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-17)/Hikal Limited has informed the Exchange about Transcript
[569] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-17)/Hikal Limited has informed the Exchange about Transcript
[570] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-17)/Hikal Limited has informed the Exchange about Transcript
[571] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-17)/Hikal Limited has informed the Exchange about Transcript
[572] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-17)/Hikal Limited has informed the Exchange about Transcript
[573] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-17)/Hikal Limited has informed the Exchange about Transcript
[574] Press Release (2026-02-06)/Jubilant Pharmova Limited has informed the Exchange regarding a press release dated February 06, 2026, titled "Press Release alongwith Earnings Presentation on the financials and operational performance of the Company for the quarter and nine months ended December 31, 2025".
[575] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-10)/Solara Active Pharma Sciences Limited has informed the Exchange about Transcript of earnings call pertaining to unaudited financial results of the Company for the quarter and nine months ended December 31, 2025.
[576] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-10)/Solara Active Pharma Sciences Limited has informed the Exchange about Transcript of earnings call pertaining to unaudited financial results of the Company for the quarter and nine months ended December 31, 2025.
[577] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-17)/Hikal Limited has informed the Exchange about Transcript
[578] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-17)/Hikal Limited has informed the Exchange about Transcript
[579] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-16)/GlaxoSmithKline Pharmaceuticals Limited has informed the Exchange about Transcript
[580] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-16)/GlaxoSmithKline Pharmaceuticals Limited has informed the Exchange about Transcript
[581] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-17)/Hikal Limited has informed the Exchange about Transcript
[582] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-17)/Hikal Limited has informed the Exchange about Transcript
[583] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-17)/Hikal Limited has informed the Exchange about Transcript
[584] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-17)/Hikal Limited has informed the Exchange about Transcript
[585] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-10)/Solara Active Pharma Sciences Limited has informed the Exchange about Transcript of earnings call pertaining to unaudited financial results of the Company for the quarter and nine months ended December 31, 2025.
[586] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-10)/Solara Active Pharma Sciences Limited has informed the Exchange about Transcript of earnings call pertaining to unaudited financial results of the Company for the quarter and nine months ended December 31, 2025.
[587] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-10)/Solara Active Pharma Sciences Limited has informed the Exchange about Transcript of earnings call pertaining to unaudited financial results of the Company for the quarter and nine months ended December 31, 2025.
[588] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-16)/Orchid Pharma Limited has informed the Exchange about Transcript
[589] Press Release (2026-02-06)/Solara Active Pharma Sciences Limited has informed the exchange regarding the press release dated February 06, 2026, titled "Solara Q3'26 Performance."
[590] Analysts/Institutional Investor Meet/Con. Call Updates (2025-11-19)/Natural Capsules Limited has informed the Exchange about Transcript
[591] Analysts/Institutional Investor Meet/Con. Call Updates (2025-11-19)/Natural Capsules Limited has informed the Exchange about Transcript
[592] Analysts/Institutional Investor Meet/Con. Call Updates (2025-11-19)/Natural Capsules Limited has informed the Exchange about Transcript
[593] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-12)/Marksans Pharma Limited transcript of Investors/Analyst meet on Q3 9M FY 26 Unaudited Financial Results held on February 06, 2026
[594] Analysts/Institutional Investor Meet/Con. Call Updates (2025-11-19)/Natural Capsules Limited has informed the Exchange about Transcript
[595] Analysts/Institutional Investor Meet/Con. Call Updates (2025-11-19)/Natural Capsules Limited has informed the Exchange about Transcript
[596] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-17)/Hikal Limited has informed the Exchange about Transcript
[597] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-17)/Hikal Limited has informed the Exchange about Transcript
[598] Investor Presentation (2026-02-13)/Natural Capsules Limited has informed the Exchange about Investor Presentation
[599] Analysts/Institutional Investor Meet/Con. Call Updates (2025-11-19)/Natural Capsules Limited has informed the Exchange about Transcript
[600] Analysts/Institutional Investor Meet/Con. Call Updates (2025-11-19)/Natural Capsules Limited has informed the Exchange about Transcript
[601] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-14)/Divi's Laboratories Limited has informed the Exchange about Transcript
[602] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-14)/Divi's Laboratories Limited has informed the Exchange about Transcript
[603] Investor Presentation (2026-01-22)/Kopran Limited has informed the Exchange about Investor Presentation
[604] Analysts/Institutional Investor Meet/Con. Call Updates (2025-11-19)/Natural Capsules Limited has informed the Exchange about Transcript
[605] Analysts/Institutional Investor Meet/Con. Call Updates (2025-11-19)/Natural Capsules Limited has informed the Exchange about Transcript
[606] Analysts/Institutional Investor Meet/Con. Call Updates (2025-11-19)/Natural Capsules Limited has informed the Exchange about Transcript
[607] Press Release (2026-02-06)/Jubilant Pharmova Limited has informed the Exchange regarding a press release dated February 06, 2026, titled "Press Release alongwith Earnings Presentation on the financials and operational performance of the Company for the quarter and nine months ended December 31, 2025".
[608] Press Release (2026-02-06)/Jubilant Pharmova Limited has informed the Exchange regarding a press release dated February 06, 2026, titled "Press Release alongwith Earnings Presentation on the financials and operational performance of the Company for the quarter and nine months ended December 31, 2025".
[609] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-17)/Hikal Limited has informed the Exchange about Transcript
[610] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-17)/Hikal Limited has informed the Exchange about Transcript
[611] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-17)/Hikal Limited has informed the Exchange about Transcript
[612] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-17)/Hikal Limited has informed the Exchange about Transcript
[613] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-17)/Hikal Limited has informed the Exchange about Transcript
[614] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-17)/Hikal Limited has informed the Exchange about Transcript
[615] Press Release (2026-02-06)/Jubilant Pharmova Limited has informed the Exchange regarding a press release dated February 06, 2026, titled "Press Release alongwith Earnings Presentation on the financials and operational performance of the Company for the quarter and nine months ended December 31, 2025".
[616] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-10)/Solara Active Pharma Sciences Limited has informed the Exchange about Transcript of earnings call pertaining to unaudited financial results of the Company for the quarter and nine months ended December 31, 2025.
[617] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-10)/Solara Active Pharma Sciences Limited has informed the Exchange about Transcript of earnings call pertaining to unaudited financial results of the Company for the quarter and nine months ended December 31, 2025.
[618] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-17)/Hikal Limited has informed the Exchange about Transcript
[619] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-17)/Hikal Limited has informed the Exchange about Transcript
[620] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-16)/GlaxoSmithKline Pharmaceuticals Limited has informed the Exchange about Transcript
[621] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-16)/GlaxoSmithKline Pharmaceuticals Limited has informed the Exchange about Transcript
[622] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-17)/Hikal Limited has informed the Exchange about Transcript
[623] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-17)/Hikal Limited has informed the Exchange about Transcript
[624] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-17)/Hikal Limited has informed the Exchange about Transcript
[625] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-17)/Hikal Limited has informed the Exchange about Transcript
[626] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-10)/Solara Active Pharma Sciences Limited has informed the Exchange about Transcript of earnings call pertaining to unaudited financial results of the Company for the quarter and nine months ended December 31, 2025.
[627] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-10)/Solara Active Pharma Sciences Limited has informed the Exchange about Transcript of earnings call pertaining to unaudited financial results of the Company for the quarter and nine months ended December 31, 2025.
[628] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-10)/Solara Active Pharma Sciences Limited has informed the Exchange about Transcript of earnings call pertaining to unaudited financial results of the Company for the quarter and nine months ended December 31, 2025.
[629] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-16)/Orchid Pharma Limited has informed the Exchange about Transcript
[630] Press Release (2026-02-06)/Solara Active Pharma Sciences Limited has informed the exchange regarding the press release dated February 06, 2026, titled "Solara Q3'26 Performance."
[631] Analysts/Institutional Investor Meet/Con. Call Updates (2025-11-19)/Natural Capsules Limited has informed the Exchange about Transcript
[632] Analysts/Institutional Investor Meet/Con. Call Updates (2025-11-19)/Natural Capsules Limited has informed the Exchange about Transcript
[633] Analysts/Institutional Investor Meet/Con. Call Updates (2025-11-19)/Natural Capsules Limited has informed the Exchange about Transcript
[634] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-12)/Marksans Pharma Limited transcript of Investors/Analyst meet on Q3 9M FY 26 Unaudited Financial Results held on February 06, 2026
[635] Analysts/Institutional Investor Meet/Con. Call Updates (2025-11-19)/Natural Capsules Limited has informed the Exchange about Transcript
[636] Analysts/Institutional Investor Meet/Con. Call Updates (2025-11-19)/Natural Capsules Limited has informed the Exchange about Transcript
[637] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-17)/Hikal Limited has informed the Exchange about Transcript
[638] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-17)/Hikal Limited has informed the Exchange about Transcript
[639] Investor Presentation (2026-02-13)/Natural Capsules Limited has informed the Exchange about Investor Presentation
[640] Analysts/Institutional Investor Meet/Con. Call Updates (2025-11-19)/Natural Capsules Limited has informed the Exchange about Transcript
[641] Analysts/Institutional Investor Meet/Con. Call Updates (2025-11-19)/Natural Capsules Limited has informed the Exchange about Transcript
[642] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-14)/Divi's Laboratories Limited has informed the Exchange about Transcript
[643] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-14)/Divi's Laboratories Limited has informed the Exchange about Transcript
[644] Investor Presentation (2026-01-22)/Kopran Limited has informed the Exchange about Investor Presentation
[645] Analysts/Institutional Investor Meet/Con. Call Updates (2025-11-19)/Natural Capsules Limited has informed the Exchange about Transcript
[646] Analysts/Institutional Investor Meet/Con. Call Updates (2025-11-19)/Natural Capsules Limited has informed the Exchange about Transcript
[647] Analysts/Institutional Investor Meet/Con. Call Updates (2025-11-19)/Natural Capsules Limited has informed the Exchange about Transcript
[648] Press Release (2026-02-06)/Jubilant Pharmova Limited has informed the Exchange regarding a press release dated February 06, 2026, titled "Press Release alongwith Earnings Presentation on the financials and operational performance of the Company for the quarter and nine months ended December 31, 2025".
[649] Press Release (2026-02-06)/Jubilant Pharmova Limited has informed the Exchange regarding a press release dated February 06, 2026, titled "Press Release alongwith Earnings Presentation on the financials and operational performance of the Company for the quarter and nine months ended December 31, 2025".
[650] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-17)/Hikal Limited has informed the Exchange about Transcript
[651] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-17)/Hikal Limited has informed the Exchange about Transcript
[652] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-17)/Hikal Limited has informed the Exchange about Transcript
[653] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-17)/Hikal Limited has informed the Exchange about Transcript
[654] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-17)/Hikal Limited has informed the Exchange about Transcript
[655] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-17)/Hikal Limited has informed the Exchange about Transcript
[656] Press Release (2026-02-06)/Jubilant Pharmova Limited has informed the Exchange regarding a press release dated February 06, 2026, titled "Press Release alongwith Earnings Presentation on the financials and operational performance of the Company for the quarter and nine months ended December 31, 2025".
[657] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-10)/Solara Active Pharma Sciences Limited has informed the Exchange about Transcript of earnings call pertaining to unaudited financial results of the Company for the quarter and nine months ended December 31, 2025.
[658] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-10)/Solara Active Pharma Sciences Limited has informed the Exchange about Transcript of earnings call pertaining to unaudited financial results of the Company for the quarter and nine months ended December 31, 2025.
[659] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-17)/Hikal Limited has informed the Exchange about Transcript
[660] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-17)/Hikal Limited has informed the Exchange about Transcript
[661] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-16)/GlaxoSmithKline Pharmaceuticals Limited has informed the Exchange about Transcript
[662] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-16)/GlaxoSmithKline Pharmaceuticals Limited has informed the Exchange about Transcript
[663] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-17)/Hikal Limited has informed the Exchange about Transcript
[664] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-17)/Hikal Limited has informed the Exchange about Transcript
[665] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-17)/Hikal Limited has informed the Exchange about Transcript
[666] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-17)/Hikal Limited has informed the Exchange about Transcript
[667] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-10)/Solara Active Pharma Sciences Limited has informed the Exchange about Transcript of earnings call pertaining to unaudited financial results of the Company for the quarter and nine months ended December 31, 2025.
[668] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-10)/Solara Active Pharma Sciences Limited has informed the Exchange about Transcript of earnings call pertaining to unaudited financial results of the Company for the quarter and nine months ended December 31, 2025.
[669] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-10)/Solara Active Pharma Sciences Limited has informed the Exchange about Transcript of earnings call pertaining to unaudited financial results of the Company for the quarter and nine months ended December 31, 2025.
[670] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-16)/Orchid Pharma Limited has informed the Exchange about Transcript
[671] Press Release (2026-02-06)/Solara Active Pharma Sciences Limited has informed the exchange regarding the press release dated February 06, 2026, titled "Solara Q3'26 Performance."
[672] Analysts/Institutional Investor Meet/Con. Call Updates (2025-11-19)/Natural Capsules Limited has informed the Exchange about Transcript
[673] Analysts/Institutional Investor Meet/Con. Call Updates (2025-11-19)/Natural Capsules Limited has informed the Exchange about Transcript
[674] Analysts/Institutional Investor Meet/Con. Call Updates (2025-11-19)/Natural Capsules Limited has informed the Exchange about Transcript
[675] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-12)/Marksans Pharma Limited transcript of Investors/Analyst meet on Q3 9M FY 26 Unaudited Financial Results held on February 06, 2026
[676] Analysts/Institutional Investor Meet/Con. Call Updates (2025-11-19)/Natural Capsules Limited has informed the Exchange about Transcript
[677] Analysts/Institutional Investor Meet/Con. Call Updates (2025-11-19)/Natural Capsules Limited has informed the Exchange about Transcript
[678] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-17)/Hikal Limited has informed the Exchange about Transcript
[679] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-17)/Hikal Limited has informed the Exchange about Transcript
[680] Investor Presentation (2026-02-13)/Natural Capsules Limited has informed the Exchange about Investor Presentation
[681] Analysts/Institutional Investor Meet/Con. Call Updates (2025-11-19)/Natural Capsules Limited has informed the Exchange about Transcript
[682] Analysts/Institutional Investor Meet/Con. Call Updates (2025-11-19)/Natural Capsules Limited has informed the Exchange about Transcript
[683] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-14)/Divi's Laboratories Limited has informed the Exchange about Transcript
[684] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-14)/Divi's Laboratories Limited has informed the Exchange about Transcript
[685] Investor Presentation (2026-01-22)/Kopran Limited has informed the Exchange about Investor Presentation
[686] Analysts/Institutional Investor Meet/Con. Call Updates (2025-11-19)/Natural Capsules Limited has informed the Exchange about Transcript
[687] Analysts/Institutional Investor Meet/Con. Call Updates (2025-11-19)/Natural Capsules Limited has informed the Exchange about Transcript
[688] Analysts/Institutional Investor Meet/Con. Call Updates (2025-11-19)/Natural Capsules Limited has informed the Exchange about Transcript
[689] Press Release (2026-02-06)/Jubilant Pharmova Limited has informed the Exchange regarding a press release dated February 06, 2026, titled "Press Release alongwith Earnings Presentation on the financials and operational performance of the Company for the quarter and nine months ended December 31, 2025".
[690] Press Release (2026-02-06)/Jubilant Pharmova Limited has informed the Exchange regarding a press release dated February 06, 2026, titled "Press Release alongwith Earnings Presentation on the financials and operational performance of the Company for the quarter and nine months ended December 31, 2025".
[691] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-17)/Hikal Limited has informed the Exchange about Transcript
[692] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-17)/Hikal Limited has informed the Exchange about Transcript
[693] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-17)/Hikal Limited has informed the Exchange about Transcript
[694] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-17)/Hikal Limited has informed the Exchange about Transcript
[695] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-17)/Hikal Limited has informed the Exchange about Transcript
[696] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-17)/Hikal Limited has informed the Exchange about Transcript
[697] Press Release (2026-02-06)/Jubilant Pharmova Limited has informed the Exchange regarding a press release dated February 06, 2026, titled "Press Release alongwith Earnings Presentation on the financials and operational performance of the Company for the quarter and nine months ended December 31, 2025".
[698] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-10)/Solara Active Pharma Sciences Limited has informed the Exchange about Transcript of earnings call pertaining to unaudited financial results of the Company for the quarter and nine months ended December 31, 2025.
[699] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-10)/Solara Active Pharma Sciences Limited has informed the Exchange about Transcript of earnings call pertaining to unaudited financial results of the Company for the quarter and nine months ended December 31, 2025.
[700] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-17)/Hikal Limited has informed the Exchange about Transcript
[701] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-17)/Hikal Limited has informed the Exchange about Transcript
[702] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-16)/GlaxoSmithKline Pharmaceuticals Limited has informed the Exchange about Transcript
[703] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-16)/GlaxoSmithKline Pharmaceuticals Limited has informed the Exchange about Transcript
[704] Analysts/Institutional Investor Meet/Con. Call Updates (2025-06-11)/Wockhardt Limited has informed the Exchange about Transcript
[705] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-17)/Hikal Limited has informed the Exchange about Transcript
[706] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-17)/Hikal Limited has informed the Exchange about Transcript
[707] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-17)/Hikal Limited has informed the Exchange about Transcript
[708] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-17)/Hikal Limited has informed the Exchange about Transcript
[709] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-10)/Solara Active Pharma Sciences Limited has informed the Exchange about Transcript of earnings call pertaining to unaudited financial results of the Company for the quarter and nine months ended December 31, 2025.
[710] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-10)/Solara Active Pharma Sciences Limited has informed the Exchange about Transcript of earnings call pertaining to unaudited financial results of the Company for the quarter and nine months ended December 31, 2025.
[711] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-10)/Solara Active Pharma Sciences Limited has informed the Exchange about Transcript of earnings call pertaining to unaudited financial results of the Company for the quarter and nine months ended December 31, 2025.
[712] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-16)/Orchid Pharma Limited has informed the Exchange about Transcript
[713] Press Release (2026-02-06)/Solara Active Pharma Sciences Limited has informed the exchange regarding the press release dated February 06, 2026, titled "Solara Q3'26 Performance."
[714] Analysts/Institutional Investor Meet/Con. Call Updates (2025-11-19)/Natural Capsules Limited has informed the Exchange about Transcript
[715] Analysts/Institutional Investor Meet/Con. Call Updates (2025-11-19)/Natural Capsules Limited has informed the Exchange about Transcript
[716] Analysts/Institutional Investor Meet/Con. Call Updates (2025-11-19)/Natural Capsules Limited has informed the Exchange about Transcript
[717] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-12)/Marksans Pharma Limited transcript of Investors/Analyst meet on Q3 9M FY 26 Unaudited Financial Results held on February 06, 2026
[718] Analysts/Institutional Investor Meet/Con. Call Updates (2025-11-19)/Natural Capsules Limited has informed the Exchange about Transcript
[719] Analysts/Institutional Investor Meet/Con. Call Updates (2025-11-19)/Natural Capsules Limited has informed the Exchange about Transcript
[720] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-17)/Hikal Limited has informed the Exchange about Transcript
[721] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-17)/Hikal Limited has informed the Exchange about Transcript
[722] Investor Presentation (2026-02-13)/Natural Capsules Limited has informed the Exchange about Investor Presentation
[723] Analysts/Institutional Investor Meet/Con. Call Updates (2025-11-19)/Natural Capsules Limited has informed the Exchange about Transcript
[724] Analysts/Institutional Investor Meet/Con. Call Updates (2025-11-19)/Natural Capsules Limited has informed the Exchange about Transcript
[725] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-14)/Divi's Laboratories Limited has informed the Exchange about Transcript
[726] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-14)/Divi's Laboratories Limited has informed the Exchange about Transcript
[727] Investor Presentation (2026-01-22)/Kopran Limited has informed the Exchange about Investor Presentation
[728] Analysts/Institutional Investor Meet/Con. Call Updates (2025-11-19)/Natural Capsules Limited has informed the Exchange about Transcript
[729] Analysts/Institutional Investor Meet/Con. Call Updates (2025-11-19)/Natural Capsules Limited has informed the Exchange about Transcript
[730] Analysts/Institutional Investor Meet/Con. Call Updates (2025-11-19)/Natural Capsules Limited has informed the Exchange about Transcript
[731] Press Release (2026-02-06)/Jubilant Pharmova Limited has informed the Exchange regarding a press release dated February 06, 2026, titled "Press Release alongwith Earnings Presentation on the financials and operational performance of the Company for the quarter and nine months ended December 31, 2025".
[732] Press Release (2026-02-06)/Jubilant Pharmova Limited has informed the Exchange regarding a press release dated February 06, 2026, titled "Press Release alongwith Earnings Presentation on the financials and operational performance of the Company for the quarter and nine months ended December 31, 2025".
[733] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-17)/Hikal Limited has informed the Exchange about Transcript
[734] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-17)/Hikal Limited has informed the Exchange about Transcript
[735] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-17)/Hikal Limited has informed the Exchange about Transcript
[736] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-17)/Hikal Limited has informed the Exchange about Transcript
[737] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-17)/Hikal Limited has informed the Exchange about Transcript
[738] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-17)/Hikal Limited has informed the Exchange about Transcript
[739] Press Release (2026-02-06)/Jubilant Pharmova Limited has informed the Exchange regarding a press release dated February 06, 2026, titled "Press Release alongwith Earnings Presentation on the financials and operational performance of the Company for the quarter and nine months ended December 31, 2025".
[740] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-10)/Solara Active Pharma Sciences Limited has informed the Exchange about Transcript of earnings call pertaining to unaudited financial results of the Company for the quarter and nine months ended December 31, 2025.
[741] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-10)/Solara Active Pharma Sciences Limited has informed the Exchange about Transcript of earnings call pertaining to unaudited financial results of the Company for the quarter and nine months ended December 31, 2025.
[742] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-17)/Hikal Limited has informed the Exchange about Transcript
[743] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-17)/Hikal Limited has informed the Exchange about Transcript
[744] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-16)/GlaxoSmithKline Pharmaceuticals Limited has informed the Exchange about Transcript
[745] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-16)/GlaxoSmithKline Pharmaceuticals Limited has informed the Exchange about Transcript
[746] Analysts/Institutional Investor Meet/Con. Call Updates (2025-06-11)/Wockhardt Limited has informed the Exchange about Transcript
[747] Analysts/Institutional Investor Meet/Con. Call Updates (2025-06-11)/Wockhardt Limited has informed the Exchange about Transcript
[748] Analysts/Institutional Investor Meet/Con. Call Updates (2025-06-11)/Wockhardt Limited has informed the Exchange about Transcript
[749] Analysts/Institutional Investor Meet/Con. Call Updates (2025-06-11)/Wockhardt Limited has informed the Exchange about Transcript
[750] Analysts/Institutional Investor Meet/Con. Call Updates (2025-06-11)/Wockhardt Limited has informed the Exchange about Transcript
[751] Analysts/Institutional Investor Meet/Con. Call Updates (2025-06-11)/Wockhardt Limited has informed the Exchange about Transcript
[752] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-17)/Hikal Limited has informed the Exchange about Transcript
[753] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-17)/Hikal Limited has informed the Exchange about Transcript
[754] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-17)/Hikal Limited has informed the Exchange about Transcript
[755] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-17)/Hikal Limited has informed the Exchange about Transcript
[756] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-10)/Solara Active Pharma Sciences Limited has informed the Exchange about Transcript of earnings call pertaining to unaudited financial results of the Company for the quarter and nine months ended December 31, 2025.
[757] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-10)/Solara Active Pharma Sciences Limited has informed the Exchange about Transcript of earnings call pertaining to unaudited financial results of the Company for the quarter and nine months ended December 31, 2025.
[758] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-10)/Solara Active Pharma Sciences Limited has informed the Exchange about Transcript of earnings call pertaining to unaudited financial results of the Company for the quarter and nine months ended December 31, 2025.
[759] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-16)/Orchid Pharma Limited has informed the Exchange about Transcript
[760] Press Release (2026-02-06)/Solara Active Pharma Sciences Limited has informed the exchange regarding the press release dated February 06, 2026, titled "Solara Q3'26 Performance."
[761] Analysts/Institutional Investor Meet/Con. Call Updates (2025-11-19)/Natural Capsules Limited has informed the Exchange about Transcript
[762] Analysts/Institutional Investor Meet/Con. Call Updates (2025-11-19)/Natural Capsules Limited has informed the Exchange about Transcript
[763] Analysts/Institutional Investor Meet/Con. Call Updates (2025-11-19)/Natural Capsules Limited has informed the Exchange about Transcript
[764] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-12)/Marksans Pharma Limited transcript of Investors/Analyst meet on Q3 9M FY 26 Unaudited Financial Results held on February 06, 2026
[765] Analysts/Institutional Investor Meet/Con. Call Updates (2025-11-19)/Natural Capsules Limited has informed the Exchange about Transcript
[766] Analysts/Institutional Investor Meet/Con. Call Updates (2025-11-19)/Natural Capsules Limited has informed the Exchange about Transcript
[767] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-17)/Hikal Limited has informed the Exchange about Transcript
[768] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-17)/Hikal Limited has informed the Exchange about Transcript
[769] Investor Presentation (2026-02-13)/Natural Capsules Limited has informed the Exchange about Investor Presentation
[770] Analysts/Institutional Investor Meet/Con. Call Updates (2025-11-19)/Natural Capsules Limited has informed the Exchange about Transcript
[771] Analysts/Institutional Investor Meet/Con. Call Updates (2025-11-19)/Natural Capsules Limited has informed the Exchange about Transcript
[772] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-14)/Divi's Laboratories Limited has informed the Exchange about Transcript
[773] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-14)/Divi's Laboratories Limited has informed the Exchange about Transcript
[774] Investor Presentation (2026-01-22)/Kopran Limited has informed the Exchange about Investor Presentation
[775] Analysts/Institutional Investor Meet/Con. Call Updates (2025-11-19)/Natural Capsules Limited has informed the Exchange about Transcript
[776] Analysts/Institutional Investor Meet/Con. Call Updates (2025-11-19)/Natural Capsules Limited has informed the Exchange about Transcript
[777] Analysts/Institutional Investor Meet/Con. Call Updates (2025-11-19)/Natural Capsules Limited has informed the Exchange about Transcript
[778] Press Release (2026-02-06)/Jubilant Pharmova Limited has informed the Exchange regarding a press release dated February 06, 2026, titled "Press Release alongwith Earnings Presentation on the financials and operational performance of the Company for the quarter and nine months ended December 31, 2025".
[779] Press Release (2026-02-06)/Jubilant Pharmova Limited has informed the Exchange regarding a press release dated February 06, 2026, titled "Press Release alongwith Earnings Presentation on the financials and operational performance of the Company for the quarter and nine months ended December 31, 2025".
[780] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-17)/Hikal Limited has informed the Exchange about Transcript
[781] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-17)/Hikal Limited has informed the Exchange about Transcript
[782] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-17)/Hikal Limited has informed the Exchange about Transcript
[783] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-17)/Hikal Limited has informed the Exchange about Transcript
[784] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-17)/Hikal Limited has informed the Exchange about Transcript
[785] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-17)/Hikal Limited has informed the Exchange about Transcript
[786] Press Release (2026-02-06)/Jubilant Pharmova Limited has informed the Exchange regarding a press release dated February 06, 2026, titled "Press Release alongwith Earnings Presentation on the financials and operational performance of the Company for the quarter and nine months ended December 31, 2025".
[787] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-10)/Solara Active Pharma Sciences Limited has informed the Exchange about Transcript of earnings call pertaining to unaudited financial results of the Company for the quarter and nine months ended December 31, 2025.
[788] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-10)/Solara Active Pharma Sciences Limited has informed the Exchange about Transcript of earnings call pertaining to unaudited financial results of the Company for the quarter and nine months ended December 31, 2025.
[789] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-17)/Hikal Limited has informed the Exchange about Transcript
[790] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-17)/Hikal Limited has informed the Exchange about Transcript
[791] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-16)/GlaxoSmithKline Pharmaceuticals Limited has informed the Exchange about Transcript
[792] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-16)/GlaxoSmithKline Pharmaceuticals Limited has informed the Exchange about Transcript
[793] Analysts/Institutional Investor Meet/Con. Call Updates (2025-06-11)/Wockhardt Limited has informed the Exchange about Transcript
[794] Analysts/Institutional Investor Meet/Con. Call Updates (2025-06-11)/Wockhardt Limited has informed the Exchange about Transcript
[795] Analysts/Institutional Investor Meet/Con. Call Updates (2025-06-11)/Wockhardt Limited has informed the Exchange about Transcript
[796] Analysts/Institutional Investor Meet/Con. Call Updates (2025-06-11)/Wockhardt Limited has informed the Exchange about Transcript
[797] Analysts/Institutional Investor Meet/Con. Call Updates (2025-06-11)/Wockhardt Limited has informed the Exchange about Transcript
[798] Analysts/Institutional Investor Meet/Con. Call Updates (2025-06-11)/Wockhardt Limited has informed the Exchange about Transcript
[799] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-17)/Hikal Limited has informed the Exchange about Transcript
[800] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-17)/Hikal Limited has informed the Exchange about Transcript
[801] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-17)/Hikal Limited has informed the Exchange about Transcript
[802] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-17)/Hikal Limited has informed the Exchange about Transcript
[803] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-10)/Solara Active Pharma Sciences Limited has informed the Exchange about Transcript of earnings call pertaining to unaudited financial results of the Company for the quarter and nine months ended December 31, 2025.
[804] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-10)/Solara Active Pharma Sciences Limited has informed the Exchange about Transcript of earnings call pertaining to unaudited financial results of the Company for the quarter and nine months ended December 31, 2025.
[805] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-10)/Solara Active Pharma Sciences Limited has informed the Exchange about Transcript of earnings call pertaining to unaudited financial results of the Company for the quarter and nine months ended December 31, 2025.
[806] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-16)/Orchid Pharma Limited has informed the Exchange about Transcript
[807] Press Release (2026-02-06)/Solara Active Pharma Sciences Limited has informed the exchange regarding the press release dated February 06, 2026, titled "Solara Q3'26 Performance."
[808] Analysts/Institutional Investor Meet/Con. Call Updates (2025-11-19)/Natural Capsules Limited has informed the Exchange about Transcript
[809] Analysts/Institutional Investor Meet/Con. Call Updates (2025-11-19)/Natural Capsules Limited has informed the Exchange about Transcript
[810] Analysts/Institutional Investor Meet/Con. Call Updates (2025-11-19)/Natural Capsules Limited has informed the Exchange about Transcript
[811] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-12)/Marksans Pharma Limited transcript of Investors/Analyst meet on Q3 9M FY 26 Unaudited Financial Results held on February 06, 2026
[812] Analysts/Institutional Investor Meet/Con. Call Updates (2025-11-19)/Natural Capsules Limited has informed the Exchange about Transcript
[813] Analysts/Institutional Investor Meet/Con. Call Updates (2025-11-19)/Natural Capsules Limited has informed the Exchange about Transcript
[814] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-17)/Hikal Limited has informed the Exchange about Transcript
[815] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-17)/Hikal Limited has informed the Exchange about Transcript
[816] Investor Presentation (2026-02-13)/Natural Capsules Limited has informed the Exchange about Investor Presentation
[817] Analysts/Institutional Investor Meet/Con. Call Updates (2025-11-19)/Natural Capsules Limited has informed the Exchange about Transcript
[818] Analysts/Institutional Investor Meet/Con. Call Updates (2025-11-19)/Natural Capsules Limited has informed the Exchange about Transcript
[819] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-14)/Divi's Laboratories Limited has informed the Exchange about Transcript
[820] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-14)/Divi's Laboratories Limited has informed the Exchange about Transcript
[821] Investor Presentation (2026-01-22)/Kopran Limited has informed the Exchange about Investor Presentation
[822] Analysts/Institutional Investor Meet/Con. Call Updates (2025-11-19)/Natural Capsules Limited has informed the Exchange about Transcript
[823] Analysts/Institutional Investor Meet/Con. Call Updates (2025-11-19)/Natural Capsules Limited has informed the Exchange about Transcript
[824] Analysts/Institutional Investor Meet/Con. Call Updates (2025-11-19)/Natural Capsules Limited has informed the Exchange about Transcript
[825] Press Release (2026-02-06)/Jubilant Pharmova Limited has informed the Exchange regarding a press release dated February 06, 2026, titled "Press Release alongwith Earnings Presentation on the financials and operational performance of the Company for the quarter and nine months ended December 31, 2025".
[826] Press Release (2026-02-06)/Jubilant Pharmova Limited has informed the Exchange regarding a press release dated February 06, 2026, titled "Press Release alongwith Earnings Presentation on the financials and operational performance of the Company for the quarter and nine months ended December 31, 2025".
[827] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-17)/Hikal Limited has informed the Exchange about Transcript
[828] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-17)/Hikal Limited has informed the Exchange about Transcript
[829] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-17)/Hikal Limited has informed the Exchange about Transcript
[830] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-17)/Hikal Limited has informed the Exchange about Transcript
[831] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-17)/Hikal Limited has informed the Exchange about Transcript
[832] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-17)/Hikal Limited has informed the Exchange about Transcript
[833] Press Release (2026-02-06)/Jubilant Pharmova Limited has informed the Exchange regarding a press release dated February 06, 2026, titled "Press Release alongwith Earnings Presentation on the financials and operational performance of the Company for the quarter and nine months ended December 31, 2025".
[834] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-10)/Solara Active Pharma Sciences Limited has informed the Exchange about Transcript of earnings call pertaining to unaudited financial results of the Company for the quarter and nine months ended December 31, 2025.
[835] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-10)/Solara Active Pharma Sciences Limited has informed the Exchange about Transcript of earnings call pertaining to unaudited financial results of the Company for the quarter and nine months ended December 31, 2025.
[836] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-17)/Hikal Limited has informed the Exchange about Transcript
[837] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-17)/Hikal Limited has informed the Exchange about Transcript
[838] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-16)/GlaxoSmithKline Pharmaceuticals Limited has informed the Exchange about Transcript
[839] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-16)/GlaxoSmithKline Pharmaceuticals Limited has informed the Exchange about Transcript
[840] Analysts/Institutional Investor Meet/Con. Call Updates (2025-06-11)/Wockhardt Limited has informed the Exchange about Transcript
[841] Analysts/Institutional Investor Meet/Con. Call Updates (2025-06-11)/Wockhardt Limited has informed the Exchange about Transcript
[842] Analysts/Institutional Investor Meet/Con. Call Updates (2025-06-11)/Wockhardt Limited has informed the Exchange about Transcript
[843] Analysts/Institutional Investor Meet/Con. Call Updates (2025-06-11)/Wockhardt Limited has informed the Exchange about Transcript
[844] Analysts/Institutional Investor Meet/Con. Call Updates (2025-06-11)/Wockhardt Limited has informed the Exchange about Transcript
[845] Analysts/Institutional Investor Meet/Con. Call Updates (2025-06-11)/Wockhardt Limited has informed the Exchange about Transcript
[846] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-17)/Hikal Limited has informed the Exchange about Transcript
[847] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-17)/Hikal Limited has informed the Exchange about Transcript
[848] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-17)/Hikal Limited has informed the Exchange about Transcript
[849] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-17)/Hikal Limited has informed the Exchange about Transcript
[850] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-10)/Solara Active Pharma Sciences Limited has informed the Exchange about Transcript of earnings call pertaining to unaudited financial results of the Company for the quarter and nine months ended December 31, 2025.
[851] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-10)/Solara Active Pharma Sciences Limited has informed the Exchange about Transcript of earnings call pertaining to unaudited financial results of the Company for the quarter and nine months ended December 31, 2025.
[852] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-10)/Solara Active Pharma Sciences Limited has informed the Exchange about Transcript of earnings call pertaining to unaudited financial results of the Company for the quarter and nine months ended December 31, 2025.
[853] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-16)/Orchid Pharma Limited has informed the Exchange about Transcript
[854] Press Release (2026-02-06)/Solara Active Pharma Sciences Limited has informed the exchange regarding the press release dated February 06, 2026, titled "Solara Q3'26 Performance."
[855] Analysts/Institutional Investor Meet/Con. Call Updates (2025-11-19)/Natural Capsules Limited has informed the Exchange about Transcript
[856] Analysts/Institutional Investor Meet/Con. Call Updates (2025-11-19)/Natural Capsules Limited has informed the Exchange about Transcript
[857] Analysts/Institutional Investor Meet/Con. Call Updates (2025-11-19)/Natural Capsules Limited has informed the Exchange about Transcript
[858] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-12)/Marksans Pharma Limited transcript of Investors/Analyst meet on Q3 9M FY 26 Unaudited Financial Results held on February 06, 2026
[859] Analysts/Institutional Investor Meet/Con. Call Updates (2025-11-19)/Natural Capsules Limited has informed the Exchange about Transcript
[860] Analysts/Institutional Investor Meet/Con. Call Updates (2025-11-19)/Natural Capsules Limited has informed the Exchange about Transcript
[861] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-17)/Hikal Limited has informed the Exchange about Transcript
[862] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-17)/Hikal Limited has informed the Exchange about Transcript
[863] Investor Presentation (2026-02-13)/Natural Capsules Limited has informed the Exchange about Investor Presentation
[864] Analysts/Institutional Investor Meet/Con. Call Updates (2025-11-19)/Natural Capsules Limited has informed the Exchange about Transcript
[865] Analysts/Institutional Investor Meet/Con. Call Updates (2025-11-19)/Natural Capsules Limited has informed the Exchange about Transcript
[866] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-14)/Divi's Laboratories Limited has informed the Exchange about Transcript
[867] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-14)/Divi's Laboratories Limited has informed the Exchange about Transcript
[868] Investor Presentation (2026-01-22)/Kopran Limited has informed the Exchange about Investor Presentation
[869] Analysts/Institutional Investor Meet/Con. Call Updates (2025-11-19)/Natural Capsules Limited has informed the Exchange about Transcript
[870] Analysts/Institutional Investor Meet/Con. Call Updates (2025-11-19)/Natural Capsules Limited has informed the Exchange about Transcript
[871] Analysts/Institutional Investor Meet/Con. Call Updates (2025-11-19)/Natural Capsules Limited has informed the Exchange about Transcript
[872] Press Release (2026-02-06)/Jubilant Pharmova Limited has informed the Exchange regarding a press release dated February 06, 2026, titled "Press Release alongwith Earnings Presentation on the financials and operational performance of the Company for the quarter and nine months ended December 31, 2025".
[873] Press Release (2026-02-06)/Jubilant Pharmova Limited has informed the Exchange regarding a press release dated February 06, 2026, titled "Press Release alongwith Earnings Presentation on the financials and operational performance of the Company for the quarter and nine months ended December 31, 2025".
[874] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-17)/Hikal Limited has informed the Exchange about Transcript
[875] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-17)/Hikal Limited has informed the Exchange about Transcript
[876] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-17)/Hikal Limited has informed the Exchange about Transcript
[877] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-17)/Hikal Limited has informed the Exchange about Transcript
[878] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-17)/Hikal Limited has informed the Exchange about Transcript
[879] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-17)/Hikal Limited has informed the Exchange about Transcript
[880] Press Release (2026-02-06)/Jubilant Pharmova Limited has informed the Exchange regarding a press release dated February 06, 2026, titled "Press Release alongwith Earnings Presentation on the financials and operational performance of the Company for the quarter and nine months ended December 31, 2025".
[881] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-10)/Solara Active Pharma Sciences Limited has informed the Exchange about Transcript of earnings call pertaining to unaudited financial results of the Company for the quarter and nine months ended December 31, 2025.
[882] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-10)/Solara Active Pharma Sciences Limited has informed the Exchange about Transcript of earnings call pertaining to unaudited financial results of the Company for the quarter and nine months ended December 31, 2025.
[883] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-17)/Hikal Limited has informed the Exchange about Transcript
[884] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-17)/Hikal Limited has informed the Exchange about Transcript
[885] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-16)/GlaxoSmithKline Pharmaceuticals Limited has informed the Exchange about Transcript
[886] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-16)/GlaxoSmithKline Pharmaceuticals Limited has informed the Exchange about Transcript
[887] Analysts/Institutional Investor Meet/Con. Call Updates (2025-06-11)/Wockhardt Limited has informed the Exchange about Transcript
[888] Analysts/Institutional Investor Meet/Con. Call Updates (2025-06-11)/Wockhardt Limited has informed the Exchange about Transcript
[889] Analysts/Institutional Investor Meet/Con. Call Updates (2025-06-11)/Wockhardt Limited has informed the Exchange about Transcript
[890] Analysts/Institutional Investor Meet/Con. Call Updates (2025-06-11)/Wockhardt Limited has informed the Exchange about Transcript
[891] Analysts/Institutional Investor Meet/Con. Call Updates (2025-06-11)/Wockhardt Limited has informed the Exchange about Transcript
[892] Analysts/Institutional Investor Meet/Con. Call Updates (2025-06-11)/Wockhardt Limited has informed the Exchange about Transcript
[893] Press Release (2026-02-06)/Jubilant Pharmova Limited has informed the Exchange regarding a press release dated February 06, 2026, titled "Press Release alongwith Earnings Presentation on the financials and operational performance of the Company for the quarter and nine months ended December 31, 2025".
[894] Press Release (2026-02-06)/Jubilant Pharmova Limited has informed the Exchange regarding a press release dated February 06, 2026, titled "Press Release alongwith Earnings Presentation on the financials and operational performance of the Company for the quarter and nine months ended December 31, 2025".
[895] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-17)/Hikal Limited has informed the Exchange about Transcript
[896] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-17)/Hikal Limited has informed the Exchange about Transcript
[897] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-17)/Hikal Limited has informed the Exchange about Transcript
[898] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-17)/Hikal Limited has informed the Exchange about Transcript
[899] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-10)/Solara Active Pharma Sciences Limited has informed the Exchange about Transcript of earnings call pertaining to unaudited financial results of the Company for the quarter and nine months ended December 31, 2025.
[900] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-10)/Solara Active Pharma Sciences Limited has informed the Exchange about Transcript of earnings call pertaining to unaudited financial results of the Company for the quarter and nine months ended December 31, 2025.
[901] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-10)/Solara Active Pharma Sciences Limited has informed the Exchange about Transcript of earnings call pertaining to unaudited financial results of the Company for the quarter and nine months ended December 31, 2025.
[902] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-16)/Orchid Pharma Limited has informed the Exchange about Transcript
[903] Press Release (2026-02-06)/Solara Active Pharma Sciences Limited has informed the exchange regarding the press release dated February 06, 2026, titled "Solara Q3'26 Performance."
[904] Analysts/Institutional Investor Meet/Con. Call Updates (2025-11-19)/Natural Capsules Limited has informed the Exchange about Transcript
[905] Analysts/Institutional Investor Meet/Con. Call Updates (2025-11-19)/Natural Capsules Limited has informed the Exchange about Transcript
[906] Analysts/Institutional Investor Meet/Con. Call Updates (2025-11-19)/Natural Capsules Limited has informed the Exchange about Transcript
[907] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-12)/Marksans Pharma Limited transcript of Investors/Analyst meet on Q3 9M FY 26 Unaudited Financial Results held on February 06, 2026
[908] Analysts/Institutional Investor Meet/Con. Call Updates (2025-11-19)/Natural Capsules Limited has informed the Exchange about Transcript
[909] Analysts/Institutional Investor Meet/Con. Call Updates (2025-11-19)/Natural Capsules Limited has informed the Exchange about Transcript
[910] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-17)/Hikal Limited has informed the Exchange about Transcript
[911] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-17)/Hikal Limited has informed the Exchange about Transcript
[912] Investor Presentation (2026-02-13)/Natural Capsules Limited has informed the Exchange about Investor Presentation
[913] Analysts/Institutional Investor Meet/Con. Call Updates (2025-11-19)/Natural Capsules Limited has informed the Exchange about Transcript
[914] Analysts/Institutional Investor Meet/Con. Call Updates (2025-11-19)/Natural Capsules Limited has informed the Exchange about Transcript
[915] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-14)/Divi's Laboratories Limited has informed the Exchange about Transcript
[916] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-14)/Divi's Laboratories Limited has informed the Exchange about Transcript
[917] Investor Presentation (2026-01-22)/Kopran Limited has informed the Exchange about Investor Presentation
[918] Analysts/Institutional Investor Meet/Con. Call Updates (2025-11-19)/Natural Capsules Limited has informed the Exchange about Transcript
[919] Analysts/Institutional Investor Meet/Con. Call Updates (2025-11-19)/Natural Capsules Limited has informed the Exchange about Transcript
[920] Analysts/Institutional Investor Meet/Con. Call Updates (2025-11-19)/Natural Capsules Limited has informed the Exchange about Transcript
[921] Press Release (2026-02-06)/Jubilant Pharmova Limited has informed the Exchange regarding a press release dated February 06, 2026, titled "Press Release alongwith Earnings Presentation on the financials and operational performance of the Company for the quarter and nine months ended December 31, 2025".
[922] Press Release (2026-02-06)/Jubilant Pharmova Limited has informed the Exchange regarding a press release dated February 06, 2026, titled "Press Release alongwith Earnings Presentation on the financials and operational performance of the Company for the quarter and nine months ended December 31, 2025".
[923] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-17)/Hikal Limited has informed the Exchange about Transcript
[924] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-17)/Hikal Limited has informed the Exchange about Transcript
[925] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-17)/Hikal Limited has informed the Exchange about Transcript
[926] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-17)/Hikal Limited has informed the Exchange about Transcript
[927] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-17)/Hikal Limited has informed the Exchange about Transcript
[928] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-17)/Hikal Limited has informed the Exchange about Transcript
[929] Press Release (2026-02-06)/Jubilant Pharmova Limited has informed the Exchange regarding a press release dated February 06, 2026, titled "Press Release alongwith Earnings Presentation on the financials and operational performance of the Company for the quarter and nine months ended December 31, 2025".
[930] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-10)/Solara Active Pharma Sciences Limited has informed the Exchange about Transcript of earnings call pertaining to unaudited financial results of the Company for the quarter and nine months ended December 31, 2025.
[931] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-10)/Solara Active Pharma Sciences Limited has informed the Exchange about Transcript of earnings call pertaining to unaudited financial results of the Company for the quarter and nine months ended December 31, 2025.
[932] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-17)/Hikal Limited has informed the Exchange about Transcript
[933] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-17)/Hikal Limited has informed the Exchange about Transcript
[934] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-16)/GlaxoSmithKline Pharmaceuticals Limited has informed the Exchange about Transcript
[935] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-16)/GlaxoSmithKline Pharmaceuticals Limited has informed the Exchange about Transcript
[936] Analysts/Institutional Investor Meet/Con. Call Updates (2025-06-11)/Wockhardt Limited has informed the Exchange about Transcript
[937] Analysts/Institutional Investor Meet/Con. Call Updates (2025-06-11)/Wockhardt Limited has informed the Exchange about Transcript
[938] Analysts/Institutional Investor Meet/Con. Call Updates (2025-06-11)/Wockhardt Limited has informed the Exchange about Transcript
[939] Analysts/Institutional Investor Meet/Con. Call Updates (2025-06-11)/Wockhardt Limited has informed the Exchange about Transcript
[940] Analysts/Institutional Investor Meet/Con. Call Updates (2025-06-11)/Wockhardt Limited has informed the Exchange about Transcript
[941] Analysts/Institutional Investor Meet/Con. Call Updates (2025-06-11)/Wockhardt Limited has informed the Exchange about Transcript
[942] Press Release (2026-02-06)/Jubilant Pharmova Limited has informed the Exchange regarding a press release dated February 06, 2026, titled "Press Release alongwith Earnings Presentation on the financials and operational performance of the Company for the quarter and nine months ended December 31, 2025".
[943] Press Release (2026-02-06)/Jubilant Pharmova Limited has informed the Exchange regarding a press release dated February 06, 2026, titled "Press Release alongwith Earnings Presentation on the financials and operational performance of the Company for the quarter and nine months ended December 31, 2025".
[944] Press Release (2026-02-06)/Jubilant Pharmova Limited has informed the Exchange regarding a press release dated February 06, 2026, titled "Press Release alongwith Earnings Presentation on the financials and operational performance of the Company for the quarter and nine months ended December 31, 2025".
[945] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-17)/Hikal Limited has informed the Exchange about Transcript
[946] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-17)/Hikal Limited has informed the Exchange about Transcript
[947] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-17)/Hikal Limited has informed the Exchange about Transcript
[948] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-17)/Hikal Limited has informed the Exchange about Transcript
[949] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-17)/Hikal Limited has informed the Exchange about Transcript
[950] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-17)/Hikal Limited has informed the Exchange about Transcript
[951] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-10)/Solara Active Pharma Sciences Limited has informed the Exchange about Transcript of earnings call pertaining to unaudited financial results of the Company for the quarter and nine months ended December 31, 2025.
[952] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-10)/Solara Active Pharma Sciences Limited has informed the Exchange about Transcript of earnings call pertaining to unaudited financial results of the Company for the quarter and nine months ended December 31, 2025.
[953] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-10)/Solara Active Pharma Sciences Limited has informed the Exchange about Transcript of earnings call pertaining to unaudited financial results of the Company for the quarter and nine months ended December 31, 2025.
[954] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-16)/Orchid Pharma Limited has informed the Exchange about Transcript
[955] Press Release (2026-02-06)/Solara Active Pharma Sciences Limited has informed the exchange regarding the press release dated February 06, 2026, titled "Solara Q3'26 Performance."
[956] Analysts/Institutional Investor Meet/Con. Call Updates (2025-11-19)/Natural Capsules Limited has informed the Exchange about Transcript
[957] Analysts/Institutional Investor Meet/Con. Call Updates (2025-11-19)/Natural Capsules Limited has informed the Exchange about Transcript
[958] Analysts/Institutional Investor Meet/Con. Call Updates (2025-11-19)/Natural Capsules Limited has informed the Exchange about Transcript
[959] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-12)/Marksans Pharma Limited transcript of Investors/Analyst meet on Q3 9M FY 26 Unaudited Financial Results held on February 06, 2026
[960] Analysts/Institutional Investor Meet/Con. Call Updates (2025-11-19)/Natural Capsules Limited has informed the Exchange about Transcript
[961] Analysts/Institutional Investor Meet/Con. Call Updates (2025-11-19)/Natural Capsules Limited has informed the Exchange about Transcript
[962] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-17)/Hikal Limited has informed the Exchange about Transcript
[963] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-17)/Hikal Limited has informed the Exchange about Transcript
[964] Investor Presentation (2026-02-13)/Natural Capsules Limited has informed the Exchange about Investor Presentation
[965] Analysts/Institutional Investor Meet/Con. Call Updates (2025-11-19)/Natural Capsules Limited has informed the Exchange about Transcript
[966] Analysts/Institutional Investor Meet/Con. Call Updates (2025-11-19)/Natural Capsules Limited has informed the Exchange about Transcript
[967] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-14)/Divi's Laboratories Limited has informed the Exchange about Transcript
[968] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-14)/Divi's Laboratories Limited has informed the Exchange about Transcript
[969] Investor Presentation (2026-01-22)/Kopran Limited has informed the Exchange about Investor Presentation
[970] Analysts/Institutional Investor Meet/Con. Call Updates (2025-11-19)/Natural Capsules Limited has informed the Exchange about Transcript
[971] Analysts/Institutional Investor Meet/Con. Call Updates (2025-11-19)/Natural Capsules Limited has informed the Exchange about Transcript
[972] Analysts/Institutional Investor Meet/Con. Call Updates (2025-11-19)/Natural Capsules Limited has informed the Exchange about Transcript
[973] Press Release (2026-02-06)/Jubilant Pharmova Limited has informed the Exchange regarding a press release dated February 06, 2026, titled "Press Release alongwith Earnings Presentation on the financials and operational performance of the Company for the quarter and nine months ended December 31, 2025".
[974] Press Release (2026-02-06)/Jubilant Pharmova Limited has informed the Exchange regarding a press release dated February 06, 2026, titled "Press Release alongwith Earnings Presentation on the financials and operational performance of the Company for the quarter and nine months ended December 31, 2025".
[975] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-17)/Hikal Limited has informed the Exchange about Transcript
[976] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-17)/Hikal Limited has informed the Exchange about Transcript
[977] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-17)/Hikal Limited has informed the Exchange about Transcript
[978] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-17)/Hikal Limited has informed the Exchange about Transcript
[979] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-17)/Hikal Limited has informed the Exchange about Transcript
[980] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-17)/Hikal Limited has informed the Exchange about Transcript
[981] Press Release (2026-02-06)/Jubilant Pharmova Limited has informed the Exchange regarding a press release dated February 06, 2026, titled "Press Release alongwith Earnings Presentation on the financials and operational performance of the Company for the quarter and nine months ended December 31, 2025".
[982] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-10)/Solara Active Pharma Sciences Limited has informed the Exchange about Transcript of earnings call pertaining to unaudited financial results of the Company for the quarter and nine months ended December 31, 2025.
[983] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-10)/Solara Active Pharma Sciences Limited has informed the Exchange about Transcript of earnings call pertaining to unaudited financial results of the Company for the quarter and nine months ended December 31, 2025.
[984] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-17)/Hikal Limited has informed the Exchange about Transcript
[985] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-17)/Hikal Limited has informed the Exchange about Transcript
[986] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-16)/GlaxoSmithKline Pharmaceuticals Limited has informed the Exchange about Transcript
[987] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-16)/GlaxoSmithKline Pharmaceuticals Limited has informed the Exchange about Transcript
[988] Analysts/Institutional Investor Meet/Con. Call Updates (2025-06-11)/Wockhardt Limited has informed the Exchange about Transcript
[989] Analysts/Institutional Investor Meet/Con. Call Updates (2025-06-11)/Wockhardt Limited has informed the Exchange about Transcript
[990] Analysts/Institutional Investor Meet/Con. Call Updates (2025-06-11)/Wockhardt Limited has informed the Exchange about Transcript
[991] Analysts/Institutional Investor Meet/Con. Call Updates (2025-06-11)/Wockhardt Limited has informed the Exchange about Transcript
[992] Analysts/Institutional Investor Meet/Con. Call Updates (2025-06-11)/Wockhardt Limited has informed the Exchange about Transcript
[993] Analysts/Institutional Investor Meet/Con. Call Updates (2025-06-11)/Wockhardt Limited has informed the Exchange about Transcript
[994] Press Release (2026-02-06)/Jubilant Pharmova Limited has informed the Exchange regarding a press release dated February 06, 2026, titled "Press Release alongwith Earnings Presentation on the financials and operational performance of the Company for the quarter and nine months ended December 31, 2025".
[995] Press Release (2026-02-06)/Jubilant Pharmova Limited has informed the Exchange regarding a press release dated February 06, 2026, titled "Press Release alongwith Earnings Presentation on the financials and operational performance of the Company for the quarter and nine months ended December 31, 2025".
[996] Press Release (2026-02-06)/Jubilant Pharmova Limited has informed the Exchange regarding a press release dated February 06, 2026, titled "Press Release alongwith Earnings Presentation on the financials and operational performance of the Company for the quarter and nine months ended December 31, 2025".
[997] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-17)/Hikal Limited has informed the Exchange about Transcript
[998] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-17)/Hikal Limited has informed the Exchange about Transcript
[999] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-17)/Hikal Limited has informed the Exchange about Transcript
[1000] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-17)/Hikal Limited has informed the Exchange about Transcript
[1001] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-17)/Hikal Limited has informed the Exchange about Transcript
[1002] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-17)/Hikal Limited has informed the Exchange about Transcript
[1003] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-17)/Hikal Limited has informed the Exchange about Transcript
[1004] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-10)/Solara Active Pharma Sciences Limited has informed the Exchange about Transcript of earnings call pertaining to unaudited financial results of the Company for the quarter and nine months ended December 31, 2025.
[1005] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-10)/Solara Active Pharma Sciences Limited has informed the Exchange about Transcript of earnings call pertaining to unaudited financial results of the Company for the quarter and nine months ended December 31, 2025.
[1006] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-10)/Solara Active Pharma Sciences Limited has informed the Exchange about Transcript of earnings call pertaining to unaudited financial results of the Company for the quarter and nine months ended December 31, 2025.
[1007] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-16)/Orchid Pharma Limited has informed the Exchange about Transcript
[1008] Press Release (2026-02-06)/Solara Active Pharma Sciences Limited has informed the exchange regarding the press release dated February 06, 2026, titled "Solara Q3'26 Performance."
[1009] Analysts/Institutional Investor Meet/Con. Call Updates (2025-11-19)/Natural Capsules Limited has informed the Exchange about Transcript
[1010] Analysts/Institutional Investor Meet/Con. Call Updates (2025-11-19)/Natural Capsules Limited has informed the Exchange about Transcript
[1011] Analysts/Institutional Investor Meet/Con. Call Updates (2025-11-19)/Natural Capsules Limited has informed the Exchange about Transcript
[1012] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-12)/Marksans Pharma Limited transcript of Investors/Analyst meet on Q3 9M FY 26 Unaudited Financial Results held on February 06, 2026
[1013] Analysts/Institutional Investor Meet/Con. Call Updates (2025-11-19)/Natural Capsules Limited has informed the Exchange about Transcript
[1014] Analysts/Institutional Investor Meet/Con. Call Updates (2025-11-19)/Natural Capsules Limited has informed the Exchange about Transcript
[1015] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-17)/Hikal Limited has informed the Exchange about Transcript
[1016] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-17)/Hikal Limited has informed the Exchange about Transcript
[1017] Investor Presentation (2026-02-13)/Natural Capsules Limited has informed the Exchange about Investor Presentation
[1018] Analysts/Institutional Investor Meet/Con. Call Updates (2025-11-19)/Natural Capsules Limited has informed the Exchange about Transcript
[1019] Analysts/Institutional Investor Meet/Con. Call Updates (2025-11-19)/Natural Capsules Limited has informed the Exchange about Transcript
[1020] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-14)/Divi's Laboratories Limited has informed the Exchange about Transcript
[1021] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-14)/Divi's Laboratories Limited has informed the Exchange about Transcript
[1022] Investor Presentation (2026-01-22)/Kopran Limited has informed the Exchange about Investor Presentation
[1023] Analysts/Institutional Investor Meet/Con. Call Updates (2025-11-19)/Natural Capsules Limited has informed the Exchange about Transcript
[1024] Analysts/Institutional Investor Meet/Con. Call Updates (2025-11-19)/Natural Capsules Limited has informed the Exchange about Transcript
[1025] Analysts/Institutional Investor Meet/Con. Call Updates (2025-11-19)/Natural Capsules Limited has informed the Exchange about Transcript
[1026] Press Release (2026-02-06)/Jubilant Pharmova Limited has informed the Exchange regarding a press release dated February 06, 2026, titled "Press Release alongwith Earnings Presentation on the financials and operational performance of the Company for the quarter and nine months ended December 31, 2025".
[1027] Press Release (2026-02-06)/Jubilant Pharmova Limited has informed the Exchange regarding a press release dated February 06, 2026, titled "Press Release alongwith Earnings Presentation on the financials and operational performance of the Company for the quarter and nine months ended December 31, 2025".
[1028] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-17)/Hikal Limited has informed the Exchange about Transcript
[1029] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-17)/Hikal Limited has informed the Exchange about Transcript
[1030] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-17)/Hikal Limited has informed the Exchange about Transcript
[1031] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-17)/Hikal Limited has informed the Exchange about Transcript
[1032] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-17)/Hikal Limited has informed the Exchange about Transcript
[1033] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-17)/Hikal Limited has informed the Exchange about Transcript
[1034] Press Release (2026-02-06)/Jubilant Pharmova Limited has informed the Exchange regarding a press release dated February 06, 2026, titled "Press Release alongwith Earnings Presentation on the financials and operational performance of the Company for the quarter and nine months ended December 31, 2025".
[1035] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-10)/Solara Active Pharma Sciences Limited has informed the Exchange about Transcript of earnings call pertaining to unaudited financial results of the Company for the quarter and nine months ended December 31, 2025.
[1036] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-10)/Solara Active Pharma Sciences Limited has informed the Exchange about Transcript of earnings call pertaining to unaudited financial results of the Company for the quarter and nine months ended December 31, 2025.
[1037] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-17)/Hikal Limited has informed the Exchange about Transcript
[1038] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-17)/Hikal Limited has informed the Exchange about Transcript
[1039] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-16)/GlaxoSmithKline Pharmaceuticals Limited has informed the Exchange about Transcript
[1040] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-16)/GlaxoSmithKline Pharmaceuticals Limited has informed the Exchange about Transcript
[1041] Analysts/Institutional Investor Meet/Con. Call Updates (2025-06-11)/Wockhardt Limited has informed the Exchange about Transcript
[1042] Analysts/Institutional Investor Meet/Con. Call Updates (2025-06-11)/Wockhardt Limited has informed the Exchange about Transcript
[1043] Analysts/Institutional Investor Meet/Con. Call Updates (2025-06-11)/Wockhardt Limited has informed the Exchange about Transcript
[1044] Analysts/Institutional Investor Meet/Con. Call Updates (2025-06-11)/Wockhardt Limited has informed the Exchange about Transcript
[1045] Analysts/Institutional Investor Meet/Con. Call Updates (2025-06-11)/Wockhardt Limited has informed the Exchange about Transcript
[1046] Analysts/Institutional Investor Meet/Con. Call Updates (2025-06-11)/Wockhardt Limited has informed the Exchange about Transcript
[1047] Press Release (2026-02-06)/Jubilant Pharmova Limited has informed the Exchange regarding a press release dated February 06, 2026, titled "Press Release alongwith Earnings Presentation on the financials and operational performance of the Company for the quarter and nine months ended December 31, 2025".
[1048] Press Release (2026-02-06)/Jubilant Pharmova Limited has informed the Exchange regarding a press release dated February 06, 2026, titled "Press Release alongwith Earnings Presentation on the financials and operational performance of the Company for the quarter and nine months ended December 31, 2025".
[1049] Press Release (2026-02-06)/Jubilant Pharmova Limited has informed the Exchange regarding a press release dated February 06, 2026, titled "Press Release alongwith Earnings Presentation on the financials and operational performance of the Company for the quarter and nine months ended December 31, 2025".
[1050] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-17)/Hikal Limited has informed the Exchange about Transcript
[1051] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-17)/Hikal Limited has informed the Exchange about Transcript
[1052] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-17)/Hikal Limited has informed the Exchange about Transcript
[1053] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-17)/Hikal Limited has informed the Exchange about Transcript
[1054] Outcome of Board Meeting (2026-02-12)/Cohance Lifesciences Limited has submitted to the Exchange, the financial results for the period ended December 31, 2025.
[1055] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-17)/Hikal Limited has informed the Exchange about Transcript
[1056] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-17)/Hikal Limited has informed the Exchange about Transcript
[1057] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-17)/Hikal Limited has informed the Exchange about Transcript
[1058] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-17)/Hikal Limited has informed the Exchange about Transcript
[1059] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-10)/Solara Active Pharma Sciences Limited has informed the Exchange about Transcript of earnings call pertaining to unaudited financial results of the Company for the quarter and nine months ended December 31, 2025.
[1060] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-10)/Solara Active Pharma Sciences Limited has informed the Exchange about Transcript of earnings call pertaining to unaudited financial results of the Company for the quarter and nine months ended December 31, 2025.
[1061] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-10)/Solara Active Pharma Sciences Limited has informed the Exchange about Transcript of earnings call pertaining to unaudited financial results of the Company for the quarter and nine months ended December 31, 2025.
[1062] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-16)/Orchid Pharma Limited has informed the Exchange about Transcript
[1063] Press Release (2026-02-06)/Solara Active Pharma Sciences Limited has informed the exchange regarding the press release dated February 06, 2026, titled "Solara Q3'26 Performance."
[1064] Analysts/Institutional Investor Meet/Con. Call Updates (2025-11-19)/Natural Capsules Limited has informed the Exchange about Transcript
[1065] Analysts/Institutional Investor Meet/Con. Call Updates (2025-11-19)/Natural Capsules Limited has informed the Exchange about Transcript
[1066] Analysts/Institutional Investor Meet/Con. Call Updates (2025-11-19)/Natural Capsules Limited has informed the Exchange about Transcript
[1067] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-12)/Marksans Pharma Limited transcript of Investors/Analyst meet on Q3 9M FY 26 Unaudited Financial Results held on February 06, 2026
[1068] Analysts/Institutional Investor Meet/Con. Call Updates (2025-11-19)/Natural Capsules Limited has informed the Exchange about Transcript
[1069] Analysts/Institutional Investor Meet/Con. Call Updates (2025-11-19)/Natural Capsules Limited has informed the Exchange about Transcript
[1070] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-17)/Hikal Limited has informed the Exchange about Transcript
[1071] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-17)/Hikal Limited has informed the Exchange about Transcript
[1072] Investor Presentation (2026-02-13)/Natural Capsules Limited has informed the Exchange about Investor Presentation
[1073] Analysts/Institutional Investor Meet/Con. Call Updates (2025-11-19)/Natural Capsules Limited has informed the Exchange about Transcript
[1074] Analysts/Institutional Investor Meet/Con. Call Updates (2025-11-19)/Natural Capsules Limited has informed the Exchange about Transcript
[1075] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-14)/Divi's Laboratories Limited has informed the Exchange about Transcript
[1076] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-14)/Divi's Laboratories Limited has informed the Exchange about Transcript
[1077] Investor Presentation (2026-01-22)/Kopran Limited has informed the Exchange about Investor Presentation
[1078] Analysts/Institutional Investor Meet/Con. Call Updates (2025-11-19)/Natural Capsules Limited has informed the Exchange about Transcript
[1079] Analysts/Institutional Investor Meet/Con. Call Updates (2025-11-19)/Natural Capsules Limited has informed the Exchange about Transcript
[1080] Analysts/Institutional Investor Meet/Con. Call Updates (2025-11-19)/Natural Capsules Limited has informed the Exchange about Transcript
[1081] Press Release (2026-02-06)/Jubilant Pharmova Limited has informed the Exchange regarding a press release dated February 06, 2026, titled "Press Release alongwith Earnings Presentation on the financials and operational performance of the Company for the quarter and nine months ended December 31, 2025".
[1082] Press Release (2026-02-06)/Jubilant Pharmova Limited has informed the Exchange regarding a press release dated February 06, 2026, titled "Press Release alongwith Earnings Presentation on the financials and operational performance of the Company for the quarter and nine months ended December 31, 2025".
[1083] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-17)/Hikal Limited has informed the Exchange about Transcript
[1084] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-17)/Hikal Limited has informed the Exchange about Transcript
[1085] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-17)/Hikal Limited has informed the Exchange about Transcript
[1086] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-17)/Hikal Limited has informed the Exchange about Transcript
[1087] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-17)/Hikal Limited has informed the Exchange about Transcript
[1088] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-17)/Hikal Limited has informed the Exchange about Transcript
[1089] Press Release (2026-02-06)/Jubilant Pharmova Limited has informed the Exchange regarding a press release dated February 06, 2026, titled "Press Release alongwith Earnings Presentation on the financials and operational performance of the Company for the quarter and nine months ended December 31, 2025".
[1090] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-10)/Solara Active Pharma Sciences Limited has informed the Exchange about Transcript of earnings call pertaining to unaudited financial results of the Company for the quarter and nine months ended December 31, 2025.
[1091] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-10)/Solara Active Pharma Sciences Limited has informed the Exchange about Transcript of earnings call pertaining to unaudited financial results of the Company for the quarter and nine months ended December 31, 2025.
[1092] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-17)/Hikal Limited has informed the Exchange about Transcript
[1093] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-17)/Hikal Limited has informed the Exchange about Transcript
[1094] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-16)/GlaxoSmithKline Pharmaceuticals Limited has informed the Exchange about Transcript
[1095] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-16)/GlaxoSmithKline Pharmaceuticals Limited has informed the Exchange about Transcript
[1096] Analysts/Institutional Investor Meet/Con. Call Updates (2025-06-11)/Wockhardt Limited has informed the Exchange about Transcript
[1097] Analysts/Institutional Investor Meet/Con. Call Updates (2025-06-11)/Wockhardt Limited has informed the Exchange about Transcript
[1098] Analysts/Institutional Investor Meet/Con. Call Updates (2025-06-11)/Wockhardt Limited has informed the Exchange about Transcript
[1099] Analysts/Institutional Investor Meet/Con. Call Updates (2025-06-11)/Wockhardt Limited has informed the Exchange about Transcript
[1100] Analysts/Institutional Investor Meet/Con. Call Updates (2025-06-11)/Wockhardt Limited has informed the Exchange about Transcript
[1101] Analysts/Institutional Investor Meet/Con. Call Updates (2025-06-11)/Wockhardt Limited has informed the Exchange about Transcript
[1102] Press Release (2026-02-06)/Jubilant Pharmova Limited has informed the Exchange regarding a press release dated February 06, 2026, titled "Press Release alongwith Earnings Presentation on the financials and operational performance of the Company for the quarter and nine months ended December 31, 2025".
[1103] Press Release (2026-02-06)/Jubilant Pharmova Limited has informed the Exchange regarding a press release dated February 06, 2026, titled "Press Release alongwith Earnings Presentation on the financials and operational performance of the Company for the quarter and nine months ended December 31, 2025".
[1104] Press Release (2026-02-06)/Jubilant Pharmova Limited has informed the Exchange regarding a press release dated February 06, 2026, titled "Press Release alongwith Earnings Presentation on the financials and operational performance of the Company for the quarter and nine months ended December 31, 2025".
[1105] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-17)/Hikal Limited has informed the Exchange about Transcript
[1106] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-17)/Hikal Limited has informed the Exchange about Transcript
[1107] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-17)/Hikal Limited has informed the Exchange about Transcript
[1108] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-17)/Hikal Limited has informed the Exchange about Transcript
[1109] Outcome of Board Meeting (2026-02-12)/Cohance Lifesciences Limited has submitted to the Exchange, the financial results for the period ended December 31, 2025.
[1110] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-17)/Hikal Limited has informed the Exchange about Transcript
[1111] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-17)/Hikal Limited has informed the Exchange about Transcript
[1112] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-17)/Hikal Limited has informed the Exchange about Transcript
[1113] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-17)/Hikal Limited has informed the Exchange about Transcript
[1114] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-10)/Solara Active Pharma Sciences Limited has informed the Exchange about Transcript of earnings call pertaining to unaudited financial results of the Company for the quarter and nine months ended December 31, 2025.
[1115] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-10)/Solara Active Pharma Sciences Limited has informed the Exchange about Transcript of earnings call pertaining to unaudited financial results of the Company for the quarter and nine months ended December 31, 2025.
[1116] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-10)/Solara Active Pharma Sciences Limited has informed the Exchange about Transcript of earnings call pertaining to unaudited financial results of the Company for the quarter and nine months ended December 31, 2025.
[1117] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-16)/Orchid Pharma Limited has informed the Exchange about Transcript
[1118] Press Release (2026-02-06)/Solara Active Pharma Sciences Limited has informed the exchange regarding the press release dated February 06, 2026, titled "Solara Q3'26 Performance."
[1119] Analysts/Institutional Investor Meet/Con. Call Updates (2025-11-19)/Natural Capsules Limited has informed the Exchange about Transcript
[1120] Analysts/Institutional Investor Meet/Con. Call Updates (2025-11-19)/Natural Capsules Limited has informed the Exchange about Transcript
[1121] Analysts/Institutional Investor Meet/Con. Call Updates (2025-11-19)/Natural Capsules Limited has informed the Exchange about Transcript
[1122] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-12)/Marksans Pharma Limited transcript of Investors/Analyst meet on Q3 9M FY 26 Unaudited Financial Results held on February 06, 2026
[1123] Analysts/Institutional Investor Meet/Con. Call Updates (2025-11-19)/Natural Capsules Limited has informed the Exchange about Transcript
[1124] Analysts/Institutional Investor Meet/Con. Call Updates (2025-11-19)/Natural Capsules Limited has informed the Exchange about Transcript
[1125] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-17)/Hikal Limited has informed the Exchange about Transcript
[1126] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-17)/Hikal Limited has informed the Exchange about Transcript
[1127] Investor Presentation (2026-02-13)/Natural Capsules Limited has informed the Exchange about Investor Presentation
[1128] Analysts/Institutional Investor Meet/Con. Call Updates (2025-11-19)/Natural Capsules Limited has informed the Exchange about Transcript
[1129] Analysts/Institutional Investor Meet/Con. Call Updates (2025-11-19)/Natural Capsules Limited has informed the Exchange about Transcript
[1130] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-14)/Divi's Laboratories Limited has informed the Exchange about Transcript
[1131] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-14)/Divi's Laboratories Limited has informed the Exchange about Transcript
[1132] Investor Presentation (2026-01-22)/Kopran Limited has informed the Exchange about Investor Presentation
[1133] Analysts/Institutional Investor Meet/Con. Call Updates (2025-11-19)/Natural Capsules Limited has informed the Exchange about Transcript
[1134] Analysts/Institutional Investor Meet/Con. Call Updates (2025-11-19)/Natural Capsules Limited has informed the Exchange about Transcript
[1135] Analysts/Institutional Investor Meet/Con. Call Updates (2025-11-19)/Natural Capsules Limited has informed the Exchange about Transcript
[1136] Press Release (2026-02-06)/Jubilant Pharmova Limited has informed the Exchange regarding a press release dated February 06, 2026, titled "Press Release alongwith Earnings Presentation on the financials and operational performance of the Company for the quarter and nine months ended December 31, 2025".
[1137] Press Release (2026-02-06)/Jubilant Pharmova Limited has informed the Exchange regarding a press release dated February 06, 2026, titled "Press Release alongwith Earnings Presentation on the financials and operational performance of the Company for the quarter and nine months ended December 31, 2025".
[1138] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-17)/Hikal Limited has informed the Exchange about Transcript
[1139] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-17)/Hikal Limited has informed the Exchange about Transcript
[1140] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-17)/Hikal Limited has informed the Exchange about Transcript
[1141] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-17)/Hikal Limited has informed the Exchange about Transcript
[1142] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-17)/Hikal Limited has informed the Exchange about Transcript
[1143] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-17)/Hikal Limited has informed the Exchange about Transcript
[1144] Press Release (2026-02-06)/Jubilant Pharmova Limited has informed the Exchange regarding a press release dated February 06, 2026, titled "Press Release alongwith Earnings Presentation on the financials and operational performance of the Company for the quarter and nine months ended December 31, 2025".
[1145] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-10)/Solara Active Pharma Sciences Limited has informed the Exchange about Transcript of earnings call pertaining to unaudited financial results of the Company for the quarter and nine months ended December 31, 2025.
[1146] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-10)/Solara Active Pharma Sciences Limited has informed the Exchange about Transcript of earnings call pertaining to unaudited financial results of the Company for the quarter and nine months ended December 31, 2025.
[1147] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-17)/Hikal Limited has informed the Exchange about Transcript
[1148] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-17)/Hikal Limited has informed the Exchange about Transcript
[1149] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-16)/GlaxoSmithKline Pharmaceuticals Limited has informed the Exchange about Transcript
[1150] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-16)/GlaxoSmithKline Pharmaceuticals Limited has informed the Exchange about Transcript
[1151] Analysts/Institutional Investor Meet/Con. Call Updates (2025-06-11)/Wockhardt Limited has informed the Exchange about Transcript
[1152] Analysts/Institutional Investor Meet/Con. Call Updates (2025-06-11)/Wockhardt Limited has informed the Exchange about Transcript
[1153] Analysts/Institutional Investor Meet/Con. Call Updates (2025-06-11)/Wockhardt Limited has informed the Exchange about Transcript
[1154] Analysts/Institutional Investor Meet/Con. Call Updates (2025-06-11)/Wockhardt Limited has informed the Exchange about Transcript
[1155] Analysts/Institutional Investor Meet/Con. Call Updates (2025-06-11)/Wockhardt Limited has informed the Exchange about Transcript
[1156] Analysts/Institutional Investor Meet/Con. Call Updates (2025-06-11)/Wockhardt Limited has informed the Exchange about Transcript
[1157] Press Release (2026-02-06)/Jubilant Pharmova Limited has informed the Exchange regarding a press release dated February 06, 2026, titled "Press Release alongwith Earnings Presentation on the financials and operational performance of the Company for the quarter and nine months ended December 31, 2025".
[1158] Press Release (2026-02-06)/Jubilant Pharmova Limited has informed the Exchange regarding a press release dated February 06, 2026, titled "Press Release alongwith Earnings Presentation on the financials and operational performance of the Company for the quarter and nine months ended December 31, 2025".
[1159] Press Release (2026-02-06)/Jubilant Pharmova Limited has informed the Exchange regarding a press release dated February 06, 2026, titled "Press Release alongwith Earnings Presentation on the financials and operational performance of the Company for the quarter and nine months ended December 31, 2025".
[1160] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-17)/Hikal Limited has informed the Exchange about Transcript
[1161] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-17)/Hikal Limited has informed the Exchange about Transcript
[1162] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-17)/Hikal Limited has informed the Exchange about Transcript
[1163] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-17)/Hikal Limited has informed the Exchange about Transcript
[1164] Outcome of Board Meeting (2026-02-12)/Cohance Lifesciences Limited has submitted to the Exchange, the financial results for the period ended December 31, 2025.
[1165] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-17)/Hikal Limited has informed the Exchange about Transcript
[1166] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-17)/Hikal Limited has informed the Exchange about Transcript
[1167] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-17)/Hikal Limited has informed the Exchange about Transcript
[1168] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-17)/Hikal Limited has informed the Exchange about Transcript
[1169] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-10)/Solara Active Pharma Sciences Limited has informed the Exchange about Transcript of earnings call pertaining to unaudited financial results of the Company for the quarter and nine months ended December 31, 2025.
[1170] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-10)/Solara Active Pharma Sciences Limited has informed the Exchange about Transcript of earnings call pertaining to unaudited financial results of the Company for the quarter and nine months ended December 31, 2025.
[1171] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-10)/Solara Active Pharma Sciences Limited has informed the Exchange about Transcript of earnings call pertaining to unaudited financial results of the Company for the quarter and nine months ended December 31, 2025.
[1172] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-16)/Orchid Pharma Limited has informed the Exchange about Transcript
[1173] Press Release (2026-02-06)/Solara Active Pharma Sciences Limited has informed the exchange regarding the press release dated February 06, 2026, titled "Solara Q3'26 Performance."
[1174] Analysts/Institutional Investor Meet/Con. Call Updates (2025-11-19)/Natural Capsules Limited has informed the Exchange about Transcript
[1175] Analysts/Institutional Investor Meet/Con. Call Updates (2025-11-19)/Natural Capsules Limited has informed the Exchange about Transcript
[1176] Analysts/Institutional Investor Meet/Con. Call Updates (2025-11-19)/Natural Capsules Limited has informed the Exchange about Transcript
[1177] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-12)/Marksans Pharma Limited transcript of Investors/Analyst meet on Q3 9M FY 26 Unaudited Financial Results held on February 06, 2026
[1178] Analysts/Institutional Investor Meet/Con. Call Updates (2025-11-19)/Natural Capsules Limited has informed the Exchange about Transcript
[1179] Analysts/Institutional Investor Meet/Con. Call Updates (2025-11-19)/Natural Capsules Limited has informed the Exchange about Transcript
[1180] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-17)/Hikal Limited has informed the Exchange about Transcript
[1181] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-17)/Hikal Limited has informed the Exchange about Transcript
[1182] Investor Presentation (2026-02-13)/Natural Capsules Limited has informed the Exchange about Investor Presentation
[1183] Analysts/Institutional Investor Meet/Con. Call Updates (2025-11-19)/Natural Capsules Limited has informed the Exchange about Transcript
[1184] Analysts/Institutional Investor Meet/Con. Call Updates (2025-11-19)/Natural Capsules Limited has informed the Exchange about Transcript
[1185] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-14)/Divi's Laboratories Limited has informed the Exchange about Transcript
[1186] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-14)/Divi's Laboratories Limited has informed the Exchange about Transcript
[1187] Investor Presentation (2026-01-22)/Kopran Limited has informed the Exchange about Investor Presentation
[1188] Analysts/Institutional Investor Meet/Con. Call Updates (2025-11-19)/Natural Capsules Limited has informed the Exchange about Transcript
[1189] Analysts/Institutional Investor Meet/Con. Call Updates (2025-11-19)/Natural Capsules Limited has informed the Exchange about Transcript
[1190] Analysts/Institutional Investor Meet/Con. Call Updates (2025-11-19)/Natural Capsules Limited has informed the Exchange about Transcript
[1191] Press Release (2026-02-06)/Jubilant Pharmova Limited has informed the Exchange regarding a press release dated February 06, 2026, titled "Press Release alongwith Earnings Presentation on the financials and operational performance of the Company for the quarter and nine months ended December 31, 2025".
[1192] Press Release (2026-02-06)/Jubilant Pharmova Limited has informed the Exchange regarding a press release dated February 06, 2026, titled "Press Release alongwith Earnings Presentation on the financials and operational performance of the Company for the quarter and nine months ended December 31, 2025".
[1193] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-17)/Hikal Limited has informed the Exchange about Transcript
[1194] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-17)/Hikal Limited has informed the Exchange about Transcript
[1195] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-17)/Hikal Limited has informed the Exchange about Transcript
[1196] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-17)/Hikal Limited has informed the Exchange about Transcript
[1197] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-17)/Hikal Limited has informed the Exchange about Transcript
[1198] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-17)/Hikal Limited has informed the Exchange about Transcript
[1199] Press Release (2026-02-06)/Jubilant Pharmova Limited has informed the Exchange regarding a press release dated February 06, 2026, titled "Press Release alongwith Earnings Presentation on the financials and operational performance of the Company for the quarter and nine months ended December 31, 2025".
[1200] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-10)/Solara Active Pharma Sciences Limited has informed the Exchange about Transcript of earnings call pertaining to unaudited financial results of the Company for the quarter and nine months ended December 31, 2025.
[1201] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-10)/Solara Active Pharma Sciences Limited has informed the Exchange about Transcript of earnings call pertaining to unaudited financial results of the Company for the quarter and nine months ended December 31, 2025.
[1202] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-17)/Hikal Limited has informed the Exchange about Transcript
[1203] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-17)/Hikal Limited has informed the Exchange about Transcript
[1204] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-16)/GlaxoSmithKline Pharmaceuticals Limited has informed the Exchange about Transcript
[1205] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-16)/GlaxoSmithKline Pharmaceuticals Limited has informed the Exchange about Transcript
[1206] Analysts/Institutional Investor Meet/Con. Call Updates (2025-06-11)/Wockhardt Limited has informed the Exchange about Transcript
[1207] Analysts/Institutional Investor Meet/Con. Call Updates (2025-06-11)/Wockhardt Limited has informed the Exchange about Transcript
[1208] Analysts/Institutional Investor Meet/Con. Call Updates (2025-06-11)/Wockhardt Limited has informed the Exchange about Transcript
[1209] Analysts/Institutional Investor Meet/Con. Call Updates (2025-06-11)/Wockhardt Limited has informed the Exchange about Transcript
[1210] Analysts/Institutional Investor Meet/Con. Call Updates (2025-06-11)/Wockhardt Limited has informed the Exchange about Transcript
[1211] Analysts/Institutional Investor Meet/Con. Call Updates (2025-06-11)/Wockhardt Limited has informed the Exchange about Transcript
[1212] Press Release (2026-02-06)/Jubilant Pharmova Limited has informed the Exchange regarding a press release dated February 06, 2026, titled "Press Release alongwith Earnings Presentation on the financials and operational performance of the Company for the quarter and nine months ended December 31, 2025".
[1213] Press Release (2026-02-06)/Jubilant Pharmova Limited has informed the Exchange regarding a press release dated February 06, 2026, titled "Press Release alongwith Earnings Presentation on the financials and operational performance of the Company for the quarter and nine months ended December 31, 2025".
[1214] Press Release (2026-02-06)/Jubilant Pharmova Limited has informed the Exchange regarding a press release dated February 06, 2026, titled "Press Release alongwith Earnings Presentation on the financials and operational performance of the Company for the quarter and nine months ended December 31, 2025".
[1215] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-17)/Hikal Limited has informed the Exchange about Transcript
[1216] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-17)/Hikal Limited has informed the Exchange about Transcript
[1217] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-17)/Hikal Limited has informed the Exchange about Transcript
[1218] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-17)/Hikal Limited has informed the Exchange about Transcript
[1219] Outcome of Board Meeting (2026-02-12)/Cohance Lifesciences Limited has submitted to the Exchange, the financial results for the period ended December 31, 2025.
[1220] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-17)/Hikal Limited has informed the Exchange about Transcript
[1221] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-17)/Hikal Limited has informed the Exchange about Transcript
[1222] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-17)/Hikal Limited has informed the Exchange about Transcript
[1223] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-17)/Hikal Limited has informed the Exchange about Transcript
[1224] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-10)/Solara Active Pharma Sciences Limited has informed the Exchange about Transcript of earnings call pertaining to unaudited financial results of the Company for the quarter and nine months ended December 31, 2025.
[1225] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-10)/Solara Active Pharma Sciences Limited has informed the Exchange about Transcript of earnings call pertaining to unaudited financial results of the Company for the quarter and nine months ended December 31, 2025.
[1226] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-10)/Solara Active Pharma Sciences Limited has informed the Exchange about Transcript of earnings call pertaining to unaudited financial results of the Company for the quarter and nine months ended December 31, 2025.
[1227] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-16)/Orchid Pharma Limited has informed the Exchange about Transcript
[1228] Press Release (2026-02-06)/Solara Active Pharma Sciences Limited has informed the exchange regarding the press release dated February 06, 2026, titled "Solara Q3'26 Performance."
[1229] Analysts/Institutional Investor Meet/Con. Call Updates (2025-11-19)/Natural Capsules Limited has informed the Exchange about Transcript
[1230] Analysts/Institutional Investor Meet/Con. Call Updates (2025-11-19)/Natural Capsules Limited has informed the Exchange about Transcript
[1231] Analysts/Institutional Investor Meet/Con. Call Updates (2025-11-19)/Natural Capsules Limited has informed the Exchange about Transcript
[1232] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-12)/Marksans Pharma Limited transcript of Investors/Analyst meet on Q3 9M FY 26 Unaudited Financial Results held on February 06, 2026
[1233] Analysts/Institutional Investor Meet/Con. Call Updates (2025-11-19)/Natural Capsules Limited has informed the Exchange about Transcript
[1234] Analysts/Institutional Investor Meet/Con. Call Updates (2025-11-19)/Natural Capsules Limited has informed the Exchange about Transcript
[1235] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-17)/Hikal Limited has informed the Exchange about Transcript
[1236] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-17)/Hikal Limited has informed the Exchange about Transcript
[1237] Investor Presentation (2026-02-13)/Natural Capsules Limited has informed the Exchange about Investor Presentation
[1238] Analysts/Institutional Investor Meet/Con. Call Updates (2025-11-19)/Natural Capsules Limited has informed the Exchange about Transcript
[1239] Analysts/Institutional Investor Meet/Con. Call Updates (2025-11-19)/Natural Capsules Limited has informed the Exchange about Transcript
[1240] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-14)/Divi's Laboratories Limited has informed the Exchange about Transcript
[1241] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-14)/Divi's Laboratories Limited has informed the Exchange about Transcript
[1242] Investor Presentation (2026-01-22)/Kopran Limited has informed the Exchange about Investor Presentation
[1243] Analysts/Institutional Investor Meet/Con. Call Updates (2025-11-19)/Natural Capsules Limited has informed the Exchange about Transcript
[1244] Analysts/Institutional Investor Meet/Con. Call Updates (2025-11-19)/Natural Capsules Limited has informed the Exchange about Transcript
[1245] Analysts/Institutional Investor Meet/Con. Call Updates (2025-11-19)/Natural Capsules Limited has informed the Exchange about Transcript
[1246] Press Release (2026-02-06)/Jubilant Pharmova Limited has informed the Exchange regarding a press release dated February 06, 2026, titled "Press Release alongwith Earnings Presentation on the financials and operational performance of the Company for the quarter and nine months ended December 31, 2025".
[1247] Press Release (2026-02-06)/Jubilant Pharmova Limited has informed the Exchange regarding a press release dated February 06, 2026, titled "Press Release alongwith Earnings Presentation on the financials and operational performance of the Company for the quarter and nine months ended December 31, 2025".
[1248] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-17)/Hikal Limited has informed the Exchange about Transcript
[1249] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-17)/Hikal Limited has informed the Exchange about Transcript
[1250] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-17)/Hikal Limited has informed the Exchange about Transcript
[1251] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-17)/Hikal Limited has informed the Exchange about Transcript
[1252] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-17)/Hikal Limited has informed the Exchange about Transcript
[1253] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-17)/Hikal Limited has informed the Exchange about Transcript
[1254] Press Release (2026-02-06)/Jubilant Pharmova Limited has informed the Exchange regarding a press release dated February 06, 2026, titled "Press Release alongwith Earnings Presentation on the financials and operational performance of the Company for the quarter and nine months ended December 31, 2025".
[1255] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-10)/Solara Active Pharma Sciences Limited has informed the Exchange about Transcript of earnings call pertaining to unaudited financial results of the Company for the quarter and nine months ended December 31, 2025.
[1256] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-10)/Solara Active Pharma Sciences Limited has informed the Exchange about Transcript of earnings call pertaining to unaudited financial results of the Company for the quarter and nine months ended December 31, 2025.
[1257] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-17)/Hikal Limited has informed the Exchange about Transcript
[1258] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-17)/Hikal Limited has informed the Exchange about Transcript
[1259] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-16)/GlaxoSmithKline Pharmaceuticals Limited has informed the Exchange about Transcript
[1260] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-16)/GlaxoSmithKline Pharmaceuticals Limited has informed the Exchange about Transcript
[1261] Analysts/Institutional Investor Meet/Con. Call Updates (2025-06-11)/Wockhardt Limited has informed the Exchange about Transcript
[1262] Analysts/Institutional Investor Meet/Con. Call Updates (2025-06-11)/Wockhardt Limited has informed the Exchange about Transcript
[1263] Analysts/Institutional Investor Meet/Con. Call Updates (2025-06-11)/Wockhardt Limited has informed the Exchange about Transcript
[1264] Analysts/Institutional Investor Meet/Con. Call Updates (2025-06-11)/Wockhardt Limited has informed the Exchange about Transcript
[1265] Analysts/Institutional Investor Meet/Con. Call Updates (2025-06-11)/Wockhardt Limited has informed the Exchange about Transcript
[1266] Analysts/Institutional Investor Meet/Con. Call Updates (2025-06-11)/Wockhardt Limited has informed the Exchange about Transcript
[1267] Press Release (2026-02-06)/Jubilant Pharmova Limited has informed the Exchange regarding a press release dated February 06, 2026, titled "Press Release alongwith Earnings Presentation on the financials and operational performance of the Company for the quarter and nine months ended December 31, 2025".
[1268] Press Release (2026-02-06)/Jubilant Pharmova Limited has informed the Exchange regarding a press release dated February 06, 2026, titled "Press Release alongwith Earnings Presentation on the financials and operational performance of the Company for the quarter and nine months ended December 31, 2025".
[1269] Press Release (2026-02-06)/Jubilant Pharmova Limited has informed the Exchange regarding a press release dated February 06, 2026, titled "Press Release alongwith Earnings Presentation on the financials and operational performance of the Company for the quarter and nine months ended December 31, 2025".
[1270] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-17)/Hikal Limited has informed the Exchange about Transcript
[1271] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-17)/Hikal Limited has informed the Exchange about Transcript
[1272] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-17)/Hikal Limited has informed the Exchange about Transcript
[1273] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-17)/Hikal Limited has informed the Exchange about Transcript
[1274] Outcome of Board Meeting (2026-02-12)/Cohance Lifesciences Limited has submitted to the Exchange, the financial results for the period ended December 31, 2025.
[1275] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-17)/Hikal Limited has informed the Exchange about Transcript
[1276] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-17)/Hikal Limited has informed the Exchange about Transcript
[1277] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-09)/Viyash Scientific Limited has informed the Exchange about Transcript
[1278] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-09)/Viyash Scientific Limited has informed the Exchange about Transcript
[1279] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-17)/Hikal Limited has informed the Exchange about Transcript
[1280] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-17)/Hikal Limited has informed the Exchange about Transcript
[1281] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-17)/Hikal Limited has informed the Exchange about Transcript
[1282] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-17)/Hikal Limited has informed the Exchange about Transcript
[1283] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-10)/Solara Active Pharma Sciences Limited has informed the Exchange about Transcript of earnings call pertaining to unaudited financial results of the Company for the quarter and nine months ended December 31, 2025.
[1284] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-10)/Solara Active Pharma Sciences Limited has informed the Exchange about Transcript of earnings call pertaining to unaudited financial results of the Company for the quarter and nine months ended December 31, 2025.
[1285] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-10)/Solara Active Pharma Sciences Limited has informed the Exchange about Transcript of earnings call pertaining to unaudited financial results of the Company for the quarter and nine months ended December 31, 2025.
[1286] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-16)/Orchid Pharma Limited has informed the Exchange about Transcript
[1287] Press Release (2026-02-06)/Solara Active Pharma Sciences Limited has informed the exchange regarding the press release dated February 06, 2026, titled "Solara Q3'26 Performance."
[1288] Analysts/Institutional Investor Meet/Con. Call Updates (2025-11-19)/Natural Capsules Limited has informed the Exchange about Transcript
[1289] Analysts/Institutional Investor Meet/Con. Call Updates (2025-11-19)/Natural Capsules Limited has informed the Exchange about Transcript
[1290] Analysts/Institutional Investor Meet/Con. Call Updates (2025-11-19)/Natural Capsules Limited has informed the Exchange about Transcript
[1291] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-12)/Marksans Pharma Limited transcript of Investors/Analyst meet on Q3 9M FY 26 Unaudited Financial Results held on February 06, 2026
[1292] Analysts/Institutional Investor Meet/Con. Call Updates (2025-11-19)/Natural Capsules Limited has informed the Exchange about Transcript
[1293] Analysts/Institutional Investor Meet/Con. Call Updates (2025-11-19)/Natural Capsules Limited has informed the Exchange about Transcript
[1294] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-17)/Hikal Limited has informed the Exchange about Transcript
[1295] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-17)/Hikal Limited has informed the Exchange about Transcript
[1296] Investor Presentation (2026-02-13)/Natural Capsules Limited has informed the Exchange about Investor Presentation
[1297] Analysts/Institutional Investor Meet/Con. Call Updates (2025-11-19)/Natural Capsules Limited has informed the Exchange about Transcript
[1298] Analysts/Institutional Investor Meet/Con. Call Updates (2025-11-19)/Natural Capsules Limited has informed the Exchange about Transcript
[1299] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-14)/Divi's Laboratories Limited has informed the Exchange about Transcript
[1300] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-14)/Divi's Laboratories Limited has informed the Exchange about Transcript
[1301] Investor Presentation (2026-01-22)/Kopran Limited has informed the Exchange about Investor Presentation
[1302] Analysts/Institutional Investor Meet/Con. Call Updates (2025-11-19)/Natural Capsules Limited has informed the Exchange about Transcript
[1303] Analysts/Institutional Investor Meet/Con. Call Updates (2025-11-19)/Natural Capsules Limited has informed the Exchange about Transcript
[1304] Analysts/Institutional Investor Meet/Con. Call Updates (2025-11-19)/Natural Capsules Limited has informed the Exchange about Transcript
[1305] Press Release (2026-02-06)/Jubilant Pharmova Limited has informed the Exchange regarding a press release dated February 06, 2026, titled "Press Release alongwith Earnings Presentation on the financials and operational performance of the Company for the quarter and nine months ended December 31, 2025".
[1306] Press Release (2026-02-06)/Jubilant Pharmova Limited has informed the Exchange regarding a press release dated February 06, 2026, titled "Press Release alongwith Earnings Presentation on the financials and operational performance of the Company for the quarter and nine months ended December 31, 2025".
[1307] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-17)/Hikal Limited has informed the Exchange about Transcript
[1308] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-17)/Hikal Limited has informed the Exchange about Transcript
[1309] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-17)/Hikal Limited has informed the Exchange about Transcript
[1310] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-17)/Hikal Limited has informed the Exchange about Transcript
[1311] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-17)/Hikal Limited has informed the Exchange about Transcript
[1312] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-17)/Hikal Limited has informed the Exchange about Transcript
[1313] Press Release (2026-02-06)/Jubilant Pharmova Limited has informed the Exchange regarding a press release dated February 06, 2026, titled "Press Release alongwith Earnings Presentation on the financials and operational performance of the Company for the quarter and nine months ended December 31, 2025".
[1314] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-10)/Solara Active Pharma Sciences Limited has informed the Exchange about Transcript of earnings call pertaining to unaudited financial results of the Company for the quarter and nine months ended December 31, 2025.
[1315] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-10)/Solara Active Pharma Sciences Limited has informed the Exchange about Transcript of earnings call pertaining to unaudited financial results of the Company for the quarter and nine months ended December 31, 2025.
[1316] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-17)/Hikal Limited has informed the Exchange about Transcript
[1317] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-17)/Hikal Limited has informed the Exchange about Transcript
[1318] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-16)/GlaxoSmithKline Pharmaceuticals Limited has informed the Exchange about Transcript
[1319] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-16)/GlaxoSmithKline Pharmaceuticals Limited has informed the Exchange about Transcript
[1320] Analysts/Institutional Investor Meet/Con. Call Updates (2025-06-11)/Wockhardt Limited has informed the Exchange about Transcript
[1321] Analysts/Institutional Investor Meet/Con. Call Updates (2025-06-11)/Wockhardt Limited has informed the Exchange about Transcript
[1322] Analysts/Institutional Investor Meet/Con. Call Updates (2025-06-11)/Wockhardt Limited has informed the Exchange about Transcript
[1323] Analysts/Institutional Investor Meet/Con. Call Updates (2025-06-11)/Wockhardt Limited has informed the Exchange about Transcript
[1324] Analysts/Institutional Investor Meet/Con. Call Updates (2025-06-11)/Wockhardt Limited has informed the Exchange about Transcript
[1325] Analysts/Institutional Investor Meet/Con. Call Updates (2025-06-11)/Wockhardt Limited has informed the Exchange about Transcript
[1326] Press Release (2026-02-06)/Jubilant Pharmova Limited has informed the Exchange regarding a press release dated February 06, 2026, titled "Press Release alongwith Earnings Presentation on the financials and operational performance of the Company for the quarter and nine months ended December 31, 2025".
[1327] Press Release (2026-02-06)/Jubilant Pharmova Limited has informed the Exchange regarding a press release dated February 06, 2026, titled "Press Release alongwith Earnings Presentation on the financials and operational performance of the Company for the quarter and nine months ended December 31, 2025".
[1328] Press Release (2026-02-06)/Jubilant Pharmova Limited has informed the Exchange regarding a press release dated February 06, 2026, titled "Press Release alongwith Earnings Presentation on the financials and operational performance of the Company for the quarter and nine months ended December 31, 2025".
[1329] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-17)/Hikal Limited has informed the Exchange about Transcript
[1330] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-17)/Hikal Limited has informed the Exchange about Transcript
[1331] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-17)/Hikal Limited has informed the Exchange about Transcript
[1332] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-17)/Hikal Limited has informed the Exchange about Transcript
[1333] Outcome of Board Meeting (2026-02-12)/Cohance Lifesciences Limited has submitted to the Exchange, the financial results for the period ended December 31, 2025.
[1334] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-17)/Hikal Limited has informed the Exchange about Transcript
[1335] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-17)/Hikal Limited has informed the Exchange about Transcript
[1336] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-09)/Viyash Scientific Limited has informed the Exchange about Transcript
[1337] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-09)/Viyash Scientific Limited has informed the Exchange about Transcript
[1338] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-09)/Viyash Scientific Limited has informed the Exchange about Transcript
[1339] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-09)/Viyash Scientific Limited has informed the Exchange about Transcript
[1340] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-09)/Viyash Scientific Limited has informed the Exchange about Transcript
[1341] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-09)/Viyash Scientific Limited has informed the Exchange about Transcript
[1342] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-17)/Hikal Limited has informed the Exchange about Transcript
[1343] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-17)/Hikal Limited has informed the Exchange about Transcript
[1344] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-17)/Hikal Limited has informed the Exchange about Transcript
[1345] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-17)/Hikal Limited has informed the Exchange about Transcript
[1346] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-10)/Solara Active Pharma Sciences Limited has informed the Exchange about Transcript of earnings call pertaining to unaudited financial results of the Company for the quarter and nine months ended December 31, 2025.
[1347] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-10)/Solara Active Pharma Sciences Limited has informed the Exchange about Transcript of earnings call pertaining to unaudited financial results of the Company for the quarter and nine months ended December 31, 2025.
[1348] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-10)/Solara Active Pharma Sciences Limited has informed the Exchange about Transcript of earnings call pertaining to unaudited financial results of the Company for the quarter and nine months ended December 31, 2025.
[1349] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-16)/Orchid Pharma Limited has informed the Exchange about Transcript
[1350] Press Release (2026-02-06)/Solara Active Pharma Sciences Limited has informed the exchange regarding the press release dated February 06, 2026, titled "Solara Q3'26 Performance."
[1351] Analysts/Institutional Investor Meet/Con. Call Updates (2025-11-19)/Natural Capsules Limited has informed the Exchange about Transcript
[1352] Analysts/Institutional Investor Meet/Con. Call Updates (2025-11-19)/Natural Capsules Limited has informed the Exchange about Transcript
[1353] Analysts/Institutional Investor Meet/Con. Call Updates (2025-11-19)/Natural Capsules Limited has informed the Exchange about Transcript
[1354] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-12)/Marksans Pharma Limited transcript of Investors/Analyst meet on Q3 9M FY 26 Unaudited Financial Results held on February 06, 2026
[1355] Analysts/Institutional Investor Meet/Con. Call Updates (2025-11-19)/Natural Capsules Limited has informed the Exchange about Transcript
[1356] Analysts/Institutional Investor Meet/Con. Call Updates (2025-11-19)/Natural Capsules Limited has informed the Exchange about Transcript
[1357] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-17)/Hikal Limited has informed the Exchange about Transcript
[1358] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-17)/Hikal Limited has informed the Exchange about Transcript
[1359] Investor Presentation (2026-02-13)/Natural Capsules Limited has informed the Exchange about Investor Presentation
[1360] Analysts/Institutional Investor Meet/Con. Call Updates (2025-11-19)/Natural Capsules Limited has informed the Exchange about Transcript
[1361] Analysts/Institutional Investor Meet/Con. Call Updates (2025-11-19)/Natural Capsules Limited has informed the Exchange about Transcript
[1362] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-14)/Divi's Laboratories Limited has informed the Exchange about Transcript
[1363] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-14)/Divi's Laboratories Limited has informed the Exchange about Transcript
[1364] Investor Presentation (2026-01-22)/Kopran Limited has informed the Exchange about Investor Presentation
[1365] Analysts/Institutional Investor Meet/Con. Call Updates (2025-11-19)/Natural Capsules Limited has informed the Exchange about Transcript
[1366] Analysts/Institutional Investor Meet/Con. Call Updates (2025-11-19)/Natural Capsules Limited has informed the Exchange about Transcript
[1367] Analysts/Institutional Investor Meet/Con. Call Updates (2025-11-19)/Natural Capsules Limited has informed the Exchange about Transcript
[1368] Press Release (2026-02-06)/Jubilant Pharmova Limited has informed the Exchange regarding a press release dated February 06, 2026, titled "Press Release alongwith Earnings Presentation on the financials and operational performance of the Company for the quarter and nine months ended December 31, 2025".
[1369] Press Release (2026-02-06)/Jubilant Pharmova Limited has informed the Exchange regarding a press release dated February 06, 2026, titled "Press Release alongwith Earnings Presentation on the financials and operational performance of the Company for the quarter and nine months ended December 31, 2025".
[1370] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-17)/Hikal Limited has informed the Exchange about Transcript
[1371] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-17)/Hikal Limited has informed the Exchange about Transcript
[1372] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-17)/Hikal Limited has informed the Exchange about Transcript
[1373] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-17)/Hikal Limited has informed the Exchange about Transcript
[1374] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-17)/Hikal Limited has informed the Exchange about Transcript
[1375] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-17)/Hikal Limited has informed the Exchange about Transcript
[1376] Press Release (2026-02-06)/Jubilant Pharmova Limited has informed the Exchange regarding a press release dated February 06, 2026, titled "Press Release alongwith Earnings Presentation on the financials and operational performance of the Company for the quarter and nine months ended December 31, 2025".
[1377] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-10)/Solara Active Pharma Sciences Limited has informed the Exchange about Transcript of earnings call pertaining to unaudited financial results of the Company for the quarter and nine months ended December 31, 2025.
[1378] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-10)/Solara Active Pharma Sciences Limited has informed the Exchange about Transcript of earnings call pertaining to unaudited financial results of the Company for the quarter and nine months ended December 31, 2025.
[1379] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-17)/Hikal Limited has informed the Exchange about Transcript
[1380] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-17)/Hikal Limited has informed the Exchange about Transcript
[1381] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-16)/GlaxoSmithKline Pharmaceuticals Limited has informed the Exchange about Transcript
[1382] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-16)/GlaxoSmithKline Pharmaceuticals Limited has informed the Exchange about Transcript
[1383] Analysts/Institutional Investor Meet/Con. Call Updates (2025-06-11)/Wockhardt Limited has informed the Exchange about Transcript
[1384] Analysts/Institutional Investor Meet/Con. Call Updates (2025-06-11)/Wockhardt Limited has informed the Exchange about Transcript
[1385] Analysts/Institutional Investor Meet/Con. Call Updates (2025-06-11)/Wockhardt Limited has informed the Exchange about Transcript
[1386] Analysts/Institutional Investor Meet/Con. Call Updates (2025-06-11)/Wockhardt Limited has informed the Exchange about Transcript
[1387] Analysts/Institutional Investor Meet/Con. Call Updates (2025-06-11)/Wockhardt Limited has informed the Exchange about Transcript
[1388] Analysts/Institutional Investor Meet/Con. Call Updates (2025-06-11)/Wockhardt Limited has informed the Exchange about Transcript
[1389] Press Release (2026-02-06)/Jubilant Pharmova Limited has informed the Exchange regarding a press release dated February 06, 2026, titled "Press Release alongwith Earnings Presentation on the financials and operational performance of the Company for the quarter and nine months ended December 31, 2025".
[1390] Press Release (2026-02-06)/Jubilant Pharmova Limited has informed the Exchange regarding a press release dated February 06, 2026, titled "Press Release alongwith Earnings Presentation on the financials and operational performance of the Company for the quarter and nine months ended December 31, 2025".
[1391] Press Release (2026-02-06)/Jubilant Pharmova Limited has informed the Exchange regarding a press release dated February 06, 2026, titled "Press Release alongwith Earnings Presentation on the financials and operational performance of the Company for the quarter and nine months ended December 31, 2025".
[1392] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-17)/Hikal Limited has informed the Exchange about Transcript
[1393] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-17)/Hikal Limited has informed the Exchange about Transcript
[1394] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-17)/Hikal Limited has informed the Exchange about Transcript
[1395] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-17)/Hikal Limited has informed the Exchange about Transcript
[1396] Outcome of Board Meeting (2026-02-12)/Cohance Lifesciences Limited has submitted to the Exchange, the financial results for the period ended December 31, 2025.
[1397] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-17)/Hikal Limited has informed the Exchange about Transcript
[1398] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-17)/Hikal Limited has informed the Exchange about Transcript
[1399] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-09)/Viyash Scientific Limited has informed the Exchange about Transcript
[1400] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-09)/Viyash Scientific Limited has informed the Exchange about Transcript
[1401] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-09)/Viyash Scientific Limited has informed the Exchange about Transcript
[1402] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-09)/Viyash Scientific Limited has informed the Exchange about Transcript
[1403] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-09)/Viyash Scientific Limited has informed the Exchange about Transcript
[1404] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-09)/Viyash Scientific Limited has informed the Exchange about Transcript
[1405] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-17)/Hikal Limited has informed the Exchange about Transcript
[1406] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-17)/Hikal Limited has informed the Exchange about Transcript
[1407] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-17)/Hikal Limited has informed the Exchange about Transcript
[1408] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-17)/Hikal Limited has informed the Exchange about Transcript
[1409] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-10)/Solara Active Pharma Sciences Limited has informed the Exchange about Transcript of earnings call pertaining to unaudited financial results of the Company for the quarter and nine months ended December 31, 2025.
[1410] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-10)/Solara Active Pharma Sciences Limited has informed the Exchange about Transcript of earnings call pertaining to unaudited financial results of the Company for the quarter and nine months ended December 31, 2025.
[1411] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-10)/Solara Active Pharma Sciences Limited has informed the Exchange about Transcript of earnings call pertaining to unaudited financial results of the Company for the quarter and nine months ended December 31, 2025.
[1412] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-16)/Orchid Pharma Limited has informed the Exchange about Transcript
[1413] Press Release (2026-02-06)/Solara Active Pharma Sciences Limited has informed the exchange regarding the press release dated February 06, 2026, titled "Solara Q3'26 Performance."
[1414] Analysts/Institutional Investor Meet/Con. Call Updates (2025-11-19)/Natural Capsules Limited has informed the Exchange about Transcript
[1415] Analysts/Institutional Investor Meet/Con. Call Updates (2025-11-19)/Natural Capsules Limited has informed the Exchange about Transcript
[1416] Analysts/Institutional Investor Meet/Con. Call Updates (2025-11-19)/Natural Capsules Limited has informed the Exchange about Transcript
[1417] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-12)/Marksans Pharma Limited transcript of Investors/Analyst meet on Q3 9M FY 26 Unaudited Financial Results held on February 06, 2026
[1418] Analysts/Institutional Investor Meet/Con. Call Updates (2025-11-19)/Natural Capsules Limited has informed the Exchange about Transcript
[1419] Analysts/Institutional Investor Meet/Con. Call Updates (2025-11-19)/Natural Capsules Limited has informed the Exchange about Transcript
[1420] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-17)/Hikal Limited has informed the Exchange about Transcript
[1421] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-17)/Hikal Limited has informed the Exchange about Transcript
[1422] Investor Presentation (2026-02-13)/Natural Capsules Limited has informed the Exchange about Investor Presentation
[1423] Analysts/Institutional Investor Meet/Con. Call Updates (2025-11-19)/Natural Capsules Limited has informed the Exchange about Transcript
[1424] Analysts/Institutional Investor Meet/Con. Call Updates (2025-11-19)/Natural Capsules Limited has informed the Exchange about Transcript
[1425] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-14)/Divi's Laboratories Limited has informed the Exchange about Transcript
[1426] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-14)/Divi's Laboratories Limited has informed the Exchange about Transcript
[1427] Investor Presentation (2026-01-22)/Kopran Limited has informed the Exchange about Investor Presentation
[1428] Analysts/Institutional Investor Meet/Con. Call Updates (2025-11-19)/Natural Capsules Limited has informed the Exchange about Transcript
[1429] Analysts/Institutional Investor Meet/Con. Call Updates (2025-11-19)/Natural Capsules Limited has informed the Exchange about Transcript
[1430] Analysts/Institutional Investor Meet/Con. Call Updates (2025-11-19)/Natural Capsules Limited has informed the Exchange about Transcript
[1431] Press Release (2026-02-06)/Jubilant Pharmova Limited has informed the Exchange regarding a press release dated February 06, 2026, titled "Press Release alongwith Earnings Presentation on the financials and operational performance of the Company for the quarter and nine months ended December 31, 2025".
[1432] Press Release (2026-02-06)/Jubilant Pharmova Limited has informed the Exchange regarding a press release dated February 06, 2026, titled "Press Release alongwith Earnings Presentation on the financials and operational performance of the Company for the quarter and nine months ended December 31, 2025".
[1433] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-17)/Hikal Limited has informed the Exchange about Transcript
[1434] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-17)/Hikal Limited has informed the Exchange about Transcript
[1435] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-17)/Hikal Limited has informed the Exchange about Transcript
[1436] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-17)/Hikal Limited has informed the Exchange about Transcript
[1437] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-17)/Hikal Limited has informed the Exchange about Transcript
[1438] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-17)/Hikal Limited has informed the Exchange about Transcript
[1439] Press Release (2026-02-06)/Jubilant Pharmova Limited has informed the Exchange regarding a press release dated February 06, 2026, titled "Press Release alongwith Earnings Presentation on the financials and operational performance of the Company for the quarter and nine months ended December 31, 2025".
[1440] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-10)/Solara Active Pharma Sciences Limited has informed the Exchange about Transcript of earnings call pertaining to unaudited financial results of the Company for the quarter and nine months ended December 31, 2025.
[1441] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-10)/Solara Active Pharma Sciences Limited has informed the Exchange about Transcript of earnings call pertaining to unaudited financial results of the Company for the quarter and nine months ended December 31, 2025.
[1442] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-17)/Hikal Limited has informed the Exchange about Transcript
[1443] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-17)/Hikal Limited has informed the Exchange about Transcript
[1444] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-16)/GlaxoSmithKline Pharmaceuticals Limited has informed the Exchange about Transcript
[1445] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-16)/GlaxoSmithKline Pharmaceuticals Limited has informed the Exchange about Transcript
[1446] Analysts/Institutional Investor Meet/Con. Call Updates (2025-06-11)/Wockhardt Limited has informed the Exchange about Transcript
[1447] Analysts/Institutional Investor Meet/Con. Call Updates (2025-06-11)/Wockhardt Limited has informed the Exchange about Transcript
[1448] Analysts/Institutional Investor Meet/Con. Call Updates (2025-06-11)/Wockhardt Limited has informed the Exchange about Transcript
[1449] Analysts/Institutional Investor Meet/Con. Call Updates (2025-06-11)/Wockhardt Limited has informed the Exchange about Transcript
[1450] Analysts/Institutional Investor Meet/Con. Call Updates (2025-06-11)/Wockhardt Limited has informed the Exchange about Transcript
[1451] Analysts/Institutional Investor Meet/Con. Call Updates (2025-06-11)/Wockhardt Limited has informed the Exchange about Transcript
[1452] Press Release (2026-02-06)/Jubilant Pharmova Limited has informed the Exchange regarding a press release dated February 06, 2026, titled "Press Release alongwith Earnings Presentation on the financials and operational performance of the Company for the quarter and nine months ended December 31, 2025".
[1453] Press Release (2026-02-06)/Jubilant Pharmova Limited has informed the Exchange regarding a press release dated February 06, 2026, titled "Press Release alongwith Earnings Presentation on the financials and operational performance of the Company for the quarter and nine months ended December 31, 2025".
[1454] Press Release (2026-02-06)/Jubilant Pharmova Limited has informed the Exchange regarding a press release dated February 06, 2026, titled "Press Release alongwith Earnings Presentation on the financials and operational performance of the Company for the quarter and nine months ended December 31, 2025".
[1455] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-17)/Hikal Limited has informed the Exchange about Transcript
[1456] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-17)/Hikal Limited has informed the Exchange about Transcript
[1457] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-17)/Hikal Limited has informed the Exchange about Transcript
[1458] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-17)/Hikal Limited has informed the Exchange about Transcript
[1459] Outcome of Board Meeting (2026-02-12)/Cohance Lifesciences Limited has submitted to the Exchange, the financial results for the period ended December 31, 2025.
[1460] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-17)/Hikal Limited has informed the Exchange about Transcript
[1461] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-17)/Hikal Limited has informed the Exchange about Transcript
[1462] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-09)/Viyash Scientific Limited has informed the Exchange about Transcript
[1463] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-09)/Viyash Scientific Limited has informed the Exchange about Transcript
[1464] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-09)/Viyash Scientific Limited has informed the Exchange about Transcript
[1465] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-09)/Viyash Scientific Limited has informed the Exchange about Transcript
[1466] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-09)/Viyash Scientific Limited has informed the Exchange about Transcript
[1467] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-09)/Viyash Scientific Limited has informed the Exchange about Transcript
[1468] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-17)/Hikal Limited has informed the Exchange about Transcript
[1469] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-17)/Hikal Limited has informed the Exchange about Transcript
[1470] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-17)/Hikal Limited has informed the Exchange about Transcript
[1471] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-17)/Hikal Limited has informed the Exchange about Transcript
[1472] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-10)/Solara Active Pharma Sciences Limited has informed the Exchange about Transcript of earnings call pertaining to unaudited financial results of the Company for the quarter and nine months ended December 31, 2025.
[1473] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-10)/Solara Active Pharma Sciences Limited has informed the Exchange about Transcript of earnings call pertaining to unaudited financial results of the Company for the quarter and nine months ended December 31, 2025.
[1474] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-10)/Solara Active Pharma Sciences Limited has informed the Exchange about Transcript of earnings call pertaining to unaudited financial results of the Company for the quarter and nine months ended December 31, 2025.
[1475] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-16)/Orchid Pharma Limited has informed the Exchange about Transcript
[1476] Press Release (2026-02-06)/Solara Active Pharma Sciences Limited has informed the exchange regarding the press release dated February 06, 2026, titled "Solara Q3'26 Performance."
[1477] Analysts/Institutional Investor Meet/Con. Call Updates (2025-11-19)/Natural Capsules Limited has informed the Exchange about Transcript
[1478] Analysts/Institutional Investor Meet/Con. Call Updates (2025-11-19)/Natural Capsules Limited has informed the Exchange about Transcript
[1479] Analysts/Institutional Investor Meet/Con. Call Updates (2025-11-19)/Natural Capsules Limited has informed the Exchange about Transcript
[1480] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-12)/Marksans Pharma Limited transcript of Investors/Analyst meet on Q3 9M FY 26 Unaudited Financial Results held on February 06, 2026
[1481] Analysts/Institutional Investor Meet/Con. Call Updates (2025-11-19)/Natural Capsules Limited has informed the Exchange about Transcript
[1482] Analysts/Institutional Investor Meet/Con. Call Updates (2025-11-19)/Natural Capsules Limited has informed the Exchange about Transcript
[1483] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-17)/Hikal Limited has informed the Exchange about Transcript
[1484] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-17)/Hikal Limited has informed the Exchange about Transcript
[1485] Investor Presentation (2026-02-13)/Natural Capsules Limited has informed the Exchange about Investor Presentation
[1486] Analysts/Institutional Investor Meet/Con. Call Updates (2025-11-19)/Natural Capsules Limited has informed the Exchange about Transcript
[1487] Analysts/Institutional Investor Meet/Con. Call Updates (2025-11-19)/Natural Capsules Limited has informed the Exchange about Transcript
[1488] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-14)/Divi's Laboratories Limited has informed the Exchange about Transcript
[1489] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-14)/Divi's Laboratories Limited has informed the Exchange about Transcript
[1490] Investor Presentation (2026-01-22)/Kopran Limited has informed the Exchange about Investor Presentation
[1491] Analysts/Institutional Investor Meet/Con. Call Updates (2025-11-19)/Natural Capsules Limited has informed the Exchange about Transcript
[1492] Analysts/Institutional Investor Meet/Con. Call Updates (2025-11-19)/Natural Capsules Limited has informed the Exchange about Transcript
[1493] Analysts/Institutional Investor Meet/Con. Call Updates (2025-11-19)/Natural Capsules Limited has informed the Exchange about Transcript
[1494] Press Release (2026-02-06)/Jubilant Pharmova Limited has informed the Exchange regarding a press release dated February 06, 2026, titled "Press Release alongwith Earnings Presentation on the financials and operational performance of the Company for the quarter and nine months ended December 31, 2025".
[1495] Press Release (2026-02-06)/Jubilant Pharmova Limited has informed the Exchange regarding a press release dated February 06, 2026, titled "Press Release alongwith Earnings Presentation on the financials and operational performance of the Company for the quarter and nine months ended December 31, 2025".
[1496] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-17)/Hikal Limited has informed the Exchange about Transcript
[1497] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-17)/Hikal Limited has informed the Exchange about Transcript
[1498] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-17)/Hikal Limited has informed the Exchange about Transcript
[1499] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-17)/Hikal Limited has informed the Exchange about Transcript
[1500] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-17)/Hikal Limited has informed the Exchange about Transcript
[1501] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-17)/Hikal Limited has informed the Exchange about Transcript
[1502] Press Release (2026-02-06)/Jubilant Pharmova Limited has informed the Exchange regarding a press release dated February 06, 2026, titled "Press Release alongwith Earnings Presentation on the financials and operational performance of the Company for the quarter and nine months ended December 31, 2025".
[1503] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-10)/Solara Active Pharma Sciences Limited has informed the Exchange about Transcript of earnings call pertaining to unaudited financial results of the Company for the quarter and nine months ended December 31, 2025.
[1504] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-10)/Solara Active Pharma Sciences Limited has informed the Exchange about Transcript of earnings call pertaining to unaudited financial results of the Company for the quarter and nine months ended December 31, 2025.
[1505] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-17)/Hikal Limited has informed the Exchange about Transcript
[1506] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-17)/Hikal Limited has informed the Exchange about Transcript
[1507] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-16)/GlaxoSmithKline Pharmaceuticals Limited has informed the Exchange about Transcript
[1508] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-16)/GlaxoSmithKline Pharmaceuticals Limited has informed the Exchange about Transcript
[1509] Analysts/Institutional Investor Meet/Con. Call Updates (2025-06-11)/Wockhardt Limited has informed the Exchange about Transcript
[1510] Analysts/Institutional Investor Meet/Con. Call Updates (2025-06-11)/Wockhardt Limited has informed the Exchange about Transcript
[1511] Analysts/Institutional Investor Meet/Con. Call Updates (2025-06-11)/Wockhardt Limited has informed the Exchange about Transcript
[1512] Analysts/Institutional Investor Meet/Con. Call Updates (2025-06-11)/Wockhardt Limited has informed the Exchange about Transcript
[1513] Analysts/Institutional Investor Meet/Con. Call Updates (2025-06-11)/Wockhardt Limited has informed the Exchange about Transcript
[1514] Analysts/Institutional Investor Meet/Con. Call Updates (2025-06-11)/Wockhardt Limited has informed the Exchange about Transcript
[1515] Press Release (2026-02-06)/Jubilant Pharmova Limited has informed the Exchange regarding a press release dated February 06, 2026, titled "Press Release alongwith Earnings Presentation on the financials and operational performance of the Company for the quarter and nine months ended December 31, 2025".
[1516] Press Release (2026-02-06)/Jubilant Pharmova Limited has informed the Exchange regarding a press release dated February 06, 2026, titled "Press Release alongwith Earnings Presentation on the financials and operational performance of the Company for the quarter and nine months ended December 31, 2025".
[1517] Press Release (2026-02-06)/Jubilant Pharmova Limited has informed the Exchange regarding a press release dated February 06, 2026, titled "Press Release alongwith Earnings Presentation on the financials and operational performance of the Company for the quarter and nine months ended December 31, 2025".
[1518] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-17)/Hikal Limited has informed the Exchange about Transcript
[1519] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-17)/Hikal Limited has informed the Exchange about Transcript
[1520] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-17)/Hikal Limited has informed the Exchange about Transcript
[1521] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-17)/Hikal Limited has informed the Exchange about Transcript
[1522] Outcome of Board Meeting (2026-02-12)/Cohance Lifesciences Limited has submitted to the Exchange, the financial results for the period ended December 31, 2025.
[1523] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-17)/Hikal Limited has informed the Exchange about Transcript
[1524] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-17)/Hikal Limited has informed the Exchange about Transcript
[1525] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-09)/Viyash Scientific Limited has informed the Exchange about Transcript
[1526] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-09)/Viyash Scientific Limited has informed the Exchange about Transcript
[1527] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-09)/Viyash Scientific Limited has informed the Exchange about Transcript
[1528] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-09)/Viyash Scientific Limited has informed the Exchange about Transcript
[1529] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-09)/Viyash Scientific Limited has informed the Exchange about Transcript
[1530] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-09)/Viyash Scientific Limited has informed the Exchange about Transcript
[1531] Analysts/Institutional Investor Meet/Con. Call Updates (2025-05-17)/Morepen Laboratories Limited has informed the Exchange about Transcript
[1532] Analysts/Institutional Investor Meet/Con. Call Updates (2025-05-17)/Morepen Laboratories Limited has informed the Exchange about Transcript
[1533] Analysts/Institutional Investor Meet/Con. Call Updates (2026-03-27)/Sanofi Consumer Healthcare India Limited has informed the Exchange about the transcript of the Institutional Investor Meet held on Tuesday, 24th March 2026
[1534] Analysts/Institutional Investor Meet/Con. Call Updates (2026-03-27)/Sanofi Consumer Healthcare India Limited has informed the Exchange about the transcript of the Institutional Investor Meet held on Tuesday, 24th March 2026
[1535] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-17)/Hikal Limited has informed the Exchange about Transcript
[1536] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-17)/Hikal Limited has informed the Exchange about Transcript
[1537] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-17)/Hikal Limited has informed the Exchange about Transcript
[1538] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-17)/Hikal Limited has informed the Exchange about Transcript
[1539] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-10)/Solara Active Pharma Sciences Limited has informed the Exchange about Transcript of earnings call pertaining to unaudited financial results of the Company for the quarter and nine months ended December 31, 2025.
[1540] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-10)/Solara Active Pharma Sciences Limited has informed the Exchange about Transcript of earnings call pertaining to unaudited financial results of the Company for the quarter and nine months ended December 31, 2025.
[1541] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-10)/Solara Active Pharma Sciences Limited has informed the Exchange about Transcript of earnings call pertaining to unaudited financial results of the Company for the quarter and nine months ended December 31, 2025.
[1542] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-16)/Orchid Pharma Limited has informed the Exchange about Transcript
[1543] Press Release (2026-02-06)/Solara Active Pharma Sciences Limited has informed the exchange regarding the press release dated February 06, 2026, titled "Solara Q3'26 Performance."
[1544] Analysts/Institutional Investor Meet/Con. Call Updates (2025-11-19)/Natural Capsules Limited has informed the Exchange about Transcript
[1545] Analysts/Institutional Investor Meet/Con. Call Updates (2025-11-19)/Natural Capsules Limited has informed the Exchange about Transcript
[1546] Analysts/Institutional Investor Meet/Con. Call Updates (2025-11-19)/Natural Capsules Limited has informed the Exchange about Transcript
[1547] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-12)/Marksans Pharma Limited transcript of Investors/Analyst meet on Q3 9M FY 26 Unaudited Financial Results held on February 06, 2026
[1548] Analysts/Institutional Investor Meet/Con. Call Updates (2025-11-19)/Natural Capsules Limited has informed the Exchange about Transcript
[1549] Analysts/Institutional Investor Meet/Con. Call Updates (2025-11-19)/Natural Capsules Limited has informed the Exchange about Transcript
[1550] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-17)/Hikal Limited has informed the Exchange about Transcript
[1551] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-17)/Hikal Limited has informed the Exchange about Transcript
[1552] Investor Presentation (2026-02-13)/Natural Capsules Limited has informed the Exchange about Investor Presentation
[1553] Analysts/Institutional Investor Meet/Con. Call Updates (2025-11-19)/Natural Capsules Limited has informed the Exchange about Transcript
[1554] Analysts/Institutional Investor Meet/Con. Call Updates (2025-11-19)/Natural Capsules Limited has informed the Exchange about Transcript
[1555] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-14)/Divi's Laboratories Limited has informed the Exchange about Transcript
[1556] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-14)/Divi's Laboratories Limited has informed the Exchange about Transcript
[1557] Investor Presentation (2026-01-22)/Kopran Limited has informed the Exchange about Investor Presentation
[1558] Analysts/Institutional Investor Meet/Con. Call Updates (2025-11-19)/Natural Capsules Limited has informed the Exchange about Transcript
[1559] Analysts/Institutional Investor Meet/Con. Call Updates (2025-11-19)/Natural Capsules Limited has informed the Exchange about Transcript
[1560] Analysts/Institutional Investor Meet/Con. Call Updates (2025-11-19)/Natural Capsules Limited has informed the Exchange about Transcript
[1561] Press Release (2026-02-06)/Jubilant Pharmova Limited has informed the Exchange regarding a press release dated February 06, 2026, titled "Press Release alongwith Earnings Presentation on the financials and operational performance of the Company for the quarter and nine months ended December 31, 2025".
[1562] Press Release (2026-02-06)/Jubilant Pharmova Limited has informed the Exchange regarding a press release dated February 06, 2026, titled "Press Release alongwith Earnings Presentation on the financials and operational performance of the Company for the quarter and nine months ended December 31, 2025".
[1563] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-17)/Hikal Limited has informed the Exchange about Transcript
[1564] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-17)/Hikal Limited has informed the Exchange about Transcript
[1565] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-17)/Hikal Limited has informed the Exchange about Transcript
[1566] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-17)/Hikal Limited has informed the Exchange about Transcript
[1567] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-17)/Hikal Limited has informed the Exchange about Transcript
[1568] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-17)/Hikal Limited has informed the Exchange about Transcript
[1569] Press Release (2026-02-06)/Jubilant Pharmova Limited has informed the Exchange regarding a press release dated February 06, 2026, titled "Press Release alongwith Earnings Presentation on the financials and operational performance of the Company for the quarter and nine months ended December 31, 2025".
[1570] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-10)/Solara Active Pharma Sciences Limited has informed the Exchange about Transcript of earnings call pertaining to unaudited financial results of the Company for the quarter and nine months ended December 31, 2025.
[1571] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-10)/Solara Active Pharma Sciences Limited has informed the Exchange about Transcript of earnings call pertaining to unaudited financial results of the Company for the quarter and nine months ended December 31, 2025.
[1572] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-17)/Hikal Limited has informed the Exchange about Transcript
[1573] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-17)/Hikal Limited has informed the Exchange about Transcript
[1574] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-16)/GlaxoSmithKline Pharmaceuticals Limited has informed the Exchange about Transcript
[1575] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-16)/GlaxoSmithKline Pharmaceuticals Limited has informed the Exchange about Transcript
[1576] Analysts/Institutional Investor Meet/Con. Call Updates (2025-06-11)/Wockhardt Limited has informed the Exchange about Transcript
[1577] Analysts/Institutional Investor Meet/Con. Call Updates (2025-06-11)/Wockhardt Limited has informed the Exchange about Transcript
[1578] Analysts/Institutional Investor Meet/Con. Call Updates (2025-06-11)/Wockhardt Limited has informed the Exchange about Transcript
[1579] Analysts/Institutional Investor Meet/Con. Call Updates (2025-06-11)/Wockhardt Limited has informed the Exchange about Transcript
[1580] Analysts/Institutional Investor Meet/Con. Call Updates (2025-06-11)/Wockhardt Limited has informed the Exchange about Transcript
[1581] Analysts/Institutional Investor Meet/Con. Call Updates (2025-06-11)/Wockhardt Limited has informed the Exchange about Transcript
[1582] Press Release (2026-02-06)/Jubilant Pharmova Limited has informed the Exchange regarding a press release dated February 06, 2026, titled "Press Release alongwith Earnings Presentation on the financials and operational performance of the Company for the quarter and nine months ended December 31, 2025".
[1583] Press Release (2026-02-06)/Jubilant Pharmova Limited has informed the Exchange regarding a press release dated February 06, 2026, titled "Press Release alongwith Earnings Presentation on the financials and operational performance of the Company for the quarter and nine months ended December 31, 2025".
[1584] Press Release (2026-02-06)/Jubilant Pharmova Limited has informed the Exchange regarding a press release dated February 06, 2026, titled "Press Release alongwith Earnings Presentation on the financials and operational performance of the Company for the quarter and nine months ended December 31, 2025".
[1585] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-17)/Hikal Limited has informed the Exchange about Transcript
[1586] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-17)/Hikal Limited has informed the Exchange about Transcript
[1587] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-17)/Hikal Limited has informed the Exchange about Transcript
[1588] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-17)/Hikal Limited has informed the Exchange about Transcript
[1589] Outcome of Board Meeting (2026-02-12)/Cohance Lifesciences Limited has submitted to the Exchange, the financial results for the period ended December 31, 2025.
[1590] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-17)/Hikal Limited has informed the Exchange about Transcript
[1591] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-17)/Hikal Limited has informed the Exchange about Transcript
[1592] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-09)/Viyash Scientific Limited has informed the Exchange about Transcript
[1593] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-09)/Viyash Scientific Limited has informed the Exchange about Transcript
[1594] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-09)/Viyash Scientific Limited has informed the Exchange about Transcript
[1595] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-09)/Viyash Scientific Limited has informed the Exchange about Transcript
[1596] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-09)/Viyash Scientific Limited has informed the Exchange about Transcript
[1597] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-09)/Viyash Scientific Limited has informed the Exchange about Transcript
[1598] Analysts/Institutional Investor Meet/Con. Call Updates (2025-05-17)/Morepen Laboratories Limited has informed the Exchange about Transcript
[1599] Analysts/Institutional Investor Meet/Con. Call Updates (2025-05-17)/Morepen Laboratories Limited has informed the Exchange about Transcript
[1600] Analysts/Institutional Investor Meet/Con. Call Updates (2026-03-27)/Sanofi Consumer Healthcare India Limited has informed the Exchange about the transcript of the Institutional Investor Meet held on Tuesday, 24th March 2026
[1601] Analysts/Institutional Investor Meet/Con. Call Updates (2026-03-27)/Sanofi Consumer Healthcare India Limited has informed the Exchange about the transcript of the Institutional Investor Meet held on Tuesday, 24th March 2026
[1602] Analysts/Institutional Investor Meet/Con. Call Updates (2026-03-27)/Sanofi Consumer Healthcare India Limited has informed the Exchange about the transcript of the Institutional Investor Meet held on Tuesday, 24th March 2026
[1603] Analysts/Institutional Investor Meet/Con. Call Updates (2026-03-27)/Sanofi Consumer Healthcare India Limited has informed the Exchange about the transcript of the Institutional Investor Meet held on Tuesday, 24th March 2026
[1604] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-17)/Hikal Limited has informed the Exchange about Transcript
[1605] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-17)/Hikal Limited has informed the Exchange about Transcript
[1606] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-17)/Hikal Limited has informed the Exchange about Transcript
[1607] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-17)/Hikal Limited has informed the Exchange about Transcript
[1608] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-10)/Solara Active Pharma Sciences Limited has informed the Exchange about Transcript of earnings call pertaining to unaudited financial results of the Company for the quarter and nine months ended December 31, 2025.
[1609] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-10)/Solara Active Pharma Sciences Limited has informed the Exchange about Transcript of earnings call pertaining to unaudited financial results of the Company for the quarter and nine months ended December 31, 2025.
[1610] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-10)/Solara Active Pharma Sciences Limited has informed the Exchange about Transcript of earnings call pertaining to unaudited financial results of the Company for the quarter and nine months ended December 31, 2025.
[1611] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-16)/Orchid Pharma Limited has informed the Exchange about Transcript
[1612] Press Release (2026-02-06)/Solara Active Pharma Sciences Limited has informed the exchange regarding the press release dated February 06, 2026, titled "Solara Q3'26 Performance."
[1613] Analysts/Institutional Investor Meet/Con. Call Updates (2025-11-19)/Natural Capsules Limited has informed the Exchange about Transcript
[1614] Analysts/Institutional Investor Meet/Con. Call Updates (2025-11-19)/Natural Capsules Limited has informed the Exchange about Transcript
[1615] Analysts/Institutional Investor Meet/Con. Call Updates (2025-11-19)/Natural Capsules Limited has informed the Exchange about Transcript
[1616] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-12)/Marksans Pharma Limited transcript of Investors/Analyst meet on Q3 9M FY 26 Unaudited Financial Results held on February 06, 2026
[1617] Analysts/Institutional Investor Meet/Con. Call Updates (2025-11-19)/Natural Capsules Limited has informed the Exchange about Transcript
[1618] Analysts/Institutional Investor Meet/Con. Call Updates (2025-11-19)/Natural Capsules Limited has informed the Exchange about Transcript
[1619] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-17)/Hikal Limited has informed the Exchange about Transcript
[1620] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-17)/Hikal Limited has informed the Exchange about Transcript
[1621] Investor Presentation (2026-02-13)/Natural Capsules Limited has informed the Exchange about Investor Presentation
[1622] Analysts/Institutional Investor Meet/Con. Call Updates (2025-11-19)/Natural Capsules Limited has informed the Exchange about Transcript
[1623] Analysts/Institutional Investor Meet/Con. Call Updates (2025-11-19)/Natural Capsules Limited has informed the Exchange about Transcript
[1624] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-14)/Divi's Laboratories Limited has informed the Exchange about Transcript
[1625] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-14)/Divi's Laboratories Limited has informed the Exchange about Transcript
[1626] Investor Presentation (2026-01-22)/Kopran Limited has informed the Exchange about Investor Presentation
[1627] Analysts/Institutional Investor Meet/Con. Call Updates (2025-11-19)/Natural Capsules Limited has informed the Exchange about Transcript
[1628] Analysts/Institutional Investor Meet/Con. Call Updates (2025-11-19)/Natural Capsules Limited has informed the Exchange about Transcript
[1629] Analysts/Institutional Investor Meet/Con. Call Updates (2025-11-19)/Natural Capsules Limited has informed the Exchange about Transcript
[1630] Press Release (2026-02-06)/Jubilant Pharmova Limited has informed the Exchange regarding a press release dated February 06, 2026, titled "Press Release alongwith Earnings Presentation on the financials and operational performance of the Company for the quarter and nine months ended December 31, 2025".
[1631] Press Release (2026-02-06)/Jubilant Pharmova Limited has informed the Exchange regarding a press release dated February 06, 2026, titled "Press Release alongwith Earnings Presentation on the financials and operational performance of the Company for the quarter and nine months ended December 31, 2025".
[1632] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-17)/Hikal Limited has informed the Exchange about Transcript
[1633] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-17)/Hikal Limited has informed the Exchange about Transcript
[1634] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-17)/Hikal Limited has informed the Exchange about Transcript
[1635] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-17)/Hikal Limited has informed the Exchange about Transcript
[1636] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-17)/Hikal Limited has informed the Exchange about Transcript
[1637] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-17)/Hikal Limited has informed the Exchange about Transcript
[1638] Press Release (2026-02-06)/Jubilant Pharmova Limited has informed the Exchange regarding a press release dated February 06, 2026, titled "Press Release alongwith Earnings Presentation on the financials and operational performance of the Company for the quarter and nine months ended December 31, 2025".
[1639] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-10)/Solara Active Pharma Sciences Limited has informed the Exchange about Transcript of earnings call pertaining to unaudited financial results of the Company for the quarter and nine months ended December 31, 2025.
[1640] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-10)/Solara Active Pharma Sciences Limited has informed the Exchange about Transcript of earnings call pertaining to unaudited financial results of the Company for the quarter and nine months ended December 31, 2025.
[1641] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-17)/Hikal Limited has informed the Exchange about Transcript
[1642] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-17)/Hikal Limited has informed the Exchange about Transcript
[1643] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-16)/GlaxoSmithKline Pharmaceuticals Limited has informed the Exchange about Transcript
[1644] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-16)/GlaxoSmithKline Pharmaceuticals Limited has informed the Exchange about Transcript
[1645] Analysts/Institutional Investor Meet/Con. Call Updates (2025-06-11)/Wockhardt Limited has informed the Exchange about Transcript
[1646] Analysts/Institutional Investor Meet/Con. Call Updates (2025-06-11)/Wockhardt Limited has informed the Exchange about Transcript
[1647] Analysts/Institutional Investor Meet/Con. Call Updates (2025-06-11)/Wockhardt Limited has informed the Exchange about Transcript
[1648] Analysts/Institutional Investor Meet/Con. Call Updates (2025-06-11)/Wockhardt Limited has informed the Exchange about Transcript
[1649] Analysts/Institutional Investor Meet/Con. Call Updates (2025-06-11)/Wockhardt Limited has informed the Exchange about Transcript
[1650] Analysts/Institutional Investor Meet/Con. Call Updates (2025-06-11)/Wockhardt Limited has informed the Exchange about Transcript
[1651] Press Release (2026-02-06)/Jubilant Pharmova Limited has informed the Exchange regarding a press release dated February 06, 2026, titled "Press Release alongwith Earnings Presentation on the financials and operational performance of the Company for the quarter and nine months ended December 31, 2025".
[1652] Press Release (2026-02-06)/Jubilant Pharmova Limited has informed the Exchange regarding a press release dated February 06, 2026, titled "Press Release alongwith Earnings Presentation on the financials and operational performance of the Company for the quarter and nine months ended December 31, 2025".
[1653] Press Release (2026-02-06)/Jubilant Pharmova Limited has informed the Exchange regarding a press release dated February 06, 2026, titled "Press Release alongwith Earnings Presentation on the financials and operational performance of the Company for the quarter and nine months ended December 31, 2025".
[1654] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-17)/Hikal Limited has informed the Exchange about Transcript
[1655] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-17)/Hikal Limited has informed the Exchange about Transcript
[1656] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-17)/Hikal Limited has informed the Exchange about Transcript
[1657] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-17)/Hikal Limited has informed the Exchange about Transcript
[1658] Outcome of Board Meeting (2026-02-12)/Cohance Lifesciences Limited has submitted to the Exchange, the financial results for the period ended December 31, 2025.
[1659] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-17)/Hikal Limited has informed the Exchange about Transcript
[1660] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-17)/Hikal Limited has informed the Exchange about Transcript
[1661] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-09)/Viyash Scientific Limited has informed the Exchange about Transcript
[1662] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-09)/Viyash Scientific Limited has informed the Exchange about Transcript
[1663] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-09)/Viyash Scientific Limited has informed the Exchange about Transcript
[1664] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-09)/Viyash Scientific Limited has informed the Exchange about Transcript
[1665] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-09)/Viyash Scientific Limited has informed the Exchange about Transcript
[1666] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-09)/Viyash Scientific Limited has informed the Exchange about Transcript
[1667] Analysts/Institutional Investor Meet/Con. Call Updates (2025-05-17)/Morepen Laboratories Limited has informed the Exchange about Transcript
[1668] Analysts/Institutional Investor Meet/Con. Call Updates (2025-05-17)/Morepen Laboratories Limited has informed the Exchange about Transcript
[1669] Analysts/Institutional Investor Meet/Con. Call Updates (2026-03-27)/Sanofi Consumer Healthcare India Limited has informed the Exchange about the transcript of the Institutional Investor Meet held on Tuesday, 24th March 2026
[1670] Analysts/Institutional Investor Meet/Con. Call Updates (2026-03-27)/Sanofi Consumer Healthcare India Limited has informed the Exchange about the transcript of the Institutional Investor Meet held on Tuesday, 24th March 2026
[1671] Analysts/Institutional Investor Meet/Con. Call Updates (2026-03-27)/Sanofi Consumer Healthcare India Limited has informed the Exchange about the transcript of the Institutional Investor Meet held on Tuesday, 24th March 2026
[1672] Analysts/Institutional Investor Meet/Con. Call Updates (2026-03-27)/Sanofi Consumer Healthcare India Limited has informed the Exchange about the transcript of the Institutional Investor Meet held on Tuesday, 24th March 2026
[1673] Investor Presentation (2026-01-29)/BALAXI PHARMACEUTICALS LIMITED has informed the Exchange about Investor Presentation
[1674] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-14)/Divi's Laboratories Limited has informed the Exchange about Transcript
[1675] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-17)/Hikal Limited has informed the Exchange about Transcript
[1676] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-17)/Hikal Limited has informed the Exchange about Transcript
[1677] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-17)/Hikal Limited has informed the Exchange about Transcript
[1678] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-17)/Hikal Limited has informed the Exchange about Transcript
[1679] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-10)/Solara Active Pharma Sciences Limited has informed the Exchange about Transcript of earnings call pertaining to unaudited financial results of the Company for the quarter and nine months ended December 31, 2025.
[1680] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-10)/Solara Active Pharma Sciences Limited has informed the Exchange about Transcript of earnings call pertaining to unaudited financial results of the Company for the quarter and nine months ended December 31, 2025.
[1681] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-10)/Solara Active Pharma Sciences Limited has informed the Exchange about Transcript of earnings call pertaining to unaudited financial results of the Company for the quarter and nine months ended December 31, 2025.
[1682] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-16)/Orchid Pharma Limited has informed the Exchange about Transcript
[1683] Press Release (2026-02-06)/Solara Active Pharma Sciences Limited has informed the exchange regarding the press release dated February 06, 2026, titled "Solara Q3'26 Performance."
[1684] Analysts/Institutional Investor Meet/Con. Call Updates (2025-11-19)/Natural Capsules Limited has informed the Exchange about Transcript
[1685] Analysts/Institutional Investor Meet/Con. Call Updates (2025-11-19)/Natural Capsules Limited has informed the Exchange about Transcript
[1686] Analysts/Institutional Investor Meet/Con. Call Updates (2025-11-19)/Natural Capsules Limited has informed the Exchange about Transcript
[1687] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-12)/Marksans Pharma Limited transcript of Investors/Analyst meet on Q3 9M FY 26 Unaudited Financial Results held on February 06, 2026
[1688] Analysts/Institutional Investor Meet/Con. Call Updates (2025-11-19)/Natural Capsules Limited has informed the Exchange about Transcript
[1689] Analysts/Institutional Investor Meet/Con. Call Updates (2025-11-19)/Natural Capsules Limited has informed the Exchange about Transcript
[1690] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-17)/Hikal Limited has informed the Exchange about Transcript
[1691] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-17)/Hikal Limited has informed the Exchange about Transcript
[1692] Investor Presentation (2026-02-13)/Natural Capsules Limited has informed the Exchange about Investor Presentation
[1693] Analysts/Institutional Investor Meet/Con. Call Updates (2025-11-19)/Natural Capsules Limited has informed the Exchange about Transcript
[1694] Analysts/Institutional Investor Meet/Con. Call Updates (2025-11-19)/Natural Capsules Limited has informed the Exchange about Transcript
[1695] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-14)/Divi's Laboratories Limited has informed the Exchange about Transcript
[1696] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-14)/Divi's Laboratories Limited has informed the Exchange about Transcript
[1697] Investor Presentation (2026-01-22)/Kopran Limited has informed the Exchange about Investor Presentation
[1698] Analysts/Institutional Investor Meet/Con. Call Updates (2025-11-19)/Natural Capsules Limited has informed the Exchange about Transcript
[1699] Analysts/Institutional Investor Meet/Con. Call Updates (2025-11-19)/Natural Capsules Limited has informed the Exchange about Transcript
[1700] Analysts/Institutional Investor Meet/Con. Call Updates (2025-11-19)/Natural Capsules Limited has informed the Exchange about Transcript
[1701] Press Release (2026-02-06)/Jubilant Pharmova Limited has informed the Exchange regarding a press release dated February 06, 2026, titled "Press Release alongwith Earnings Presentation on the financials and operational performance of the Company for the quarter and nine months ended December 31, 2025".
[1702] Press Release (2026-02-06)/Jubilant Pharmova Limited has informed the Exchange regarding a press release dated February 06, 2026, titled "Press Release alongwith Earnings Presentation on the financials and operational performance of the Company for the quarter and nine months ended December 31, 2025".
[1703] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-17)/Hikal Limited has informed the Exchange about Transcript
[1704] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-17)/Hikal Limited has informed the Exchange about Transcript
[1705] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-17)/Hikal Limited has informed the Exchange about Transcript
[1706] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-17)/Hikal Limited has informed the Exchange about Transcript
[1707] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-17)/Hikal Limited has informed the Exchange about Transcript
[1708] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-17)/Hikal Limited has informed the Exchange about Transcript
[1709] Press Release (2026-02-06)/Jubilant Pharmova Limited has informed the Exchange regarding a press release dated February 06, 2026, titled "Press Release alongwith Earnings Presentation on the financials and operational performance of the Company for the quarter and nine months ended December 31, 2025".
[1710] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-10)/Solara Active Pharma Sciences Limited has informed the Exchange about Transcript of earnings call pertaining to unaudited financial results of the Company for the quarter and nine months ended December 31, 2025.
[1711] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-10)/Solara Active Pharma Sciences Limited has informed the Exchange about Transcript of earnings call pertaining to unaudited financial results of the Company for the quarter and nine months ended December 31, 2025.
[1712] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-17)/Hikal Limited has informed the Exchange about Transcript
[1713] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-17)/Hikal Limited has informed the Exchange about Transcript
[1714] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-16)/GlaxoSmithKline Pharmaceuticals Limited has informed the Exchange about Transcript
[1715] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-16)/GlaxoSmithKline Pharmaceuticals Limited has informed the Exchange about Transcript
[1716] Analysts/Institutional Investor Meet/Con. Call Updates (2025-06-11)/Wockhardt Limited has informed the Exchange about Transcript
[1717] Analysts/Institutional Investor Meet/Con. Call Updates (2025-06-11)/Wockhardt Limited has informed the Exchange about Transcript
[1718] Analysts/Institutional Investor Meet/Con. Call Updates (2025-06-11)/Wockhardt Limited has informed the Exchange about Transcript
[1719] Analysts/Institutional Investor Meet/Con. Call Updates (2025-06-11)/Wockhardt Limited has informed the Exchange about Transcript
[1720] Analysts/Institutional Investor Meet/Con. Call Updates (2025-06-11)/Wockhardt Limited has informed the Exchange about Transcript
[1721] Analysts/Institutional Investor Meet/Con. Call Updates (2025-06-11)/Wockhardt Limited has informed the Exchange about Transcript
[1722] Press Release (2026-02-06)/Jubilant Pharmova Limited has informed the Exchange regarding a press release dated February 06, 2026, titled "Press Release alongwith Earnings Presentation on the financials and operational performance of the Company for the quarter and nine months ended December 31, 2025".
[1723] Press Release (2026-02-06)/Jubilant Pharmova Limited has informed the Exchange regarding a press release dated February 06, 2026, titled "Press Release alongwith Earnings Presentation on the financials and operational performance of the Company for the quarter and nine months ended December 31, 2025".
[1724] Press Release (2026-02-06)/Jubilant Pharmova Limited has informed the Exchange regarding a press release dated February 06, 2026, titled "Press Release alongwith Earnings Presentation on the financials and operational performance of the Company for the quarter and nine months ended December 31, 2025".
[1725] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-17)/Hikal Limited has informed the Exchange about Transcript
[1726] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-17)/Hikal Limited has informed the Exchange about Transcript
[1727] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-17)/Hikal Limited has informed the Exchange about Transcript
[1728] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-17)/Hikal Limited has informed the Exchange about Transcript
[1729] Outcome of Board Meeting (2026-02-12)/Cohance Lifesciences Limited has submitted to the Exchange, the financial results for the period ended December 31, 2025.
[1730] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-17)/Hikal Limited has informed the Exchange about Transcript
[1731] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-17)/Hikal Limited has informed the Exchange about Transcript
[1732] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-09)/Viyash Scientific Limited has informed the Exchange about Transcript
[1733] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-09)/Viyash Scientific Limited has informed the Exchange about Transcript
[1734] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-09)/Viyash Scientific Limited has informed the Exchange about Transcript
[1735] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-09)/Viyash Scientific Limited has informed the Exchange about Transcript
[1736] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-09)/Viyash Scientific Limited has informed the Exchange about Transcript
[1737] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-09)/Viyash Scientific Limited has informed the Exchange about Transcript
[1738] Analysts/Institutional Investor Meet/Con. Call Updates (2025-05-17)/Morepen Laboratories Limited has informed the Exchange about Transcript
[1739] Analysts/Institutional Investor Meet/Con. Call Updates (2025-05-17)/Morepen Laboratories Limited has informed the Exchange about Transcript
[1740] Analysts/Institutional Investor Meet/Con. Call Updates (2026-03-27)/Sanofi Consumer Healthcare India Limited has informed the Exchange about the transcript of the Institutional Investor Meet held on Tuesday, 24th March 2026
[1741] Analysts/Institutional Investor Meet/Con. Call Updates (2026-03-27)/Sanofi Consumer Healthcare India Limited has informed the Exchange about the transcript of the Institutional Investor Meet held on Tuesday, 24th March 2026
[1742] Analysts/Institutional Investor Meet/Con. Call Updates (2026-03-27)/Sanofi Consumer Healthcare India Limited has informed the Exchange about the transcript of the Institutional Investor Meet held on Tuesday, 24th March 2026
[1743] Analysts/Institutional Investor Meet/Con. Call Updates (2026-03-27)/Sanofi Consumer Healthcare India Limited has informed the Exchange about the transcript of the Institutional Investor Meet held on Tuesday, 24th March 2026
[1744] Investor Presentation (2026-01-29)/BALAXI PHARMACEUTICALS LIMITED has informed the Exchange about Investor Presentation
[1745] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-14)/Divi's Laboratories Limited has informed the Exchange about Transcript
[1746] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-14)/Divi's Laboratories Limited has informed the Exchange about Transcript
[1747] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-17)/Sakar Healthcare Limited has informed the Exchange about Transcript
[1748] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-17)/Sakar Healthcare Limited has informed the Exchange about Transcript
[1749] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-17)/Hikal Limited has informed the Exchange about Transcript
[1750] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-17)/Hikal Limited has informed the Exchange about Transcript
[1751] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-17)/Hikal Limited has informed the Exchange about Transcript
[1752] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-17)/Hikal Limited has informed the Exchange about Transcript
[1753] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-10)/Solara Active Pharma Sciences Limited has informed the Exchange about Transcript of earnings call pertaining to unaudited financial results of the Company for the quarter and nine months ended December 31, 2025.
[1754] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-10)/Solara Active Pharma Sciences Limited has informed the Exchange about Transcript of earnings call pertaining to unaudited financial results of the Company for the quarter and nine months ended December 31, 2025.
[1755] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-10)/Solara Active Pharma Sciences Limited has informed the Exchange about Transcript of earnings call pertaining to unaudited financial results of the Company for the quarter and nine months ended December 31, 2025.
[1756] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-16)/Orchid Pharma Limited has informed the Exchange about Transcript
[1757] Press Release (2026-02-06)/Solara Active Pharma Sciences Limited has informed the exchange regarding the press release dated February 06, 2026, titled "Solara Q3'26 Performance."
[1758] Analysts/Institutional Investor Meet/Con. Call Updates (2025-11-19)/Natural Capsules Limited has informed the Exchange about Transcript
[1759] Analysts/Institutional Investor Meet/Con. Call Updates (2025-11-19)/Natural Capsules Limited has informed the Exchange about Transcript
[1760] Analysts/Institutional Investor Meet/Con. Call Updates (2025-11-19)/Natural Capsules Limited has informed the Exchange about Transcript
[1761] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-12)/Marksans Pharma Limited transcript of Investors/Analyst meet on Q3 9M FY 26 Unaudited Financial Results held on February 06, 2026
[1762] Analysts/Institutional Investor Meet/Con. Call Updates (2025-11-19)/Natural Capsules Limited has informed the Exchange about Transcript
[1763] Analysts/Institutional Investor Meet/Con. Call Updates (2025-11-19)/Natural Capsules Limited has informed the Exchange about Transcript
[1764] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-17)/Hikal Limited has informed the Exchange about Transcript
[1765] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-17)/Hikal Limited has informed the Exchange about Transcript
[1766] Investor Presentation (2026-02-13)/Natural Capsules Limited has informed the Exchange about Investor Presentation
[1767] Analysts/Institutional Investor Meet/Con. Call Updates (2025-11-19)/Natural Capsules Limited has informed the Exchange about Transcript
[1768] Analysts/Institutional Investor Meet/Con. Call Updates (2025-11-19)/Natural Capsules Limited has informed the Exchange about Transcript
[1769] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-14)/Divi's Laboratories Limited has informed the Exchange about Transcript
[1770] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-14)/Divi's Laboratories Limited has informed the Exchange about Transcript
[1771] Investor Presentation (2026-01-22)/Kopran Limited has informed the Exchange about Investor Presentation
[1772] Analysts/Institutional Investor Meet/Con. Call Updates (2025-11-19)/Natural Capsules Limited has informed the Exchange about Transcript
[1773] Analysts/Institutional Investor Meet/Con. Call Updates (2025-11-19)/Natural Capsules Limited has informed the Exchange about Transcript
[1774] Analysts/Institutional Investor Meet/Con. Call Updates (2025-11-19)/Natural Capsules Limited has informed the Exchange about Transcript
[1775] Press Release (2026-02-06)/Jubilant Pharmova Limited has informed the Exchange regarding a press release dated February 06, 2026, titled "Press Release alongwith Earnings Presentation on the financials and operational performance of the Company for the quarter and nine months ended December 31, 2025".
[1776] Press Release (2026-02-06)/Jubilant Pharmova Limited has informed the Exchange regarding a press release dated February 06, 2026, titled "Press Release alongwith Earnings Presentation on the financials and operational performance of the Company for the quarter and nine months ended December 31, 2025".
[1777] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-17)/Hikal Limited has informed the Exchange about Transcript
[1778] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-17)/Hikal Limited has informed the Exchange about Transcript
[1779] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-17)/Hikal Limited has informed the Exchange about Transcript
[1780] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-17)/Hikal Limited has informed the Exchange about Transcript
[1781] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-17)/Hikal Limited has informed the Exchange about Transcript
[1782] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-17)/Hikal Limited has informed the Exchange about Transcript
[1783] Press Release (2026-02-06)/Jubilant Pharmova Limited has informed the Exchange regarding a press release dated February 06, 2026, titled "Press Release alongwith Earnings Presentation on the financials and operational performance of the Company for the quarter and nine months ended December 31, 2025".
[1784] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-10)/Solara Active Pharma Sciences Limited has informed the Exchange about Transcript of earnings call pertaining to unaudited financial results of the Company for the quarter and nine months ended December 31, 2025.
[1785] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-10)/Solara Active Pharma Sciences Limited has informed the Exchange about Transcript of earnings call pertaining to unaudited financial results of the Company for the quarter and nine months ended December 31, 2025.
[1786] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-17)/Hikal Limited has informed the Exchange about Transcript
[1787] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-17)/Hikal Limited has informed the Exchange about Transcript
[1788] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-16)/GlaxoSmithKline Pharmaceuticals Limited has informed the Exchange about Transcript
[1789] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-16)/GlaxoSmithKline Pharmaceuticals Limited has informed the Exchange about Transcript
[1790] Analysts/Institutional Investor Meet/Con. Call Updates (2025-06-11)/Wockhardt Limited has informed the Exchange about Transcript
[1791] Analysts/Institutional Investor Meet/Con. Call Updates (2025-06-11)/Wockhardt Limited has informed the Exchange about Transcript
[1792] Analysts/Institutional Investor Meet/Con. Call Updates (2025-06-11)/Wockhardt Limited has informed the Exchange about Transcript
[1793] Analysts/Institutional Investor Meet/Con. Call Updates (2025-06-11)/Wockhardt Limited has informed the Exchange about Transcript
[1794] Analysts/Institutional Investor Meet/Con. Call Updates (2025-06-11)/Wockhardt Limited has informed the Exchange about Transcript
[1795] Analysts/Institutional Investor Meet/Con. Call Updates (2025-06-11)/Wockhardt Limited has informed the Exchange about Transcript
[1796] Press Release (2026-02-06)/Jubilant Pharmova Limited has informed the Exchange regarding a press release dated February 06, 2026, titled "Press Release alongwith Earnings Presentation on the financials and operational performance of the Company for the quarter and nine months ended December 31, 2025".
[1797] Press Release (2026-02-06)/Jubilant Pharmova Limited has informed the Exchange regarding a press release dated February 06, 2026, titled "Press Release alongwith Earnings Presentation on the financials and operational performance of the Company for the quarter and nine months ended December 31, 2025".
[1798] Press Release (2026-02-06)/Jubilant Pharmova Limited has informed the Exchange regarding a press release dated February 06, 2026, titled "Press Release alongwith Earnings Presentation on the financials and operational performance of the Company for the quarter and nine months ended December 31, 2025".
[1799] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-17)/Hikal Limited has informed the Exchange about Transcript
[1800] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-17)/Hikal Limited has informed the Exchange about Transcript
[1801] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-17)/Hikal Limited has informed the Exchange about Transcript
[1802] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-17)/Hikal Limited has informed the Exchange about Transcript
[1803] Outcome of Board Meeting (2026-02-12)/Cohance Lifesciences Limited has submitted to the Exchange, the financial results for the period ended December 31, 2025.
[1804] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-17)/Hikal Limited has informed the Exchange about Transcript
[1805] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-17)/Hikal Limited has informed the Exchange about Transcript
[1806] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-09)/Viyash Scientific Limited has informed the Exchange about Transcript
[1807] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-09)/Viyash Scientific Limited has informed the Exchange about Transcript
[1808] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-09)/Viyash Scientific Limited has informed the Exchange about Transcript
[1809] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-09)/Viyash Scientific Limited has informed the Exchange about Transcript
[1810] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-09)/Viyash Scientific Limited has informed the Exchange about Transcript
[1811] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-09)/Viyash Scientific Limited has informed the Exchange about Transcript
[1812] Analysts/Institutional Investor Meet/Con. Call Updates (2025-05-17)/Morepen Laboratories Limited has informed the Exchange about Transcript
[1813] Analysts/Institutional Investor Meet/Con. Call Updates (2025-05-17)/Morepen Laboratories Limited has informed the Exchange about Transcript
[1814] Analysts/Institutional Investor Meet/Con. Call Updates (2026-03-27)/Sanofi Consumer Healthcare India Limited has informed the Exchange about the transcript of the Institutional Investor Meet held on Tuesday, 24th March 2026
[1815] Analysts/Institutional Investor Meet/Con. Call Updates (2026-03-27)/Sanofi Consumer Healthcare India Limited has informed the Exchange about the transcript of the Institutional Investor Meet held on Tuesday, 24th March 2026
[1816] Analysts/Institutional Investor Meet/Con. Call Updates (2026-03-27)/Sanofi Consumer Healthcare India Limited has informed the Exchange about the transcript of the Institutional Investor Meet held on Tuesday, 24th March 2026
[1817] Analysts/Institutional Investor Meet/Con. Call Updates (2026-03-27)/Sanofi Consumer Healthcare India Limited has informed the Exchange about the transcript of the Institutional Investor Meet held on Tuesday, 24th March 2026
[1818] Investor Presentation (2026-01-29)/BALAXI PHARMACEUTICALS LIMITED has informed the Exchange about Investor Presentation
[1819] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-14)/Divi's Laboratories Limited has informed the Exchange about Transcript
[1820] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-14)/Divi's Laboratories Limited has informed the Exchange about Transcript
[1821] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-17)/Sakar Healthcare Limited has informed the Exchange about Transcript
[1822] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-17)/Sakar Healthcare Limited has informed the Exchange about Transcript
[1823] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-17)/Hikal Limited has informed the Exchange about Transcript
[1824] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-17)/Hikal Limited has informed the Exchange about Transcript
[1825] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-17)/Hikal Limited has informed the Exchange about Transcript
[1826] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-17)/Hikal Limited has informed the Exchange about Transcript
[1827] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-10)/Solara Active Pharma Sciences Limited has informed the Exchange about Transcript of earnings call pertaining to unaudited financial results of the Company for the quarter and nine months ended December 31, 2025.
[1828] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-10)/Solara Active Pharma Sciences Limited has informed the Exchange about Transcript of earnings call pertaining to unaudited financial results of the Company for the quarter and nine months ended December 31, 2025.
[1829] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-10)/Solara Active Pharma Sciences Limited has informed the Exchange about Transcript of earnings call pertaining to unaudited financial results of the Company for the quarter and nine months ended December 31, 2025.
[1830] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-16)/Orchid Pharma Limited has informed the Exchange about Transcript
[1831] Press Release (2026-02-06)/Solara Active Pharma Sciences Limited has informed the exchange regarding the press release dated February 06, 2026, titled "Solara Q3'26 Performance."
[1832] Analysts/Institutional Investor Meet/Con. Call Updates (2025-11-19)/Natural Capsules Limited has informed the Exchange about Transcript
[1833] Analysts/Institutional Investor Meet/Con. Call Updates (2025-11-19)/Natural Capsules Limited has informed the Exchange about Transcript
[1834] Analysts/Institutional Investor Meet/Con. Call Updates (2025-11-19)/Natural Capsules Limited has informed the Exchange about Transcript
[1835] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-12)/Marksans Pharma Limited transcript of Investors/Analyst meet on Q3 9M FY 26 Unaudited Financial Results held on February 06, 2026
[1836] Analysts/Institutional Investor Meet/Con. Call Updates (2025-11-19)/Natural Capsules Limited has informed the Exchange about Transcript
[1837] Analysts/Institutional Investor Meet/Con. Call Updates (2025-11-19)/Natural Capsules Limited has informed the Exchange about Transcript
[1838] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-17)/Hikal Limited has informed the Exchange about Transcript
[1839] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-17)/Hikal Limited has informed the Exchange about Transcript
[1840] Investor Presentation (2026-02-13)/Natural Capsules Limited has informed the Exchange about Investor Presentation
[1841] Analysts/Institutional Investor Meet/Con. Call Updates (2025-11-19)/Natural Capsules Limited has informed the Exchange about Transcript
[1842] Analysts/Institutional Investor Meet/Con. Call Updates (2025-11-19)/Natural Capsules Limited has informed the Exchange about Transcript
[1843] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-14)/Divi's Laboratories Limited has informed the Exchange about Transcript
[1844] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-14)/Divi's Laboratories Limited has informed the Exchange about Transcript
[1845] Investor Presentation (2026-01-22)/Kopran Limited has informed the Exchange about Investor Presentation
[1846] Analysts/Institutional Investor Meet/Con. Call Updates (2025-11-19)/Natural Capsules Limited has informed the Exchange about Transcript
[1847] Analysts/Institutional Investor Meet/Con. Call Updates (2025-11-19)/Natural Capsules Limited has informed the Exchange about Transcript
[1848] Analysts/Institutional Investor Meet/Con. Call Updates (2025-11-19)/Natural Capsules Limited has informed the Exchange about Transcript
[1849] Press Release (2026-02-06)/Jubilant Pharmova Limited has informed the Exchange regarding a press release dated February 06, 2026, titled "Press Release alongwith Earnings Presentation on the financials and operational performance of the Company for the quarter and nine months ended December 31, 2025".
[1850] Press Release (2026-02-06)/Jubilant Pharmova Limited has informed the Exchange regarding a press release dated February 06, 2026, titled "Press Release alongwith Earnings Presentation on the financials and operational performance of the Company for the quarter and nine months ended December 31, 2025".
[1851] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-17)/Hikal Limited has informed the Exchange about Transcript
[1852] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-17)/Hikal Limited has informed the Exchange about Transcript
[1853] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-17)/Hikal Limited has informed the Exchange about Transcript
[1854] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-17)/Hikal Limited has informed the Exchange about Transcript
[1855] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-17)/Hikal Limited has informed the Exchange about Transcript
[1856] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-17)/Hikal Limited has informed the Exchange about Transcript
[1857] Press Release (2026-02-06)/Jubilant Pharmova Limited has informed the Exchange regarding a press release dated February 06, 2026, titled "Press Release alongwith Earnings Presentation on the financials and operational performance of the Company for the quarter and nine months ended December 31, 2025".
[1858] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-10)/Solara Active Pharma Sciences Limited has informed the Exchange about Transcript of earnings call pertaining to unaudited financial results of the Company for the quarter and nine months ended December 31, 2025.
[1859] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-10)/Solara Active Pharma Sciences Limited has informed the Exchange about Transcript of earnings call pertaining to unaudited financial results of the Company for the quarter and nine months ended December 31, 2025.
[1860] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-17)/Hikal Limited has informed the Exchange about Transcript
[1861] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-17)/Hikal Limited has informed the Exchange about Transcript
[1862] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-16)/GlaxoSmithKline Pharmaceuticals Limited has informed the Exchange about Transcript
[1863] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-16)/GlaxoSmithKline Pharmaceuticals Limited has informed the Exchange about Transcript
[1864] Analysts/Institutional Investor Meet/Con. Call Updates (2025-06-11)/Wockhardt Limited has informed the Exchange about Transcript
[1865] Analysts/Institutional Investor Meet/Con. Call Updates (2025-06-11)/Wockhardt Limited has informed the Exchange about Transcript
[1866] Analysts/Institutional Investor Meet/Con. Call Updates (2025-06-11)/Wockhardt Limited has informed the Exchange about Transcript
[1867] Analysts/Institutional Investor Meet/Con. Call Updates (2025-06-11)/Wockhardt Limited has informed the Exchange about Transcript
[1868] Analysts/Institutional Investor Meet/Con. Call Updates (2025-06-11)/Wockhardt Limited has informed the Exchange about Transcript
[1869] Analysts/Institutional Investor Meet/Con. Call Updates (2025-06-11)/Wockhardt Limited has informed the Exchange about Transcript
[1870] Press Release (2026-02-06)/Jubilant Pharmova Limited has informed the Exchange regarding a press release dated February 06, 2026, titled "Press Release alongwith Earnings Presentation on the financials and operational performance of the Company for the quarter and nine months ended December 31, 2025".
[1871] Press Release (2026-02-06)/Jubilant Pharmova Limited has informed the Exchange regarding a press release dated February 06, 2026, titled "Press Release alongwith Earnings Presentation on the financials and operational performance of the Company for the quarter and nine months ended December 31, 2025".
[1872] Press Release (2026-02-06)/Jubilant Pharmova Limited has informed the Exchange regarding a press release dated February 06, 2026, titled "Press Release alongwith Earnings Presentation on the financials and operational performance of the Company for the quarter and nine months ended December 31, 2025".
[1873] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-17)/Hikal Limited has informed the Exchange about Transcript
[1874] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-17)/Hikal Limited has informed the Exchange about Transcript
[1875] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-17)/Hikal Limited has informed the Exchange about Transcript
[1876] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-17)/Hikal Limited has informed the Exchange about Transcript
[1877] Outcome of Board Meeting (2026-02-12)/Cohance Lifesciences Limited has submitted to the Exchange, the financial results for the period ended December 31, 2025.
[1878] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-17)/Hikal Limited has informed the Exchange about Transcript
[1879] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-17)/Hikal Limited has informed the Exchange about Transcript
[1880] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-09)/Viyash Scientific Limited has informed the Exchange about Transcript
[1881] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-09)/Viyash Scientific Limited has informed the Exchange about Transcript
[1882] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-09)/Viyash Scientific Limited has informed the Exchange about Transcript
[1883] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-09)/Viyash Scientific Limited has informed the Exchange about Transcript
[1884] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-09)/Viyash Scientific Limited has informed the Exchange about Transcript
[1885] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-09)/Viyash Scientific Limited has informed the Exchange about Transcript
[1886] Analysts/Institutional Investor Meet/Con. Call Updates (2025-05-17)/Morepen Laboratories Limited has informed the Exchange about Transcript
[1887] Analysts/Institutional Investor Meet/Con. Call Updates (2025-05-17)/Morepen Laboratories Limited has informed the Exchange about Transcript
[1888] Analysts/Institutional Investor Meet/Con. Call Updates (2026-03-27)/Sanofi Consumer Healthcare India Limited has informed the Exchange about the transcript of the Institutional Investor Meet held on Tuesday, 24th March 2026
[1889] Analysts/Institutional Investor Meet/Con. Call Updates (2026-03-27)/Sanofi Consumer Healthcare India Limited has informed the Exchange about the transcript of the Institutional Investor Meet held on Tuesday, 24th March 2026
[1890] Analysts/Institutional Investor Meet/Con. Call Updates (2026-03-27)/Sanofi Consumer Healthcare India Limited has informed the Exchange about the transcript of the Institutional Investor Meet held on Tuesday, 24th March 2026
[1891] Analysts/Institutional Investor Meet/Con. Call Updates (2026-03-27)/Sanofi Consumer Healthcare India Limited has informed the Exchange about the transcript of the Institutional Investor Meet held on Tuesday, 24th March 2026
[1892] Investor Presentation (2026-01-29)/BALAXI PHARMACEUTICALS LIMITED has informed the Exchange about Investor Presentation
[1893] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-14)/Divi's Laboratories Limited has informed the Exchange about Transcript
[1894] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-14)/Divi's Laboratories Limited has informed the Exchange about Transcript
[1895] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-17)/Sakar Healthcare Limited has informed the Exchange about Transcript
[1896] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-17)/Sakar Healthcare Limited has informed the Exchange about Transcript
[1897] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-14)/Divi's Laboratories Limited has informed the Exchange about Transcript
[1898] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-17)/Hikal Limited has informed the Exchange about Transcript
[1899] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-17)/Hikal Limited has informed the Exchange about Transcript
[1900] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-17)/Hikal Limited has informed the Exchange about Transcript
[1901] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-17)/Hikal Limited has informed the Exchange about Transcript
[1902] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-10)/Solara Active Pharma Sciences Limited has informed the Exchange about Transcript of earnings call pertaining to unaudited financial results of the Company for the quarter and nine months ended December 31, 2025.
[1903] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-10)/Solara Active Pharma Sciences Limited has informed the Exchange about Transcript of earnings call pertaining to unaudited financial results of the Company for the quarter and nine months ended December 31, 2025.
[1904] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-10)/Solara Active Pharma Sciences Limited has informed the Exchange about Transcript of earnings call pertaining to unaudited financial results of the Company for the quarter and nine months ended December 31, 2025.
[1905] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-16)/Orchid Pharma Limited has informed the Exchange about Transcript
[1906] Press Release (2026-02-06)/Solara Active Pharma Sciences Limited has informed the exchange regarding the press release dated February 06, 2026, titled "Solara Q3'26 Performance."
[1907] Analysts/Institutional Investor Meet/Con. Call Updates (2025-11-19)/Natural Capsules Limited has informed the Exchange about Transcript
[1908] Analysts/Institutional Investor Meet/Con. Call Updates (2025-11-19)/Natural Capsules Limited has informed the Exchange about Transcript
[1909] Analysts/Institutional Investor Meet/Con. Call Updates (2025-11-19)/Natural Capsules Limited has informed the Exchange about Transcript
[1910] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-12)/Marksans Pharma Limited transcript of Investors/Analyst meet on Q3 9M FY 26 Unaudited Financial Results held on February 06, 2026
[1911] Analysts/Institutional Investor Meet/Con. Call Updates (2025-11-19)/Natural Capsules Limited has informed the Exchange about Transcript
[1912] Analysts/Institutional Investor Meet/Con. Call Updates (2025-11-19)/Natural Capsules Limited has informed the Exchange about Transcript
[1913] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-17)/Hikal Limited has informed the Exchange about Transcript
[1914] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-17)/Hikal Limited has informed the Exchange about Transcript
[1915] Investor Presentation (2026-02-13)/Natural Capsules Limited has informed the Exchange about Investor Presentation
[1916] Analysts/Institutional Investor Meet/Con. Call Updates (2025-11-19)/Natural Capsules Limited has informed the Exchange about Transcript
[1917] Analysts/Institutional Investor Meet/Con. Call Updates (2025-11-19)/Natural Capsules Limited has informed the Exchange about Transcript
[1918] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-14)/Divi's Laboratories Limited has informed the Exchange about Transcript
[1919] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-14)/Divi's Laboratories Limited has informed the Exchange about Transcript
[1920] Investor Presentation (2026-01-22)/Kopran Limited has informed the Exchange about Investor Presentation
[1921] Analysts/Institutional Investor Meet/Con. Call Updates (2025-11-19)/Natural Capsules Limited has informed the Exchange about Transcript
[1922] Analysts/Institutional Investor Meet/Con. Call Updates (2025-11-19)/Natural Capsules Limited has informed the Exchange about Transcript
[1923] Analysts/Institutional Investor Meet/Con. Call Updates (2025-11-19)/Natural Capsules Limited has informed the Exchange about Transcript
[1924] Press Release (2026-02-06)/Jubilant Pharmova Limited has informed the Exchange regarding a press release dated February 06, 2026, titled "Press Release alongwith Earnings Presentation on the financials and operational performance of the Company for the quarter and nine months ended December 31, 2025".
[1925] Press Release (2026-02-06)/Jubilant Pharmova Limited has informed the Exchange regarding a press release dated February 06, 2026, titled "Press Release alongwith Earnings Presentation on the financials and operational performance of the Company for the quarter and nine months ended December 31, 2025".
[1926] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-17)/Hikal Limited has informed the Exchange about Transcript
[1927] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-17)/Hikal Limited has informed the Exchange about Transcript
[1928] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-17)/Hikal Limited has informed the Exchange about Transcript
[1929] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-17)/Hikal Limited has informed the Exchange about Transcript
[1930] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-17)/Hikal Limited has informed the Exchange about Transcript
[1931] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-17)/Hikal Limited has informed the Exchange about Transcript
[1932] Press Release (2026-02-06)/Jubilant Pharmova Limited has informed the Exchange regarding a press release dated February 06, 2026, titled "Press Release alongwith Earnings Presentation on the financials and operational performance of the Company for the quarter and nine months ended December 31, 2025".
[1933] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-10)/Solara Active Pharma Sciences Limited has informed the Exchange about Transcript of earnings call pertaining to unaudited financial results of the Company for the quarter and nine months ended December 31, 2025.
[1934] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-10)/Solara Active Pharma Sciences Limited has informed the Exchange about Transcript of earnings call pertaining to unaudited financial results of the Company for the quarter and nine months ended December 31, 2025.
[1935] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-17)/Hikal Limited has informed the Exchange about Transcript
[1936] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-17)/Hikal Limited has informed the Exchange about Transcript
[1937] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-16)/GlaxoSmithKline Pharmaceuticals Limited has informed the Exchange about Transcript
[1938] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-16)/GlaxoSmithKline Pharmaceuticals Limited has informed the Exchange about Transcript
[1939] Analysts/Institutional Investor Meet/Con. Call Updates (2025-06-11)/Wockhardt Limited has informed the Exchange about Transcript
[1940] Analysts/Institutional Investor Meet/Con. Call Updates (2025-06-11)/Wockhardt Limited has informed the Exchange about Transcript
[1941] Analysts/Institutional Investor Meet/Con. Call Updates (2025-06-11)/Wockhardt Limited has informed the Exchange about Transcript
[1942] Analysts/Institutional Investor Meet/Con. Call Updates (2025-06-11)/Wockhardt Limited has informed the Exchange about Transcript
[1943] Analysts/Institutional Investor Meet/Con. Call Updates (2025-06-11)/Wockhardt Limited has informed the Exchange about Transcript
[1944] Analysts/Institutional Investor Meet/Con. Call Updates (2025-06-11)/Wockhardt Limited has informed the Exchange about Transcript
[1945] Press Release (2026-02-06)/Jubilant Pharmova Limited has informed the Exchange regarding a press release dated February 06, 2026, titled "Press Release alongwith Earnings Presentation on the financials and operational performance of the Company for the quarter and nine months ended December 31, 2025".
[1946] Press Release (2026-02-06)/Jubilant Pharmova Limited has informed the Exchange regarding a press release dated February 06, 2026, titled "Press Release alongwith Earnings Presentation on the financials and operational performance of the Company for the quarter and nine months ended December 31, 2025".
[1947] Press Release (2026-02-06)/Jubilant Pharmova Limited has informed the Exchange regarding a press release dated February 06, 2026, titled "Press Release alongwith Earnings Presentation on the financials and operational performance of the Company for the quarter and nine months ended December 31, 2025".
[1948] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-17)/Hikal Limited has informed the Exchange about Transcript
[1949] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-17)/Hikal Limited has informed the Exchange about Transcript
[1950] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-17)/Hikal Limited has informed the Exchange about Transcript
[1951] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-17)/Hikal Limited has informed the Exchange about Transcript
[1952] Outcome of Board Meeting (2026-02-12)/Cohance Lifesciences Limited has submitted to the Exchange, the financial results for the period ended December 31, 2025.
[1953] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-17)/Hikal Limited has informed the Exchange about Transcript
[1954] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-17)/Hikal Limited has informed the Exchange about Transcript
[1955] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-09)/Viyash Scientific Limited has informed the Exchange about Transcript
[1956] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-09)/Viyash Scientific Limited has informed the Exchange about Transcript
[1957] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-09)/Viyash Scientific Limited has informed the Exchange about Transcript
[1958] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-09)/Viyash Scientific Limited has informed the Exchange about Transcript
[1959] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-09)/Viyash Scientific Limited has informed the Exchange about Transcript
[1960] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-09)/Viyash Scientific Limited has informed the Exchange about Transcript
[1961] Analysts/Institutional Investor Meet/Con. Call Updates (2025-05-17)/Morepen Laboratories Limited has informed the Exchange about Transcript
[1962] Analysts/Institutional Investor Meet/Con. Call Updates (2025-05-17)/Morepen Laboratories Limited has informed the Exchange about Transcript
[1963] Analysts/Institutional Investor Meet/Con. Call Updates (2026-03-27)/Sanofi Consumer Healthcare India Limited has informed the Exchange about the transcript of the Institutional Investor Meet held on Tuesday, 24th March 2026
[1964] Analysts/Institutional Investor Meet/Con. Call Updates (2026-03-27)/Sanofi Consumer Healthcare India Limited has informed the Exchange about the transcript of the Institutional Investor Meet held on Tuesday, 24th March 2026
[1965] Analysts/Institutional Investor Meet/Con. Call Updates (2026-03-27)/Sanofi Consumer Healthcare India Limited has informed the Exchange about the transcript of the Institutional Investor Meet held on Tuesday, 24th March 2026
[1966] Analysts/Institutional Investor Meet/Con. Call Updates (2026-03-27)/Sanofi Consumer Healthcare India Limited has informed the Exchange about the transcript of the Institutional Investor Meet held on Tuesday, 24th March 2026
[1967] Investor Presentation (2026-01-29)/BALAXI PHARMACEUTICALS LIMITED has informed the Exchange about Investor Presentation
[1968] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-14)/Divi's Laboratories Limited has informed the Exchange about Transcript
[1969] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-14)/Divi's Laboratories Limited has informed the Exchange about Transcript
[1970] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-17)/Sakar Healthcare Limited has informed the Exchange about Transcript
[1971] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-17)/Sakar Healthcare Limited has informed the Exchange about Transcript
[1972] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-14)/Divi's Laboratories Limited has informed the Exchange about Transcript
[1973] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-14)/Divi's Laboratories Limited has informed the Exchange about Transcript
[1974] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-14)/Divi's Laboratories Limited has informed the Exchange about Transcript
[1975] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-14)/Divi's Laboratories Limited has informed the Exchange about Transcript
[1976] Outcome of Board Meeting (2026-02-05)/Caplin Point Laboratories Limited has submitted to the Exchange, the financial results for the period ended December 31, 2025.
[1977] Outcome of Board Meeting (2026-02-05)/Caplin Point Laboratories Limited has submitted to the Exchange, the financial results for the period ended December 31, 2025.
[1978] Investor Presentation (2026-02-09)/Wanbury Limited has informed the Exchange about Investor Presentation
[1979] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-17)/Hikal Limited has informed the Exchange about Transcript
[1980] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-17)/Hikal Limited has informed the Exchange about Transcript
[1981] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-17)/Hikal Limited has informed the Exchange about Transcript
[1982] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-17)/Hikal Limited has informed the Exchange about Transcript
[1983] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-10)/Solara Active Pharma Sciences Limited has informed the Exchange about Transcript of earnings call pertaining to unaudited financial results of the Company for the quarter and nine months ended December 31, 2025.
[1984] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-10)/Solara Active Pharma Sciences Limited has informed the Exchange about Transcript of earnings call pertaining to unaudited financial results of the Company for the quarter and nine months ended December 31, 2025.
[1985] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-10)/Solara Active Pharma Sciences Limited has informed the Exchange about Transcript of earnings call pertaining to unaudited financial results of the Company for the quarter and nine months ended December 31, 2025.
[1986] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-16)/Orchid Pharma Limited has informed the Exchange about Transcript
[1987] Press Release (2026-02-06)/Solara Active Pharma Sciences Limited has informed the exchange regarding the press release dated February 06, 2026, titled "Solara Q3'26 Performance."
[1988] Analysts/Institutional Investor Meet/Con. Call Updates (2025-11-19)/Natural Capsules Limited has informed the Exchange about Transcript
[1989] Analysts/Institutional Investor Meet/Con. Call Updates (2025-11-19)/Natural Capsules Limited has informed the Exchange about Transcript
[1990] Analysts/Institutional Investor Meet/Con. Call Updates (2025-11-19)/Natural Capsules Limited has informed the Exchange about Transcript
[1991] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-12)/Marksans Pharma Limited transcript of Investors/Analyst meet on Q3 9M FY 26 Unaudited Financial Results held on February 06, 2026
[1992] Analysts/Institutional Investor Meet/Con. Call Updates (2025-11-19)/Natural Capsules Limited has informed the Exchange about Transcript
[1993] Analysts/Institutional Investor Meet/Con. Call Updates (2025-11-19)/Natural Capsules Limited has informed the Exchange about Transcript
[1994] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-17)/Hikal Limited has informed the Exchange about Transcript
[1995] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-17)/Hikal Limited has informed the Exchange about Transcript
[1996] Investor Presentation (2026-02-13)/Natural Capsules Limited has informed the Exchange about Investor Presentation
[1997] Analysts/Institutional Investor Meet/Con. Call Updates (2025-11-19)/Natural Capsules Limited has informed the Exchange about Transcript
[1998] Analysts/Institutional Investor Meet/Con. Call Updates (2025-11-19)/Natural Capsules Limited has informed the Exchange about Transcript
[1999] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-14)/Divi's Laboratories Limited has informed the Exchange about Transcript
[2000] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-14)/Divi's Laboratories Limited has informed the Exchange about Transcript
[2001] Investor Presentation (2026-01-22)/Kopran Limited has informed the Exchange about Investor Presentation
[2002] Analysts/Institutional Investor Meet/Con. Call Updates (2025-11-19)/Natural Capsules Limited has informed the Exchange about Transcript
[2003] Analysts/Institutional Investor Meet/Con. Call Updates (2025-11-19)/Natural Capsules Limited has informed the Exchange about Transcript
[2004] Analysts/Institutional Investor Meet/Con. Call Updates (2025-11-19)/Natural Capsules Limited has informed the Exchange about Transcript
[2005] Press Release (2026-02-06)/Jubilant Pharmova Limited has informed the Exchange regarding a press release dated February 06, 2026, titled "Press Release alongwith Earnings Presentation on the financials and operational performance of the Company for the quarter and nine months ended December 31, 2025".
[2006] Press Release (2026-02-06)/Jubilant Pharmova Limited has informed the Exchange regarding a press release dated February 06, 2026, titled "Press Release alongwith Earnings Presentation on the financials and operational performance of the Company for the quarter and nine months ended December 31, 2025".
[2007] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-17)/Hikal Limited has informed the Exchange about Transcript
[2008] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-17)/Hikal Limited has informed the Exchange about Transcript
[2009] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-17)/Hikal Limited has informed the Exchange about Transcript
[2010] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-17)/Hikal Limited has informed the Exchange about Transcript
[2011] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-17)/Hikal Limited has informed the Exchange about Transcript
[2012] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-17)/Hikal Limited has informed the Exchange about Transcript
[2013] Press Release (2026-02-06)/Jubilant Pharmova Limited has informed the Exchange regarding a press release dated February 06, 2026, titled "Press Release alongwith Earnings Presentation on the financials and operational performance of the Company for the quarter and nine months ended December 31, 2025".
[2014] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-10)/Solara Active Pharma Sciences Limited has informed the Exchange about Transcript of earnings call pertaining to unaudited financial results of the Company for the quarter and nine months ended December 31, 2025.
[2015] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-10)/Solara Active Pharma Sciences Limited has informed the Exchange about Transcript of earnings call pertaining to unaudited financial results of the Company for the quarter and nine months ended December 31, 2025.
[2016] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-17)/Hikal Limited has informed the Exchange about Transcript
[2017] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-17)/Hikal Limited has informed the Exchange about Transcript
[2018] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-16)/GlaxoSmithKline Pharmaceuticals Limited has informed the Exchange about Transcript
[2019] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-16)/GlaxoSmithKline Pharmaceuticals Limited has informed the Exchange about Transcript
[2020] Analysts/Institutional Investor Meet/Con. Call Updates (2025-06-11)/Wockhardt Limited has informed the Exchange about Transcript
[2021] Analysts/Institutional Investor Meet/Con. Call Updates (2025-06-11)/Wockhardt Limited has informed the Exchange about Transcript
[2022] Analysts/Institutional Investor Meet/Con. Call Updates (2025-06-11)/Wockhardt Limited has informed the Exchange about Transcript
[2023] Analysts/Institutional Investor Meet/Con. Call Updates (2025-06-11)/Wockhardt Limited has informed the Exchange about Transcript
[2024] Analysts/Institutional Investor Meet/Con. Call Updates (2025-06-11)/Wockhardt Limited has informed the Exchange about Transcript
[2025] Analysts/Institutional Investor Meet/Con. Call Updates (2025-06-11)/Wockhardt Limited has informed the Exchange about Transcript
[2026] Press Release (2026-02-06)/Jubilant Pharmova Limited has informed the Exchange regarding a press release dated February 06, 2026, titled "Press Release alongwith Earnings Presentation on the financials and operational performance of the Company for the quarter and nine months ended December 31, 2025".
[2027] Press Release (2026-02-06)/Jubilant Pharmova Limited has informed the Exchange regarding a press release dated February 06, 2026, titled "Press Release alongwith Earnings Presentation on the financials and operational performance of the Company for the quarter and nine months ended December 31, 2025".
[2028] Press Release (2026-02-06)/Jubilant Pharmova Limited has informed the Exchange regarding a press release dated February 06, 2026, titled "Press Release alongwith Earnings Presentation on the financials and operational performance of the Company for the quarter and nine months ended December 31, 2025".
[2029] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-17)/Hikal Limited has informed the Exchange about Transcript
[2030] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-17)/Hikal Limited has informed the Exchange about Transcript
[2031] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-17)/Hikal Limited has informed the Exchange about Transcript
[2032] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-17)/Hikal Limited has informed the Exchange about Transcript
[2033] Outcome of Board Meeting (2026-02-12)/Cohance Lifesciences Limited has submitted to the Exchange, the financial results for the period ended December 31, 2025.
[2034] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-17)/Hikal Limited has informed the Exchange about Transcript
[2035] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-17)/Hikal Limited has informed the Exchange about Transcript
[2036] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-09)/Viyash Scientific Limited has informed the Exchange about Transcript
[2037] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-09)/Viyash Scientific Limited has informed the Exchange about Transcript
[2038] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-09)/Viyash Scientific Limited has informed the Exchange about Transcript
[2039] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-09)/Viyash Scientific Limited has informed the Exchange about Transcript
[2040] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-09)/Viyash Scientific Limited has informed the Exchange about Transcript
[2041] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-09)/Viyash Scientific Limited has informed the Exchange about Transcript
[2042] Analysts/Institutional Investor Meet/Con. Call Updates (2025-05-17)/Morepen Laboratories Limited has informed the Exchange about Transcript
[2043] Analysts/Institutional Investor Meet/Con. Call Updates (2025-05-17)/Morepen Laboratories Limited has informed the Exchange about Transcript
[2044] Analysts/Institutional Investor Meet/Con. Call Updates (2026-03-27)/Sanofi Consumer Healthcare India Limited has informed the Exchange about the transcript of the Institutional Investor Meet held on Tuesday, 24th March 2026
[2045] Analysts/Institutional Investor Meet/Con. Call Updates (2026-03-27)/Sanofi Consumer Healthcare India Limited has informed the Exchange about the transcript of the Institutional Investor Meet held on Tuesday, 24th March 2026
[2046] Analysts/Institutional Investor Meet/Con. Call Updates (2026-03-27)/Sanofi Consumer Healthcare India Limited has informed the Exchange about the transcript of the Institutional Investor Meet held on Tuesday, 24th March 2026
[2047] Analysts/Institutional Investor Meet/Con. Call Updates (2026-03-27)/Sanofi Consumer Healthcare India Limited has informed the Exchange about the transcript of the Institutional Investor Meet held on Tuesday, 24th March 2026
[2048] Investor Presentation (2026-01-29)/BALAXI PHARMACEUTICALS LIMITED has informed the Exchange about Investor Presentation
[2049] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-14)/Divi's Laboratories Limited has informed the Exchange about Transcript
[2050] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-14)/Divi's Laboratories Limited has informed the Exchange about Transcript
[2051] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-17)/Sakar Healthcare Limited has informed the Exchange about Transcript
[2052] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-17)/Sakar Healthcare Limited has informed the Exchange about Transcript
[2053] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-14)/Divi's Laboratories Limited has informed the Exchange about Transcript
[2054] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-14)/Divi's Laboratories Limited has informed the Exchange about Transcript
[2055] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-14)/Divi's Laboratories Limited has informed the Exchange about Transcript
[2056] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-14)/Divi's Laboratories Limited has informed the Exchange about Transcript
[2057] Outcome of Board Meeting (2026-02-05)/Caplin Point Laboratories Limited has submitted to the Exchange, the financial results for the period ended December 31, 2025.
[2058] Outcome of Board Meeting (2026-02-05)/Caplin Point Laboratories Limited has submitted to the Exchange, the financial results for the period ended December 31, 2025.
[2059] Investor Presentation (2026-02-09)/Wanbury Limited has informed the Exchange about Investor Presentation
[2060] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-17)/Hikal Limited has informed the Exchange about Transcript
[2061] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-17)/Hikal Limited has informed the Exchange about Transcript
[2062] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-17)/Hikal Limited has informed the Exchange about Transcript
[2063] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-17)/Hikal Limited has informed the Exchange about Transcript
[2064] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-10)/Solara Active Pharma Sciences Limited has informed the Exchange about Transcript of earnings call pertaining to unaudited financial results of the Company for the quarter and nine months ended December 31, 2025.
[2065] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-10)/Solara Active Pharma Sciences Limited has informed the Exchange about Transcript of earnings call pertaining to unaudited financial results of the Company for the quarter and nine months ended December 31, 2025.
[2066] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-10)/Solara Active Pharma Sciences Limited has informed the Exchange about Transcript of earnings call pertaining to unaudited financial results of the Company for the quarter and nine months ended December 31, 2025.
[2067] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-16)/Orchid Pharma Limited has informed the Exchange about Transcript
[2068] Press Release (2026-02-06)/Solara Active Pharma Sciences Limited has informed the exchange regarding the press release dated February 06, 2026, titled "Solara Q3'26 Performance."
[2069] Analysts/Institutional Investor Meet/Con. Call Updates (2025-11-19)/Natural Capsules Limited has informed the Exchange about Transcript
[2070] Analysts/Institutional Investor Meet/Con. Call Updates (2025-11-19)/Natural Capsules Limited has informed the Exchange about Transcript
[2071] Analysts/Institutional Investor Meet/Con. Call Updates (2025-11-19)/Natural Capsules Limited has informed the Exchange about Transcript
[2072] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-12)/Marksans Pharma Limited transcript of Investors/Analyst meet on Q3 9M FY 26 Unaudited Financial Results held on February 06, 2026
[2073] Analysts/Institutional Investor Meet/Con. Call Updates (2025-11-19)/Natural Capsules Limited has informed the Exchange about Transcript
[2074] Analysts/Institutional Investor Meet/Con. Call Updates (2025-11-19)/Natural Capsules Limited has informed the Exchange about Transcript
[2075] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-17)/Hikal Limited has informed the Exchange about Transcript
[2076] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-17)/Hikal Limited has informed the Exchange about Transcript
[2077] Investor Presentation (2026-02-13)/Natural Capsules Limited has informed the Exchange about Investor Presentation
[2078] Analysts/Institutional Investor Meet/Con. Call Updates (2025-11-19)/Natural Capsules Limited has informed the Exchange about Transcript
[2079] Analysts/Institutional Investor Meet/Con. Call Updates (2025-11-19)/Natural Capsules Limited has informed the Exchange about Transcript
[2080] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-14)/Divi's Laboratories Limited has informed the Exchange about Transcript
[2081] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-14)/Divi's Laboratories Limited has informed the Exchange about Transcript
[2082] Investor Presentation (2026-01-22)/Kopran Limited has informed the Exchange about Investor Presentation
[2083] Analysts/Institutional Investor Meet/Con. Call Updates (2025-11-19)/Natural Capsules Limited has informed the Exchange about Transcript
[2084] Analysts/Institutional Investor Meet/Con. Call Updates (2025-11-19)/Natural Capsules Limited has informed the Exchange about Transcript
[2085] Analysts/Institutional Investor Meet/Con. Call Updates (2025-11-19)/Natural Capsules Limited has informed the Exchange about Transcript
[2086] Press Release (2026-02-06)/Jubilant Pharmova Limited has informed the Exchange regarding a press release dated February 06, 2026, titled "Press Release alongwith Earnings Presentation on the financials and operational performance of the Company for the quarter and nine months ended December 31, 2025".
[2087] Press Release (2026-02-06)/Jubilant Pharmova Limited has informed the Exchange regarding a press release dated February 06, 2026, titled "Press Release alongwith Earnings Presentation on the financials and operational performance of the Company for the quarter and nine months ended December 31, 2025".
[2088] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-17)/Hikal Limited has informed the Exchange about Transcript
[2089] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-17)/Hikal Limited has informed the Exchange about Transcript
[2090] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-17)/Hikal Limited has informed the Exchange about Transcript
[2091] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-17)/Hikal Limited has informed the Exchange about Transcript
[2092] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-17)/Hikal Limited has informed the Exchange about Transcript
[2093] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-17)/Hikal Limited has informed the Exchange about Transcript
[2094] Press Release (2026-02-06)/Jubilant Pharmova Limited has informed the Exchange regarding a press release dated February 06, 2026, titled "Press Release alongwith Earnings Presentation on the financials and operational performance of the Company for the quarter and nine months ended December 31, 2025".
[2095] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-10)/Solara Active Pharma Sciences Limited has informed the Exchange about Transcript of earnings call pertaining to unaudited financial results of the Company for the quarter and nine months ended December 31, 2025.
[2096] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-10)/Solara Active Pharma Sciences Limited has informed the Exchange about Transcript of earnings call pertaining to unaudited financial results of the Company for the quarter and nine months ended December 31, 2025.
[2097] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-17)/Hikal Limited has informed the Exchange about Transcript
[2098] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-17)/Hikal Limited has informed the Exchange about Transcript
[2099] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-16)/GlaxoSmithKline Pharmaceuticals Limited has informed the Exchange about Transcript
[2100] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-16)/GlaxoSmithKline Pharmaceuticals Limited has informed the Exchange about Transcript
[2101] Analysts/Institutional Investor Meet/Con. Call Updates (2025-06-11)/Wockhardt Limited has informed the Exchange about Transcript
[2102] Analysts/Institutional Investor Meet/Con. Call Updates (2025-06-11)/Wockhardt Limited has informed the Exchange about Transcript
[2103] Analysts/Institutional Investor Meet/Con. Call Updates (2025-06-11)/Wockhardt Limited has informed the Exchange about Transcript
[2104] Analysts/Institutional Investor Meet/Con. Call Updates (2025-06-11)/Wockhardt Limited has informed the Exchange about Transcript
[2105] Analysts/Institutional Investor Meet/Con. Call Updates (2025-06-11)/Wockhardt Limited has informed the Exchange about Transcript
[2106] Analysts/Institutional Investor Meet/Con. Call Updates (2025-06-11)/Wockhardt Limited has informed the Exchange about Transcript
[2107] Press Release (2026-02-06)/Jubilant Pharmova Limited has informed the Exchange regarding a press release dated February 06, 2026, titled "Press Release alongwith Earnings Presentation on the financials and operational performance of the Company for the quarter and nine months ended December 31, 2025".
[2108] Press Release (2026-02-06)/Jubilant Pharmova Limited has informed the Exchange regarding a press release dated February 06, 2026, titled "Press Release alongwith Earnings Presentation on the financials and operational performance of the Company for the quarter and nine months ended December 31, 2025".
[2109] Press Release (2026-02-06)/Jubilant Pharmova Limited has informed the Exchange regarding a press release dated February 06, 2026, titled "Press Release alongwith Earnings Presentation on the financials and operational performance of the Company for the quarter and nine months ended December 31, 2025".
[2110] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-17)/Hikal Limited has informed the Exchange about Transcript
[2111] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-17)/Hikal Limited has informed the Exchange about Transcript
[2112] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-17)/Hikal Limited has informed the Exchange about Transcript
[2113] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-17)/Hikal Limited has informed the Exchange about Transcript
[2114] Outcome of Board Meeting (2026-02-12)/Cohance Lifesciences Limited has submitted to the Exchange, the financial results for the period ended December 31, 2025.
[2115] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-17)/Hikal Limited has informed the Exchange about Transcript
[2116] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-17)/Hikal Limited has informed the Exchange about Transcript
[2117] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-09)/Viyash Scientific Limited has informed the Exchange about Transcript
[2118] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-09)/Viyash Scientific Limited has informed the Exchange about Transcript
[2119] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-09)/Viyash Scientific Limited has informed the Exchange about Transcript
[2120] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-09)/Viyash Scientific Limited has informed the Exchange about Transcript
[2121] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-09)/Viyash Scientific Limited has informed the Exchange about Transcript
[2122] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-09)/Viyash Scientific Limited has informed the Exchange about Transcript
[2123] Analysts/Institutional Investor Meet/Con. Call Updates (2025-05-17)/Morepen Laboratories Limited has informed the Exchange about Transcript
[2124] Analysts/Institutional Investor Meet/Con. Call Updates (2025-05-17)/Morepen Laboratories Limited has informed the Exchange about Transcript
[2125] Analysts/Institutional Investor Meet/Con. Call Updates (2026-03-27)/Sanofi Consumer Healthcare India Limited has informed the Exchange about the transcript of the Institutional Investor Meet held on Tuesday, 24th March 2026
[2126] Analysts/Institutional Investor Meet/Con. Call Updates (2026-03-27)/Sanofi Consumer Healthcare India Limited has informed the Exchange about the transcript of the Institutional Investor Meet held on Tuesday, 24th March 2026
[2127] Analysts/Institutional Investor Meet/Con. Call Updates (2026-03-27)/Sanofi Consumer Healthcare India Limited has informed the Exchange about the transcript of the Institutional Investor Meet held on Tuesday, 24th March 2026
[2128] Analysts/Institutional Investor Meet/Con. Call Updates (2026-03-27)/Sanofi Consumer Healthcare India Limited has informed the Exchange about the transcript of the Institutional Investor Meet held on Tuesday, 24th March 2026
[2129] Investor Presentation (2026-01-29)/BALAXI PHARMACEUTICALS LIMITED has informed the Exchange about Investor Presentation
[2130] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-14)/Divi's Laboratories Limited has informed the Exchange about Transcript
[2131] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-14)/Divi's Laboratories Limited has informed the Exchange about Transcript
[2132] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-17)/Sakar Healthcare Limited has informed the Exchange about Transcript
[2133] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-17)/Sakar Healthcare Limited has informed the Exchange about Transcript
[2134] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-14)/Divi's Laboratories Limited has informed the Exchange about Transcript
[2135] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-14)/Divi's Laboratories Limited has informed the Exchange about Transcript
[2136] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-14)/Divi's Laboratories Limited has informed the Exchange about Transcript
[2137] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-14)/Divi's Laboratories Limited has informed the Exchange about Transcript
[2138] Outcome of Board Meeting (2026-02-05)/Caplin Point Laboratories Limited has submitted to the Exchange, the financial results for the period ended December 31, 2025.
[2139] Outcome of Board Meeting (2026-02-05)/Caplin Point Laboratories Limited has submitted to the Exchange, the financial results for the period ended December 31, 2025.
[2140] Investor Presentation (2026-02-09)/Wanbury Limited has informed the Exchange about Investor Presentation
[2141] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-17)/Hikal Limited has informed the Exchange about Transcript
[2142] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-17)/Hikal Limited has informed the Exchange about Transcript
[2143] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-17)/Hikal Limited has informed the Exchange about Transcript
[2144] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-17)/Hikal Limited has informed the Exchange about Transcript
[2145] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-10)/Solara Active Pharma Sciences Limited has informed the Exchange about Transcript of earnings call pertaining to unaudited financial results of the Company for the quarter and nine months ended December 31, 2025.
[2146] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-10)/Solara Active Pharma Sciences Limited has informed the Exchange about Transcript of earnings call pertaining to unaudited financial results of the Company for the quarter and nine months ended December 31, 2025.
[2147] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-10)/Solara Active Pharma Sciences Limited has informed the Exchange about Transcript of earnings call pertaining to unaudited financial results of the Company for the quarter and nine months ended December 31, 2025.
[2148] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-16)/Orchid Pharma Limited has informed the Exchange about Transcript
[2149] Press Release (2026-02-06)/Solara Active Pharma Sciences Limited has informed the exchange regarding the press release dated February 06, 2026, titled "Solara Q3'26 Performance."
[2150] Analysts/Institutional Investor Meet/Con. Call Updates (2025-11-19)/Natural Capsules Limited has informed the Exchange about Transcript
[2151] Analysts/Institutional Investor Meet/Con. Call Updates (2025-11-19)/Natural Capsules Limited has informed the Exchange about Transcript
[2152] Analysts/Institutional Investor Meet/Con. Call Updates (2025-11-19)/Natural Capsules Limited has informed the Exchange about Transcript
[2153] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-12)/Marksans Pharma Limited transcript of Investors/Analyst meet on Q3 9M FY 26 Unaudited Financial Results held on February 06, 2026
[2154] Analysts/Institutional Investor Meet/Con. Call Updates (2025-11-19)/Natural Capsules Limited has informed the Exchange about Transcript
[2155] Analysts/Institutional Investor Meet/Con. Call Updates (2025-11-19)/Natural Capsules Limited has informed the Exchange about Transcript
[2156] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-17)/Hikal Limited has informed the Exchange about Transcript
[2157] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-17)/Hikal Limited has informed the Exchange about Transcript
[2158] Investor Presentation (2026-02-13)/Natural Capsules Limited has informed the Exchange about Investor Presentation
[2159] Analysts/Institutional Investor Meet/Con. Call Updates (2025-11-19)/Natural Capsules Limited has informed the Exchange about Transcript
[2160] Analysts/Institutional Investor Meet/Con. Call Updates (2025-11-19)/Natural Capsules Limited has informed the Exchange about Transcript
[2161] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-14)/Divi's Laboratories Limited has informed the Exchange about Transcript
[2162] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-14)/Divi's Laboratories Limited has informed the Exchange about Transcript
[2163] Investor Presentation (2026-01-22)/Kopran Limited has informed the Exchange about Investor Presentation
[2164] Analysts/Institutional Investor Meet/Con. Call Updates (2025-11-19)/Natural Capsules Limited has informed the Exchange about Transcript
[2165] Analysts/Institutional Investor Meet/Con. Call Updates (2025-11-19)/Natural Capsules Limited has informed the Exchange about Transcript
[2166] Analysts/Institutional Investor Meet/Con. Call Updates (2025-11-19)/Natural Capsules Limited has informed the Exchange about Transcript
[2167] Press Release (2026-02-06)/Jubilant Pharmova Limited has informed the Exchange regarding a press release dated February 06, 2026, titled "Press Release alongwith Earnings Presentation on the financials and operational performance of the Company for the quarter and nine months ended December 31, 2025".
[2168] Press Release (2026-02-06)/Jubilant Pharmova Limited has informed the Exchange regarding a press release dated February 06, 2026, titled "Press Release alongwith Earnings Presentation on the financials and operational performance of the Company for the quarter and nine months ended December 31, 2025".
[2169] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-17)/Hikal Limited has informed the Exchange about Transcript
[2170] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-17)/Hikal Limited has informed the Exchange about Transcript
[2171] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-17)/Hikal Limited has informed the Exchange about Transcript
[2172] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-17)/Hikal Limited has informed the Exchange about Transcript
[2173] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-17)/Hikal Limited has informed the Exchange about Transcript
[2174] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-17)/Hikal Limited has informed the Exchange about Transcript
[2175] Press Release (2026-02-06)/Jubilant Pharmova Limited has informed the Exchange regarding a press release dated February 06, 2026, titled "Press Release alongwith Earnings Presentation on the financials and operational performance of the Company for the quarter and nine months ended December 31, 2025".
[2176] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-10)/Solara Active Pharma Sciences Limited has informed the Exchange about Transcript of earnings call pertaining to unaudited financial results of the Company for the quarter and nine months ended December 31, 2025.
[2177] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-10)/Solara Active Pharma Sciences Limited has informed the Exchange about Transcript of earnings call pertaining to unaudited financial results of the Company for the quarter and nine months ended December 31, 2025.
[2178] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-17)/Hikal Limited has informed the Exchange about Transcript
[2179] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-17)/Hikal Limited has informed the Exchange about Transcript
[2180] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-16)/GlaxoSmithKline Pharmaceuticals Limited has informed the Exchange about Transcript
[2181] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-16)/GlaxoSmithKline Pharmaceuticals Limited has informed the Exchange about Transcript
[2182] Analysts/Institutional Investor Meet/Con. Call Updates (2025-06-11)/Wockhardt Limited has informed the Exchange about Transcript
[2183] Analysts/Institutional Investor Meet/Con. Call Updates (2025-06-11)/Wockhardt Limited has informed the Exchange about Transcript
[2184] Analysts/Institutional Investor Meet/Con. Call Updates (2025-06-11)/Wockhardt Limited has informed the Exchange about Transcript
[2185] Analysts/Institutional Investor Meet/Con. Call Updates (2025-06-11)/Wockhardt Limited has informed the Exchange about Transcript
[2186] Analysts/Institutional Investor Meet/Con. Call Updates (2025-06-11)/Wockhardt Limited has informed the Exchange about Transcript
[2187] Analysts/Institutional Investor Meet/Con. Call Updates (2025-06-11)/Wockhardt Limited has informed the Exchange about Transcript
[2188] Press Release (2026-02-06)/Jubilant Pharmova Limited has informed the Exchange regarding a press release dated February 06, 2026, titled "Press Release alongwith Earnings Presentation on the financials and operational performance of the Company for the quarter and nine months ended December 31, 2025".
[2189] Press Release (2026-02-06)/Jubilant Pharmova Limited has informed the Exchange regarding a press release dated February 06, 2026, titled "Press Release alongwith Earnings Presentation on the financials and operational performance of the Company for the quarter and nine months ended December 31, 2025".
[2190] Press Release (2026-02-06)/Jubilant Pharmova Limited has informed the Exchange regarding a press release dated February 06, 2026, titled "Press Release alongwith Earnings Presentation on the financials and operational performance of the Company for the quarter and nine months ended December 31, 2025".
[2191] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-17)/Hikal Limited has informed the Exchange about Transcript
[2192] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-17)/Hikal Limited has informed the Exchange about Transcript
[2193] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-17)/Hikal Limited has informed the Exchange about Transcript
[2194] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-17)/Hikal Limited has informed the Exchange about Transcript
[2195] Outcome of Board Meeting (2026-02-12)/Cohance Lifesciences Limited has submitted to the Exchange, the financial results for the period ended December 31, 2025.
[2196] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-17)/Hikal Limited has informed the Exchange about Transcript
[2197] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-17)/Hikal Limited has informed the Exchange about Transcript
[2198] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-09)/Viyash Scientific Limited has informed the Exchange about Transcript
[2199] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-09)/Viyash Scientific Limited has informed the Exchange about Transcript
[2200] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-09)/Viyash Scientific Limited has informed the Exchange about Transcript
[2201] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-09)/Viyash Scientific Limited has informed the Exchange about Transcript
[2202] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-09)/Viyash Scientific Limited has informed the Exchange about Transcript
[2203] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-09)/Viyash Scientific Limited has informed the Exchange about Transcript
[2204] Analysts/Institutional Investor Meet/Con. Call Updates (2025-05-17)/Morepen Laboratories Limited has informed the Exchange about Transcript
[2205] Analysts/Institutional Investor Meet/Con. Call Updates (2025-05-17)/Morepen Laboratories Limited has informed the Exchange about Transcript
[2206] Analysts/Institutional Investor Meet/Con. Call Updates (2026-03-27)/Sanofi Consumer Healthcare India Limited has informed the Exchange about the transcript of the Institutional Investor Meet held on Tuesday, 24th March 2026
[2207] Analysts/Institutional Investor Meet/Con. Call Updates (2026-03-27)/Sanofi Consumer Healthcare India Limited has informed the Exchange about the transcript of the Institutional Investor Meet held on Tuesday, 24th March 2026
[2208] Analysts/Institutional Investor Meet/Con. Call Updates (2026-03-27)/Sanofi Consumer Healthcare India Limited has informed the Exchange about the transcript of the Institutional Investor Meet held on Tuesday, 24th March 2026
[2209] Analysts/Institutional Investor Meet/Con. Call Updates (2026-03-27)/Sanofi Consumer Healthcare India Limited has informed the Exchange about the transcript of the Institutional Investor Meet held on Tuesday, 24th March 2026
[2210] Investor Presentation (2026-01-29)/BALAXI PHARMACEUTICALS LIMITED has informed the Exchange about Investor Presentation
[2211] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-14)/Divi's Laboratories Limited has informed the Exchange about Transcript
[2212] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-14)/Divi's Laboratories Limited has informed the Exchange about Transcript
[2213] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-17)/Sakar Healthcare Limited has informed the Exchange about Transcript
[2214] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-17)/Sakar Healthcare Limited has informed the Exchange about Transcript
[2215] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-14)/Divi's Laboratories Limited has informed the Exchange about Transcript
[2216] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-14)/Divi's Laboratories Limited has informed the Exchange about Transcript
[2217] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-14)/Divi's Laboratories Limited has informed the Exchange about Transcript
[2218] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-14)/Divi's Laboratories Limited has informed the Exchange about Transcript
[2219] Outcome of Board Meeting (2026-02-05)/Caplin Point Laboratories Limited has submitted to the Exchange, the financial results for the period ended December 31, 2025.
[2220] Outcome of Board Meeting (2026-02-05)/Caplin Point Laboratories Limited has submitted to the Exchange, the financial results for the period ended December 31, 2025.
[2221] Investor Presentation (2026-02-09)/Wanbury Limited has informed the Exchange about Investor Presentation
[2222] Investor Presentation (2026-01-29)/BALAXI PHARMACEUTICALS LIMITED has informed the Exchange about Investor Presentation
[2223] Investor Presentation (2026-01-29)/BALAXI PHARMACEUTICALS LIMITED has informed the Exchange about Investor Presentation
[2224] Outcome of Board Meeting (2026-02-05)/Caplin Point Laboratories Limited has submitted to the Exchange, the financial results for the period ended December 31, 2025.
[2225] Outcome of Board Meeting (2026-01-30)/Ajanta Pharma Limited has submitted to the Exchange, the financial results for the period ended December 31, 2025.
[2226] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-17)/Hikal Limited has informed the Exchange about Transcript
[2227] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-17)/Hikal Limited has informed the Exchange about Transcript
[2228] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-17)/Hikal Limited has informed the Exchange about Transcript
[2229] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-17)/Hikal Limited has informed the Exchange about Transcript
[2230] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-10)/Solara Active Pharma Sciences Limited has informed the Exchange about Transcript of earnings call pertaining to unaudited financial results of the Company for the quarter and nine months ended December 31, 2025.
[2231] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-10)/Solara Active Pharma Sciences Limited has informed the Exchange about Transcript of earnings call pertaining to unaudited financial results of the Company for the quarter and nine months ended December 31, 2025.
[2232] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-10)/Solara Active Pharma Sciences Limited has informed the Exchange about Transcript of earnings call pertaining to unaudited financial results of the Company for the quarter and nine months ended December 31, 2025.
[2233] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-16)/Orchid Pharma Limited has informed the Exchange about Transcript
[2234] Press Release (2026-02-06)/Solara Active Pharma Sciences Limited has informed the exchange regarding the press release dated February 06, 2026, titled "Solara Q3'26 Performance."
[2235] Analysts/Institutional Investor Meet/Con. Call Updates (2025-11-19)/Natural Capsules Limited has informed the Exchange about Transcript
[2236] Analysts/Institutional Investor Meet/Con. Call Updates (2025-11-19)/Natural Capsules Limited has informed the Exchange about Transcript
[2237] Analysts/Institutional Investor Meet/Con. Call Updates (2025-11-19)/Natural Capsules Limited has informed the Exchange about Transcript
[2238] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-12)/Marksans Pharma Limited transcript of Investors/Analyst meet on Q3 9M FY 26 Unaudited Financial Results held on February 06, 2026
[2239] Analysts/Institutional Investor Meet/Con. Call Updates (2025-11-19)/Natural Capsules Limited has informed the Exchange about Transcript
[2240] Analysts/Institutional Investor Meet/Con. Call Updates (2025-11-19)/Natural Capsules Limited has informed the Exchange about Transcript
[2241] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-17)/Hikal Limited has informed the Exchange about Transcript
[2242] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-17)/Hikal Limited has informed the Exchange about Transcript
[2243] Investor Presentation (2026-02-13)/Natural Capsules Limited has informed the Exchange about Investor Presentation
[2244] Analysts/Institutional Investor Meet/Con. Call Updates (2025-11-19)/Natural Capsules Limited has informed the Exchange about Transcript
[2245] Analysts/Institutional Investor Meet/Con. Call Updates (2025-11-19)/Natural Capsules Limited has informed the Exchange about Transcript
[2246] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-14)/Divi's Laboratories Limited has informed the Exchange about Transcript
[2247] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-14)/Divi's Laboratories Limited has informed the Exchange about Transcript
[2248] Investor Presentation (2026-01-22)/Kopran Limited has informed the Exchange about Investor Presentation
[2249] Analysts/Institutional Investor Meet/Con. Call Updates (2025-11-19)/Natural Capsules Limited has informed the Exchange about Transcript
[2250] Analysts/Institutional Investor Meet/Con. Call Updates (2025-11-19)/Natural Capsules Limited has informed the Exchange about Transcript
[2251] Analysts/Institutional Investor Meet/Con. Call Updates (2025-11-19)/Natural Capsules Limited has informed the Exchange about Transcript
[2252] Press Release (2026-02-06)/Jubilant Pharmova Limited has informed the Exchange regarding a press release dated February 06, 2026, titled "Press Release alongwith Earnings Presentation on the financials and operational performance of the Company for the quarter and nine months ended December 31, 2025".
[2253] Press Release (2026-02-06)/Jubilant Pharmova Limited has informed the Exchange regarding a press release dated February 06, 2026, titled "Press Release alongwith Earnings Presentation on the financials and operational performance of the Company for the quarter and nine months ended December 31, 2025".
[2254] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-17)/Hikal Limited has informed the Exchange about Transcript
[2255] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-17)/Hikal Limited has informed the Exchange about Transcript
[2256] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-17)/Hikal Limited has informed the Exchange about Transcript
[2257] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-17)/Hikal Limited has informed the Exchange about Transcript
[2258] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-17)/Hikal Limited has informed the Exchange about Transcript
[2259] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-17)/Hikal Limited has informed the Exchange about Transcript
[2260] Press Release (2026-02-06)/Jubilant Pharmova Limited has informed the Exchange regarding a press release dated February 06, 2026, titled "Press Release alongwith Earnings Presentation on the financials and operational performance of the Company for the quarter and nine months ended December 31, 2025".
[2261] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-10)/Solara Active Pharma Sciences Limited has informed the Exchange about Transcript of earnings call pertaining to unaudited financial results of the Company for the quarter and nine months ended December 31, 2025.
[2262] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-10)/Solara Active Pharma Sciences Limited has informed the Exchange about Transcript of earnings call pertaining to unaudited financial results of the Company for the quarter and nine months ended December 31, 2025.
[2263] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-17)/Hikal Limited has informed the Exchange about Transcript
[2264] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-17)/Hikal Limited has informed the Exchange about Transcript
[2265] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-16)/GlaxoSmithKline Pharmaceuticals Limited has informed the Exchange about Transcript
[2266] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-16)/GlaxoSmithKline Pharmaceuticals Limited has informed the Exchange about Transcript
[2267] Analysts/Institutional Investor Meet/Con. Call Updates (2025-06-11)/Wockhardt Limited has informed the Exchange about Transcript
[2268] Analysts/Institutional Investor Meet/Con. Call Updates (2025-06-11)/Wockhardt Limited has informed the Exchange about Transcript
[2269] Analysts/Institutional Investor Meet/Con. Call Updates (2025-06-11)/Wockhardt Limited has informed the Exchange about Transcript
[2270] Analysts/Institutional Investor Meet/Con. Call Updates (2025-06-11)/Wockhardt Limited has informed the Exchange about Transcript
[2271] Analysts/Institutional Investor Meet/Con. Call Updates (2025-06-11)/Wockhardt Limited has informed the Exchange about Transcript
[2272] Analysts/Institutional Investor Meet/Con. Call Updates (2025-06-11)/Wockhardt Limited has informed the Exchange about Transcript
[2273] Press Release (2026-02-06)/Jubilant Pharmova Limited has informed the Exchange regarding a press release dated February 06, 2026, titled "Press Release alongwith Earnings Presentation on the financials and operational performance of the Company for the quarter and nine months ended December 31, 2025".
[2274] Press Release (2026-02-06)/Jubilant Pharmova Limited has informed the Exchange regarding a press release dated February 06, 2026, titled "Press Release alongwith Earnings Presentation on the financials and operational performance of the Company for the quarter and nine months ended December 31, 2025".
[2275] Press Release (2026-02-06)/Jubilant Pharmova Limited has informed the Exchange regarding a press release dated February 06, 2026, titled "Press Release alongwith Earnings Presentation on the financials and operational performance of the Company for the quarter and nine months ended December 31, 2025".
[2276] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-17)/Hikal Limited has informed the Exchange about Transcript
[2277] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-17)/Hikal Limited has informed the Exchange about Transcript
[2278] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-17)/Hikal Limited has informed the Exchange about Transcript
[2279] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-17)/Hikal Limited has informed the Exchange about Transcript
[2280] Outcome of Board Meeting (2026-02-12)/Cohance Lifesciences Limited has submitted to the Exchange, the financial results for the period ended December 31, 2025.
[2281] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-17)/Hikal Limited has informed the Exchange about Transcript
[2282] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-17)/Hikal Limited has informed the Exchange about Transcript
[2283] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-09)/Viyash Scientific Limited has informed the Exchange about Transcript
[2284] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-09)/Viyash Scientific Limited has informed the Exchange about Transcript
[2285] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-09)/Viyash Scientific Limited has informed the Exchange about Transcript
[2286] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-09)/Viyash Scientific Limited has informed the Exchange about Transcript
[2287] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-09)/Viyash Scientific Limited has informed the Exchange about Transcript
[2288] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-09)/Viyash Scientific Limited has informed the Exchange about Transcript
[2289] Analysts/Institutional Investor Meet/Con. Call Updates (2025-05-17)/Morepen Laboratories Limited has informed the Exchange about Transcript
[2290] Analysts/Institutional Investor Meet/Con. Call Updates (2025-05-17)/Morepen Laboratories Limited has informed the Exchange about Transcript
[2291] Analysts/Institutional Investor Meet/Con. Call Updates (2026-03-27)/Sanofi Consumer Healthcare India Limited has informed the Exchange about the transcript of the Institutional Investor Meet held on Tuesday, 24th March 2026
[2292] Analysts/Institutional Investor Meet/Con. Call Updates (2026-03-27)/Sanofi Consumer Healthcare India Limited has informed the Exchange about the transcript of the Institutional Investor Meet held on Tuesday, 24th March 2026
[2293] Analysts/Institutional Investor Meet/Con. Call Updates (2026-03-27)/Sanofi Consumer Healthcare India Limited has informed the Exchange about the transcript of the Institutional Investor Meet held on Tuesday, 24th March 2026
[2294] Analysts/Institutional Investor Meet/Con. Call Updates (2026-03-27)/Sanofi Consumer Healthcare India Limited has informed the Exchange about the transcript of the Institutional Investor Meet held on Tuesday, 24th March 2026
[2295] Investor Presentation (2026-01-29)/BALAXI PHARMACEUTICALS LIMITED has informed the Exchange about Investor Presentation
[2296] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-14)/Divi's Laboratories Limited has informed the Exchange about Transcript
[2297] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-14)/Divi's Laboratories Limited has informed the Exchange about Transcript
[2298] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-17)/Sakar Healthcare Limited has informed the Exchange about Transcript
[2299] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-17)/Sakar Healthcare Limited has informed the Exchange about Transcript
[2300] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-14)/Divi's Laboratories Limited has informed the Exchange about Transcript
[2301] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-14)/Divi's Laboratories Limited has informed the Exchange about Transcript
[2302] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-14)/Divi's Laboratories Limited has informed the Exchange about Transcript
[2303] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-14)/Divi's Laboratories Limited has informed the Exchange about Transcript
[2304] Outcome of Board Meeting (2026-02-05)/Caplin Point Laboratories Limited has submitted to the Exchange, the financial results for the period ended December 31, 2025.
[2305] Outcome of Board Meeting (2026-02-05)/Caplin Point Laboratories Limited has submitted to the Exchange, the financial results for the period ended December 31, 2025.
[2306] Investor Presentation (2026-02-09)/Wanbury Limited has informed the Exchange about Investor Presentation
[2307] Investor Presentation (2026-01-29)/BALAXI PHARMACEUTICALS LIMITED has informed the Exchange about Investor Presentation
[2308] Investor Presentation (2026-01-29)/BALAXI PHARMACEUTICALS LIMITED has informed the Exchange about Investor Presentation
[2309] Outcome of Board Meeting (2026-02-05)/Caplin Point Laboratories Limited has submitted to the Exchange, the financial results for the period ended December 31, 2025.
[2310] Outcome of Board Meeting (2026-01-30)/Ajanta Pharma Limited has submitted to the Exchange, the financial results for the period ended December 31, 2025.
[2311] Press Release (2026-02-11)/Hikal Limited has informed the Exchange regarding a press release dated February 11, 2026, titled "Q3 FY26 Earnings Release".
[2312] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-17)/Hikal Limited has informed the Exchange about Transcript
[2313] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-17)/Hikal Limited has informed the Exchange about Transcript
[2314] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-17)/Hikal Limited has informed the Exchange about Transcript
[2315] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-17)/Hikal Limited has informed the Exchange about Transcript
[2316] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-10)/Solara Active Pharma Sciences Limited has informed the Exchange about Transcript of earnings call pertaining to unaudited financial results of the Company for the quarter and nine months ended December 31, 2025.
[2317] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-10)/Solara Active Pharma Sciences Limited has informed the Exchange about Transcript of earnings call pertaining to unaudited financial results of the Company for the quarter and nine months ended December 31, 2025.
[2318] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-10)/Solara Active Pharma Sciences Limited has informed the Exchange about Transcript of earnings call pertaining to unaudited financial results of the Company for the quarter and nine months ended December 31, 2025.
[2319] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-16)/Orchid Pharma Limited has informed the Exchange about Transcript
[2320] Press Release (2026-02-06)/Solara Active Pharma Sciences Limited has informed the exchange regarding the press release dated February 06, 2026, titled "Solara Q3'26 Performance."
[2321] Analysts/Institutional Investor Meet/Con. Call Updates (2025-11-19)/Natural Capsules Limited has informed the Exchange about Transcript
[2322] Analysts/Institutional Investor Meet/Con. Call Updates (2025-11-19)/Natural Capsules Limited has informed the Exchange about Transcript
[2323] Analysts/Institutional Investor Meet/Con. Call Updates (2025-11-19)/Natural Capsules Limited has informed the Exchange about Transcript
[2324] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-12)/Marksans Pharma Limited transcript of Investors/Analyst meet on Q3 9M FY 26 Unaudited Financial Results held on February 06, 2026
[2325] Analysts/Institutional Investor Meet/Con. Call Updates (2025-11-19)/Natural Capsules Limited has informed the Exchange about Transcript
[2326] Analysts/Institutional Investor Meet/Con. Call Updates (2025-11-19)/Natural Capsules Limited has informed the Exchange about Transcript
[2327] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-17)/Hikal Limited has informed the Exchange about Transcript
[2328] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-17)/Hikal Limited has informed the Exchange about Transcript
[2329] Investor Presentation (2026-02-13)/Natural Capsules Limited has informed the Exchange about Investor Presentation
[2330] Analysts/Institutional Investor Meet/Con. Call Updates (2025-11-19)/Natural Capsules Limited has informed the Exchange about Transcript
[2331] Analysts/Institutional Investor Meet/Con. Call Updates (2025-11-19)/Natural Capsules Limited has informed the Exchange about Transcript
[2332] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-14)/Divi's Laboratories Limited has informed the Exchange about Transcript
[2333] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-14)/Divi's Laboratories Limited has informed the Exchange about Transcript
[2334] Investor Presentation (2026-01-22)/Kopran Limited has informed the Exchange about Investor Presentation
[2335] Analysts/Institutional Investor Meet/Con. Call Updates (2025-11-19)/Natural Capsules Limited has informed the Exchange about Transcript
[2336] Analysts/Institutional Investor Meet/Con. Call Updates (2025-11-19)/Natural Capsules Limited has informed the Exchange about Transcript
[2337] Analysts/Institutional Investor Meet/Con. Call Updates (2025-11-19)/Natural Capsules Limited has informed the Exchange about Transcript
[2338] Press Release (2026-02-06)/Jubilant Pharmova Limited has informed the Exchange regarding a press release dated February 06, 2026, titled "Press Release alongwith Earnings Presentation on the financials and operational performance of the Company for the quarter and nine months ended December 31, 2025".
[2339] Press Release (2026-02-06)/Jubilant Pharmova Limited has informed the Exchange regarding a press release dated February 06, 2026, titled "Press Release alongwith Earnings Presentation on the financials and operational performance of the Company for the quarter and nine months ended December 31, 2025".
[2340] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-17)/Hikal Limited has informed the Exchange about Transcript
[2341] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-17)/Hikal Limited has informed the Exchange about Transcript
[2342] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-17)/Hikal Limited has informed the Exchange about Transcript
[2343] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-17)/Hikal Limited has informed the Exchange about Transcript
[2344] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-17)/Hikal Limited has informed the Exchange about Transcript
[2345] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-17)/Hikal Limited has informed the Exchange about Transcript
[2346] Press Release (2026-02-06)/Jubilant Pharmova Limited has informed the Exchange regarding a press release dated February 06, 2026, titled "Press Release alongwith Earnings Presentation on the financials and operational performance of the Company for the quarter and nine months ended December 31, 2025".
[2347] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-10)/Solara Active Pharma Sciences Limited has informed the Exchange about Transcript of earnings call pertaining to unaudited financial results of the Company for the quarter and nine months ended December 31, 2025.
[2348] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-10)/Solara Active Pharma Sciences Limited has informed the Exchange about Transcript of earnings call pertaining to unaudited financial results of the Company for the quarter and nine months ended December 31, 2025.
[2349] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-17)/Hikal Limited has informed the Exchange about Transcript
[2350] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-17)/Hikal Limited has informed the Exchange about Transcript
[2351] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-16)/GlaxoSmithKline Pharmaceuticals Limited has informed the Exchange about Transcript
[2352] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-16)/GlaxoSmithKline Pharmaceuticals Limited has informed the Exchange about Transcript
[2353] Analysts/Institutional Investor Meet/Con. Call Updates (2025-06-11)/Wockhardt Limited has informed the Exchange about Transcript
[2354] Analysts/Institutional Investor Meet/Con. Call Updates (2025-06-11)/Wockhardt Limited has informed the Exchange about Transcript
[2355] Analysts/Institutional Investor Meet/Con. Call Updates (2025-06-11)/Wockhardt Limited has informed the Exchange about Transcript
[2356] Analysts/Institutional Investor Meet/Con. Call Updates (2025-06-11)/Wockhardt Limited has informed the Exchange about Transcript
[2357] Analysts/Institutional Investor Meet/Con. Call Updates (2025-06-11)/Wockhardt Limited has informed the Exchange about Transcript
[2358] Analysts/Institutional Investor Meet/Con. Call Updates (2025-06-11)/Wockhardt Limited has informed the Exchange about Transcript
[2359] Press Release (2026-02-06)/Jubilant Pharmova Limited has informed the Exchange regarding a press release dated February 06, 2026, titled "Press Release alongwith Earnings Presentation on the financials and operational performance of the Company for the quarter and nine months ended December 31, 2025".
[2360] Press Release (2026-02-06)/Jubilant Pharmova Limited has informed the Exchange regarding a press release dated February 06, 2026, titled "Press Release alongwith Earnings Presentation on the financials and operational performance of the Company for the quarter and nine months ended December 31, 2025".
[2361] Press Release (2026-02-06)/Jubilant Pharmova Limited has informed the Exchange regarding a press release dated February 06, 2026, titled "Press Release alongwith Earnings Presentation on the financials and operational performance of the Company for the quarter and nine months ended December 31, 2025".
[2362] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-17)/Hikal Limited has informed the Exchange about Transcript
[2363] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-17)/Hikal Limited has informed the Exchange about Transcript
[2364] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-17)/Hikal Limited has informed the Exchange about Transcript
[2365] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-17)/Hikal Limited has informed the Exchange about Transcript
[2366] Outcome of Board Meeting (2026-02-12)/Cohance Lifesciences Limited has submitted to the Exchange, the financial results for the period ended December 31, 2025.
[2367] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-17)/Hikal Limited has informed the Exchange about Transcript
[2368] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-17)/Hikal Limited has informed the Exchange about Transcript
[2369] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-09)/Viyash Scientific Limited has informed the Exchange about Transcript
[2370] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-09)/Viyash Scientific Limited has informed the Exchange about Transcript
[2371] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-09)/Viyash Scientific Limited has informed the Exchange about Transcript
[2372] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-09)/Viyash Scientific Limited has informed the Exchange about Transcript
[2373] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-09)/Viyash Scientific Limited has informed the Exchange about Transcript
[2374] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-09)/Viyash Scientific Limited has informed the Exchange about Transcript
[2375] Analysts/Institutional Investor Meet/Con. Call Updates (2025-05-17)/Morepen Laboratories Limited has informed the Exchange about Transcript
[2376] Analysts/Institutional Investor Meet/Con. Call Updates (2025-05-17)/Morepen Laboratories Limited has informed the Exchange about Transcript
[2377] Analysts/Institutional Investor Meet/Con. Call Updates (2026-03-27)/Sanofi Consumer Healthcare India Limited has informed the Exchange about the transcript of the Institutional Investor Meet held on Tuesday, 24th March 2026
[2378] Analysts/Institutional Investor Meet/Con. Call Updates (2026-03-27)/Sanofi Consumer Healthcare India Limited has informed the Exchange about the transcript of the Institutional Investor Meet held on Tuesday, 24th March 2026
[2379] Analysts/Institutional Investor Meet/Con. Call Updates (2026-03-27)/Sanofi Consumer Healthcare India Limited has informed the Exchange about the transcript of the Institutional Investor Meet held on Tuesday, 24th March 2026
[2380] Analysts/Institutional Investor Meet/Con. Call Updates (2026-03-27)/Sanofi Consumer Healthcare India Limited has informed the Exchange about the transcript of the Institutional Investor Meet held on Tuesday, 24th March 2026
[2381] Investor Presentation (2026-01-29)/BALAXI PHARMACEUTICALS LIMITED has informed the Exchange about Investor Presentation
[2382] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-14)/Divi's Laboratories Limited has informed the Exchange about Transcript
[2383] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-14)/Divi's Laboratories Limited has informed the Exchange about Transcript
[2384] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-17)/Sakar Healthcare Limited has informed the Exchange about Transcript
[2385] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-17)/Sakar Healthcare Limited has informed the Exchange about Transcript
[2386] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-14)/Divi's Laboratories Limited has informed the Exchange about Transcript
[2387] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-14)/Divi's Laboratories Limited has informed the Exchange about Transcript
[2388] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-14)/Divi's Laboratories Limited has informed the Exchange about Transcript
[2389] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-14)/Divi's Laboratories Limited has informed the Exchange about Transcript
[2390] Outcome of Board Meeting (2026-02-05)/Caplin Point Laboratories Limited has submitted to the Exchange, the financial results for the period ended December 31, 2025.
[2391] Outcome of Board Meeting (2026-02-05)/Caplin Point Laboratories Limited has submitted to the Exchange, the financial results for the period ended December 31, 2025.
[2392] Investor Presentation (2026-02-09)/Wanbury Limited has informed the Exchange about Investor Presentation
[2393] Investor Presentation (2026-01-29)/BALAXI PHARMACEUTICALS LIMITED has informed the Exchange about Investor Presentation
[2394] Investor Presentation (2026-01-29)/BALAXI PHARMACEUTICALS LIMITED has informed the Exchange about Investor Presentation
[2395] Outcome of Board Meeting (2026-02-05)/Caplin Point Laboratories Limited has submitted to the Exchange, the financial results for the period ended December 31, 2025.
[2396] Outcome of Board Meeting (2026-01-30)/Ajanta Pharma Limited has submitted to the Exchange, the financial results for the period ended December 31, 2025.
[2397] Press Release (2026-02-11)/Hikal Limited has informed the Exchange regarding a press release dated February 11, 2026, titled "Q3 FY26 Earnings Release".
[2398] Outcome of Board Meeting (2026-02-05)/Caplin Point Laboratories Limited has submitted to the Exchange, the financial results for the period ended December 31, 2025.
[2399] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-17)/Hikal Limited has informed the Exchange about Transcript
[2400] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-17)/Hikal Limited has informed the Exchange about Transcript
[2401] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-17)/Hikal Limited has informed the Exchange about Transcript
[2402] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-17)/Hikal Limited has informed the Exchange about Transcript
[2403] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-10)/Solara Active Pharma Sciences Limited has informed the Exchange about Transcript of earnings call pertaining to unaudited financial results of the Company for the quarter and nine months ended December 31, 2025.
[2404] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-10)/Solara Active Pharma Sciences Limited has informed the Exchange about Transcript of earnings call pertaining to unaudited financial results of the Company for the quarter and nine months ended December 31, 2025.
[2405] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-10)/Solara Active Pharma Sciences Limited has informed the Exchange about Transcript of earnings call pertaining to unaudited financial results of the Company for the quarter and nine months ended December 31, 2025.
[2406] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-16)/Orchid Pharma Limited has informed the Exchange about Transcript
[2407] Press Release (2026-02-06)/Solara Active Pharma Sciences Limited has informed the exchange regarding the press release dated February 06, 2026, titled "Solara Q3'26 Performance."
[2408] Analysts/Institutional Investor Meet/Con. Call Updates (2025-11-19)/Natural Capsules Limited has informed the Exchange about Transcript
[2409] Analysts/Institutional Investor Meet/Con. Call Updates (2025-11-19)/Natural Capsules Limited has informed the Exchange about Transcript
[2410] Analysts/Institutional Investor Meet/Con. Call Updates (2025-11-19)/Natural Capsules Limited has informed the Exchange about Transcript
[2411] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-12)/Marksans Pharma Limited transcript of Investors/Analyst meet on Q3 9M FY 26 Unaudited Financial Results held on February 06, 2026
[2412] Analysts/Institutional Investor Meet/Con. Call Updates (2025-11-19)/Natural Capsules Limited has informed the Exchange about Transcript
[2413] Analysts/Institutional Investor Meet/Con. Call Updates (2025-11-19)/Natural Capsules Limited has informed the Exchange about Transcript
[2414] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-17)/Hikal Limited has informed the Exchange about Transcript
[2415] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-17)/Hikal Limited has informed the Exchange about Transcript
[2416] Investor Presentation (2026-02-13)/Natural Capsules Limited has informed the Exchange about Investor Presentation
[2417] Analysts/Institutional Investor Meet/Con. Call Updates (2025-11-19)/Natural Capsules Limited has informed the Exchange about Transcript
[2418] Analysts/Institutional Investor Meet/Con. Call Updates (2025-11-19)/Natural Capsules Limited has informed the Exchange about Transcript
[2419] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-14)/Divi's Laboratories Limited has informed the Exchange about Transcript
[2420] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-14)/Divi's Laboratories Limited has informed the Exchange about Transcript
[2421] Investor Presentation (2026-01-22)/Kopran Limited has informed the Exchange about Investor Presentation
[2422] Analysts/Institutional Investor Meet/Con. Call Updates (2025-11-19)/Natural Capsules Limited has informed the Exchange about Transcript
[2423] Analysts/Institutional Investor Meet/Con. Call Updates (2025-11-19)/Natural Capsules Limited has informed the Exchange about Transcript
[2424] Analysts/Institutional Investor Meet/Con. Call Updates (2025-11-19)/Natural Capsules Limited has informed the Exchange about Transcript
[2425] Press Release (2026-02-06)/Jubilant Pharmova Limited has informed the Exchange regarding a press release dated February 06, 2026, titled "Press Release alongwith Earnings Presentation on the financials and operational performance of the Company for the quarter and nine months ended December 31, 2025".
[2426] Press Release (2026-02-06)/Jubilant Pharmova Limited has informed the Exchange regarding a press release dated February 06, 2026, titled "Press Release alongwith Earnings Presentation on the financials and operational performance of the Company for the quarter and nine months ended December 31, 2025".
[2427] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-17)/Hikal Limited has informed the Exchange about Transcript
[2428] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-17)/Hikal Limited has informed the Exchange about Transcript
[2429] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-17)/Hikal Limited has informed the Exchange about Transcript
[2430] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-17)/Hikal Limited has informed the Exchange about Transcript
[2431] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-17)/Hikal Limited has informed the Exchange about Transcript
[2432] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-17)/Hikal Limited has informed the Exchange about Transcript
[2433] Press Release (2026-02-06)/Jubilant Pharmova Limited has informed the Exchange regarding a press release dated February 06, 2026, titled "Press Release alongwith Earnings Presentation on the financials and operational performance of the Company for the quarter and nine months ended December 31, 2025".
[2434] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-10)/Solara Active Pharma Sciences Limited has informed the Exchange about Transcript of earnings call pertaining to unaudited financial results of the Company for the quarter and nine months ended December 31, 2025.
[2435] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-10)/Solara Active Pharma Sciences Limited has informed the Exchange about Transcript of earnings call pertaining to unaudited financial results of the Company for the quarter and nine months ended December 31, 2025.
[2436] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-17)/Hikal Limited has informed the Exchange about Transcript
[2437] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-17)/Hikal Limited has informed the Exchange about Transcript
[2438] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-16)/GlaxoSmithKline Pharmaceuticals Limited has informed the Exchange about Transcript
[2439] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-16)/GlaxoSmithKline Pharmaceuticals Limited has informed the Exchange about Transcript
[2440] Analysts/Institutional Investor Meet/Con. Call Updates (2025-06-11)/Wockhardt Limited has informed the Exchange about Transcript
[2441] Analysts/Institutional Investor Meet/Con. Call Updates (2025-06-11)/Wockhardt Limited has informed the Exchange about Transcript
[2442] Analysts/Institutional Investor Meet/Con. Call Updates (2025-06-11)/Wockhardt Limited has informed the Exchange about Transcript
[2443] Analysts/Institutional Investor Meet/Con. Call Updates (2025-06-11)/Wockhardt Limited has informed the Exchange about Transcript
[2444] Analysts/Institutional Investor Meet/Con. Call Updates (2025-06-11)/Wockhardt Limited has informed the Exchange about Transcript
[2445] Analysts/Institutional Investor Meet/Con. Call Updates (2025-06-11)/Wockhardt Limited has informed the Exchange about Transcript
[2446] Press Release (2026-02-06)/Jubilant Pharmova Limited has informed the Exchange regarding a press release dated February 06, 2026, titled "Press Release alongwith Earnings Presentation on the financials and operational performance of the Company for the quarter and nine months ended December 31, 2025".
[2447] Press Release (2026-02-06)/Jubilant Pharmova Limited has informed the Exchange regarding a press release dated February 06, 2026, titled "Press Release alongwith Earnings Presentation on the financials and operational performance of the Company for the quarter and nine months ended December 31, 2025".
[2448] Press Release (2026-02-06)/Jubilant Pharmova Limited has informed the Exchange regarding a press release dated February 06, 2026, titled "Press Release alongwith Earnings Presentation on the financials and operational performance of the Company for the quarter and nine months ended December 31, 2025".
[2449] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-17)/Hikal Limited has informed the Exchange about Transcript
[2450] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-17)/Hikal Limited has informed the Exchange about Transcript
[2451] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-17)/Hikal Limited has informed the Exchange about Transcript
[2452] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-17)/Hikal Limited has informed the Exchange about Transcript
[2453] Outcome of Board Meeting (2026-02-12)/Cohance Lifesciences Limited has submitted to the Exchange, the financial results for the period ended December 31, 2025.
[2454] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-17)/Hikal Limited has informed the Exchange about Transcript
[2455] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-17)/Hikal Limited has informed the Exchange about Transcript
[2456] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-09)/Viyash Scientific Limited has informed the Exchange about Transcript
[2457] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-09)/Viyash Scientific Limited has informed the Exchange about Transcript
[2458] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-09)/Viyash Scientific Limited has informed the Exchange about Transcript
[2459] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-09)/Viyash Scientific Limited has informed the Exchange about Transcript
[2460] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-09)/Viyash Scientific Limited has informed the Exchange about Transcript
[2461] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-09)/Viyash Scientific Limited has informed the Exchange about Transcript
[2462] Analysts/Institutional Investor Meet/Con. Call Updates (2025-05-17)/Morepen Laboratories Limited has informed the Exchange about Transcript
[2463] Analysts/Institutional Investor Meet/Con. Call Updates (2025-05-17)/Morepen Laboratories Limited has informed the Exchange about Transcript
[2464] Analysts/Institutional Investor Meet/Con. Call Updates (2026-03-27)/Sanofi Consumer Healthcare India Limited has informed the Exchange about the transcript of the Institutional Investor Meet held on Tuesday, 24th March 2026
[2465] Analysts/Institutional Investor Meet/Con. Call Updates (2026-03-27)/Sanofi Consumer Healthcare India Limited has informed the Exchange about the transcript of the Institutional Investor Meet held on Tuesday, 24th March 2026
[2466] Analysts/Institutional Investor Meet/Con. Call Updates (2026-03-27)/Sanofi Consumer Healthcare India Limited has informed the Exchange about the transcript of the Institutional Investor Meet held on Tuesday, 24th March 2026
[2467] Analysts/Institutional Investor Meet/Con. Call Updates (2026-03-27)/Sanofi Consumer Healthcare India Limited has informed the Exchange about the transcript of the Institutional Investor Meet held on Tuesday, 24th March 2026
[2468] Investor Presentation (2026-01-29)/BALAXI PHARMACEUTICALS LIMITED has informed the Exchange about Investor Presentation
[2469] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-14)/Divi's Laboratories Limited has informed the Exchange about Transcript
[2470] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-14)/Divi's Laboratories Limited has informed the Exchange about Transcript
[2471] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-17)/Sakar Healthcare Limited has informed the Exchange about Transcript
[2472] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-17)/Sakar Healthcare Limited has informed the Exchange about Transcript
[2473] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-14)/Divi's Laboratories Limited has informed the Exchange about Transcript
[2474] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-14)/Divi's Laboratories Limited has informed the Exchange about Transcript
[2475] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-14)/Divi's Laboratories Limited has informed the Exchange about Transcript
[2476] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-14)/Divi's Laboratories Limited has informed the Exchange about Transcript
[2477] Outcome of Board Meeting (2026-02-05)/Caplin Point Laboratories Limited has submitted to the Exchange, the financial results for the period ended December 31, 2025.
[2478] Outcome of Board Meeting (2026-02-05)/Caplin Point Laboratories Limited has submitted to the Exchange, the financial results for the period ended December 31, 2025.
[2479] Investor Presentation (2026-02-09)/Wanbury Limited has informed the Exchange about Investor Presentation
[2480] Investor Presentation (2026-01-29)/BALAXI PHARMACEUTICALS LIMITED has informed the Exchange about Investor Presentation
[2481] Investor Presentation (2026-01-29)/BALAXI PHARMACEUTICALS LIMITED has informed the Exchange about Investor Presentation
[2482] Outcome of Board Meeting (2026-02-05)/Caplin Point Laboratories Limited has submitted to the Exchange, the financial results for the period ended December 31, 2025.
[2483] Outcome of Board Meeting (2026-01-30)/Ajanta Pharma Limited has submitted to the Exchange, the financial results for the period ended December 31, 2025.
[2484] Press Release (2026-02-11)/Hikal Limited has informed the Exchange regarding a press release dated February 11, 2026, titled "Q3 FY26 Earnings Release".
[2485] Outcome of Board Meeting (2026-02-05)/Caplin Point Laboratories Limited has submitted to the Exchange, the financial results for the period ended December 31, 2025.
[2486] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-17)/Hikal Limited has informed the Exchange about Transcript
[2487] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-17)/Hikal Limited has informed the Exchange about Transcript
[2488] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-17)/Hikal Limited has informed the Exchange about Transcript
[2489] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-17)/Hikal Limited has informed the Exchange about Transcript
[2490] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-10)/Solara Active Pharma Sciences Limited has informed the Exchange about Transcript of earnings call pertaining to unaudited financial results of the Company for the quarter and nine months ended December 31, 2025.
[2491] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-10)/Solara Active Pharma Sciences Limited has informed the Exchange about Transcript of earnings call pertaining to unaudited financial results of the Company for the quarter and nine months ended December 31, 2025.
[2492] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-10)/Solara Active Pharma Sciences Limited has informed the Exchange about Transcript of earnings call pertaining to unaudited financial results of the Company for the quarter and nine months ended December 31, 2025.
[2493] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-16)/Orchid Pharma Limited has informed the Exchange about Transcript
[2494] Press Release (2026-02-06)/Solara Active Pharma Sciences Limited has informed the exchange regarding the press release dated February 06, 2026, titled "Solara Q3'26 Performance."
[2495] Analysts/Institutional Investor Meet/Con. Call Updates (2025-11-19)/Natural Capsules Limited has informed the Exchange about Transcript
[2496] Analysts/Institutional Investor Meet/Con. Call Updates (2025-11-19)/Natural Capsules Limited has informed the Exchange about Transcript
[2497] Analysts/Institutional Investor Meet/Con. Call Updates (2025-11-19)/Natural Capsules Limited has informed the Exchange about Transcript
[2498] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-12)/Marksans Pharma Limited transcript of Investors/Analyst meet on Q3 9M FY 26 Unaudited Financial Results held on February 06, 2026
[2499] Analysts/Institutional Investor Meet/Con. Call Updates (2025-11-19)/Natural Capsules Limited has informed the Exchange about Transcript
[2500] Analysts/Institutional Investor Meet/Con. Call Updates (2025-11-19)/Natural Capsules Limited has informed the Exchange about Transcript
[2501] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-17)/Hikal Limited has informed the Exchange about Transcript
[2502] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-17)/Hikal Limited has informed the Exchange about Transcript
[2503] Investor Presentation (2026-02-13)/Natural Capsules Limited has informed the Exchange about Investor Presentation
[2504] Analysts/Institutional Investor Meet/Con. Call Updates (2025-11-19)/Natural Capsules Limited has informed the Exchange about Transcript
[2505] Analysts/Institutional Investor Meet/Con. Call Updates (2025-11-19)/Natural Capsules Limited has informed the Exchange about Transcript
[2506] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-14)/Divi's Laboratories Limited has informed the Exchange about Transcript
[2507] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-14)/Divi's Laboratories Limited has informed the Exchange about Transcript
[2508] Investor Presentation (2026-01-22)/Kopran Limited has informed the Exchange about Investor Presentation
[2509] Analysts/Institutional Investor Meet/Con. Call Updates (2025-11-19)/Natural Capsules Limited has informed the Exchange about Transcript
[2510] Analysts/Institutional Investor Meet/Con. Call Updates (2025-11-19)/Natural Capsules Limited has informed the Exchange about Transcript
[2511] Analysts/Institutional Investor Meet/Con. Call Updates (2025-11-19)/Natural Capsules Limited has informed the Exchange about Transcript
[2512] Press Release (2026-02-06)/Jubilant Pharmova Limited has informed the Exchange regarding a press release dated February 06, 2026, titled "Press Release alongwith Earnings Presentation on the financials and operational performance of the Company for the quarter and nine months ended December 31, 2025".
[2513] Press Release (2026-02-06)/Jubilant Pharmova Limited has informed the Exchange regarding a press release dated February 06, 2026, titled "Press Release alongwith Earnings Presentation on the financials and operational performance of the Company for the quarter and nine months ended December 31, 2025".
[2514] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-17)/Hikal Limited has informed the Exchange about Transcript
[2515] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-17)/Hikal Limited has informed the Exchange about Transcript
[2516] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-17)/Hikal Limited has informed the Exchange about Transcript
[2517] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-17)/Hikal Limited has informed the Exchange about Transcript
[2518] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-17)/Hikal Limited has informed the Exchange about Transcript
[2519] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-17)/Hikal Limited has informed the Exchange about Transcript
[2520] Press Release (2026-02-06)/Jubilant Pharmova Limited has informed the Exchange regarding a press release dated February 06, 2026, titled "Press Release alongwith Earnings Presentation on the financials and operational performance of the Company for the quarter and nine months ended December 31, 2025".
[2521] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-10)/Solara Active Pharma Sciences Limited has informed the Exchange about Transcript of earnings call pertaining to unaudited financial results of the Company for the quarter and nine months ended December 31, 2025.
[2522] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-10)/Solara Active Pharma Sciences Limited has informed the Exchange about Transcript of earnings call pertaining to unaudited financial results of the Company for the quarter and nine months ended December 31, 2025.
[2523] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-17)/Hikal Limited has informed the Exchange about Transcript
[2524] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-17)/Hikal Limited has informed the Exchange about Transcript
[2525] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-16)/GlaxoSmithKline Pharmaceuticals Limited has informed the Exchange about Transcript
[2526] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-16)/GlaxoSmithKline Pharmaceuticals Limited has informed the Exchange about Transcript
[2527] Analysts/Institutional Investor Meet/Con. Call Updates (2025-06-11)/Wockhardt Limited has informed the Exchange about Transcript
[2528] Analysts/Institutional Investor Meet/Con. Call Updates (2025-06-11)/Wockhardt Limited has informed the Exchange about Transcript
[2529] Analysts/Institutional Investor Meet/Con. Call Updates (2025-06-11)/Wockhardt Limited has informed the Exchange about Transcript
[2530] Analysts/Institutional Investor Meet/Con. Call Updates (2025-06-11)/Wockhardt Limited has informed the Exchange about Transcript
[2531] Analysts/Institutional Investor Meet/Con. Call Updates (2025-06-11)/Wockhardt Limited has informed the Exchange about Transcript
[2532] Analysts/Institutional Investor Meet/Con. Call Updates (2025-06-11)/Wockhardt Limited has informed the Exchange about Transcript
[2533] Press Release (2026-02-06)/Jubilant Pharmova Limited has informed the Exchange regarding a press release dated February 06, 2026, titled "Press Release alongwith Earnings Presentation on the financials and operational performance of the Company for the quarter and nine months ended December 31, 2025".
[2534] Press Release (2026-02-06)/Jubilant Pharmova Limited has informed the Exchange regarding a press release dated February 06, 2026, titled "Press Release alongwith Earnings Presentation on the financials and operational performance of the Company for the quarter and nine months ended December 31, 2025".
[2535] Press Release (2026-02-06)/Jubilant Pharmova Limited has informed the Exchange regarding a press release dated February 06, 2026, titled "Press Release alongwith Earnings Presentation on the financials and operational performance of the Company for the quarter and nine months ended December 31, 2025".
[2536] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-17)/Hikal Limited has informed the Exchange about Transcript
[2537] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-17)/Hikal Limited has informed the Exchange about Transcript
[2538] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-17)/Hikal Limited has informed the Exchange about Transcript
[2539] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-17)/Hikal Limited has informed the Exchange about Transcript
[2540] Outcome of Board Meeting (2026-02-12)/Cohance Lifesciences Limited has submitted to the Exchange, the financial results for the period ended December 31, 2025.
[2541] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-17)/Hikal Limited has informed the Exchange about Transcript
[2542] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-17)/Hikal Limited has informed the Exchange about Transcript
[2543] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-09)/Viyash Scientific Limited has informed the Exchange about Transcript
[2544] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-09)/Viyash Scientific Limited has informed the Exchange about Transcript
[2545] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-09)/Viyash Scientific Limited has informed the Exchange about Transcript
[2546] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-09)/Viyash Scientific Limited has informed the Exchange about Transcript
[2547] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-09)/Viyash Scientific Limited has informed the Exchange about Transcript
[2548] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-09)/Viyash Scientific Limited has informed the Exchange about Transcript
[2549] Analysts/Institutional Investor Meet/Con. Call Updates (2025-05-17)/Morepen Laboratories Limited has informed the Exchange about Transcript
[2550] Analysts/Institutional Investor Meet/Con. Call Updates (2025-05-17)/Morepen Laboratories Limited has informed the Exchange about Transcript
[2551] Analysts/Institutional Investor Meet/Con. Call Updates (2026-03-27)/Sanofi Consumer Healthcare India Limited has informed the Exchange about the transcript of the Institutional Investor Meet held on Tuesday, 24th March 2026
[2552] Analysts/Institutional Investor Meet/Con. Call Updates (2026-03-27)/Sanofi Consumer Healthcare India Limited has informed the Exchange about the transcript of the Institutional Investor Meet held on Tuesday, 24th March 2026
[2553] Analysts/Institutional Investor Meet/Con. Call Updates (2026-03-27)/Sanofi Consumer Healthcare India Limited has informed the Exchange about the transcript of the Institutional Investor Meet held on Tuesday, 24th March 2026
[2554] Analysts/Institutional Investor Meet/Con. Call Updates (2026-03-27)/Sanofi Consumer Healthcare India Limited has informed the Exchange about the transcript of the Institutional Investor Meet held on Tuesday, 24th March 2026
[2555] Investor Presentation (2026-01-29)/BALAXI PHARMACEUTICALS LIMITED has informed the Exchange about Investor Presentation
[2556] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-14)/Divi's Laboratories Limited has informed the Exchange about Transcript
[2557] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-14)/Divi's Laboratories Limited has informed the Exchange about Transcript
[2558] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-17)/Sakar Healthcare Limited has informed the Exchange about Transcript
[2559] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-17)/Sakar Healthcare Limited has informed the Exchange about Transcript
[2560] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-14)/Divi's Laboratories Limited has informed the Exchange about Transcript
[2561] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-14)/Divi's Laboratories Limited has informed the Exchange about Transcript
[2562] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-14)/Divi's Laboratories Limited has informed the Exchange about Transcript
[2563] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-14)/Divi's Laboratories Limited has informed the Exchange about Transcript
[2564] Outcome of Board Meeting (2026-02-05)/Caplin Point Laboratories Limited has submitted to the Exchange, the financial results for the period ended December 31, 2025.
[2565] Outcome of Board Meeting (2026-02-05)/Caplin Point Laboratories Limited has submitted to the Exchange, the financial results for the period ended December 31, 2025.
[2566] Investor Presentation (2026-02-09)/Wanbury Limited has informed the Exchange about Investor Presentation
[2567] Investor Presentation (2026-01-29)/BALAXI PHARMACEUTICALS LIMITED has informed the Exchange about Investor Presentation
[2568] Investor Presentation (2026-01-29)/BALAXI PHARMACEUTICALS LIMITED has informed the Exchange about Investor Presentation
[2569] Outcome of Board Meeting (2026-02-05)/Caplin Point Laboratories Limited has submitted to the Exchange, the financial results for the period ended December 31, 2025.
[2570] Outcome of Board Meeting (2026-01-30)/Ajanta Pharma Limited has submitted to the Exchange, the financial results for the period ended December 31, 2025.
[2571] Press Release (2026-02-11)/Hikal Limited has informed the Exchange regarding a press release dated February 11, 2026, titled "Q3 FY26 Earnings Release".
[2572] Outcome of Board Meeting (2026-02-05)/Caplin Point Laboratories Limited has submitted to the Exchange, the financial results for the period ended December 31, 2025.
[2573] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-17)/Hikal Limited has informed the Exchange about Transcript
[2574] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-17)/Hikal Limited has informed the Exchange about Transcript
[2575] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-17)/Hikal Limited has informed the Exchange about Transcript
[2576] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-17)/Hikal Limited has informed the Exchange about Transcript
[2577] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-10)/Solara Active Pharma Sciences Limited has informed the Exchange about Transcript of earnings call pertaining to unaudited financial results of the Company for the quarter and nine months ended December 31, 2025.
[2578] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-10)/Solara Active Pharma Sciences Limited has informed the Exchange about Transcript of earnings call pertaining to unaudited financial results of the Company for the quarter and nine months ended December 31, 2025.
[2579] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-10)/Solara Active Pharma Sciences Limited has informed the Exchange about Transcript of earnings call pertaining to unaudited financial results of the Company for the quarter and nine months ended December 31, 2025.
[2580] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-16)/Orchid Pharma Limited has informed the Exchange about Transcript
[2581] Press Release (2026-02-06)/Solara Active Pharma Sciences Limited has informed the exchange regarding the press release dated February 06, 2026, titled "Solara Q3'26 Performance."
[2582] Analysts/Institutional Investor Meet/Con. Call Updates (2025-11-19)/Natural Capsules Limited has informed the Exchange about Transcript
[2583] Analysts/Institutional Investor Meet/Con. Call Updates (2025-11-19)/Natural Capsules Limited has informed the Exchange about Transcript
[2584] Analysts/Institutional Investor Meet/Con. Call Updates (2025-11-19)/Natural Capsules Limited has informed the Exchange about Transcript
[2585] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-12)/Marksans Pharma Limited transcript of Investors/Analyst meet on Q3 9M FY 26 Unaudited Financial Results held on February 06, 2026
[2586] Analysts/Institutional Investor Meet/Con. Call Updates (2025-11-19)/Natural Capsules Limited has informed the Exchange about Transcript
[2587] Analysts/Institutional Investor Meet/Con. Call Updates (2025-11-19)/Natural Capsules Limited has informed the Exchange about Transcript
[2588] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-17)/Hikal Limited has informed the Exchange about Transcript
[2589] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-17)/Hikal Limited has informed the Exchange about Transcript
[2590] Investor Presentation (2026-02-13)/Natural Capsules Limited has informed the Exchange about Investor Presentation
[2591] Analysts/Institutional Investor Meet/Con. Call Updates (2025-11-19)/Natural Capsules Limited has informed the Exchange about Transcript
[2592] Analysts/Institutional Investor Meet/Con. Call Updates (2025-11-19)/Natural Capsules Limited has informed the Exchange about Transcript
[2593] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-14)/Divi's Laboratories Limited has informed the Exchange about Transcript
[2594] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-14)/Divi's Laboratories Limited has informed the Exchange about Transcript
[2595] Investor Presentation (2026-01-22)/Kopran Limited has informed the Exchange about Investor Presentation
[2596] Analysts/Institutional Investor Meet/Con. Call Updates (2025-11-19)/Natural Capsules Limited has informed the Exchange about Transcript
[2597] Analysts/Institutional Investor Meet/Con. Call Updates (2025-11-19)/Natural Capsules Limited has informed the Exchange about Transcript
[2598] Analysts/Institutional Investor Meet/Con. Call Updates (2025-11-19)/Natural Capsules Limited has informed the Exchange about Transcript
[2599] Press Release (2026-02-06)/Jubilant Pharmova Limited has informed the Exchange regarding a press release dated February 06, 2026, titled "Press Release alongwith Earnings Presentation on the financials and operational performance of the Company for the quarter and nine months ended December 31, 2025".
[2600] Press Release (2026-02-06)/Jubilant Pharmova Limited has informed the Exchange regarding a press release dated February 06, 2026, titled "Press Release alongwith Earnings Presentation on the financials and operational performance of the Company for the quarter and nine months ended December 31, 2025".
[2601] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-17)/Hikal Limited has informed the Exchange about Transcript
[2602] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-17)/Hikal Limited has informed the Exchange about Transcript
[2603] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-17)/Hikal Limited has informed the Exchange about Transcript
[2604] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-17)/Hikal Limited has informed the Exchange about Transcript
[2605] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-17)/Hikal Limited has informed the Exchange about Transcript
[2606] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-17)/Hikal Limited has informed the Exchange about Transcript
[2607] Press Release (2026-02-06)/Jubilant Pharmova Limited has informed the Exchange regarding a press release dated February 06, 2026, titled "Press Release alongwith Earnings Presentation on the financials and operational performance of the Company for the quarter and nine months ended December 31, 2025".
[2608] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-10)/Solara Active Pharma Sciences Limited has informed the Exchange about Transcript of earnings call pertaining to unaudited financial results of the Company for the quarter and nine months ended December 31, 2025.
[2609] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-10)/Solara Active Pharma Sciences Limited has informed the Exchange about Transcript of earnings call pertaining to unaudited financial results of the Company for the quarter and nine months ended December 31, 2025.
[2610] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-17)/Hikal Limited has informed the Exchange about Transcript
[2611] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-17)/Hikal Limited has informed the Exchange about Transcript
[2612] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-16)/GlaxoSmithKline Pharmaceuticals Limited has informed the Exchange about Transcript
[2613] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-16)/GlaxoSmithKline Pharmaceuticals Limited has informed the Exchange about Transcript
[2614] Analysts/Institutional Investor Meet/Con. Call Updates (2025-06-11)/Wockhardt Limited has informed the Exchange about Transcript
[2615] Analysts/Institutional Investor Meet/Con. Call Updates (2025-06-11)/Wockhardt Limited has informed the Exchange about Transcript
[2616] Analysts/Institutional Investor Meet/Con. Call Updates (2025-06-11)/Wockhardt Limited has informed the Exchange about Transcript
[2617] Analysts/Institutional Investor Meet/Con. Call Updates (2025-06-11)/Wockhardt Limited has informed the Exchange about Transcript
[2618] Analysts/Institutional Investor Meet/Con. Call Updates (2025-06-11)/Wockhardt Limited has informed the Exchange about Transcript
[2619] Analysts/Institutional Investor Meet/Con. Call Updates (2025-06-11)/Wockhardt Limited has informed the Exchange about Transcript
[2620] Press Release (2026-02-06)/Jubilant Pharmova Limited has informed the Exchange regarding a press release dated February 06, 2026, titled "Press Release alongwith Earnings Presentation on the financials and operational performance of the Company for the quarter and nine months ended December 31, 2025".
[2621] Press Release (2026-02-06)/Jubilant Pharmova Limited has informed the Exchange regarding a press release dated February 06, 2026, titled "Press Release alongwith Earnings Presentation on the financials and operational performance of the Company for the quarter and nine months ended December 31, 2025".
[2622] Press Release (2026-02-06)/Jubilant Pharmova Limited has informed the Exchange regarding a press release dated February 06, 2026, titled "Press Release alongwith Earnings Presentation on the financials and operational performance of the Company for the quarter and nine months ended December 31, 2025".
[2623] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-17)/Hikal Limited has informed the Exchange about Transcript
[2624] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-17)/Hikal Limited has informed the Exchange about Transcript
[2625] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-17)/Hikal Limited has informed the Exchange about Transcript
[2626] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-17)/Hikal Limited has informed the Exchange about Transcript
[2627] Outcome of Board Meeting (2026-02-12)/Cohance Lifesciences Limited has submitted to the Exchange, the financial results for the period ended December 31, 2025.
[2628] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-17)/Hikal Limited has informed the Exchange about Transcript
[2629] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-17)/Hikal Limited has informed the Exchange about Transcript
[2630] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-09)/Viyash Scientific Limited has informed the Exchange about Transcript
[2631] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-09)/Viyash Scientific Limited has informed the Exchange about Transcript
[2632] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-09)/Viyash Scientific Limited has informed the Exchange about Transcript
[2633] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-09)/Viyash Scientific Limited has informed the Exchange about Transcript
[2634] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-09)/Viyash Scientific Limited has informed the Exchange about Transcript
[2635] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-09)/Viyash Scientific Limited has informed the Exchange about Transcript
[2636] Analysts/Institutional Investor Meet/Con. Call Updates (2025-05-17)/Morepen Laboratories Limited has informed the Exchange about Transcript
[2637] Analysts/Institutional Investor Meet/Con. Call Updates (2025-05-17)/Morepen Laboratories Limited has informed the Exchange about Transcript
[2638] Analysts/Institutional Investor Meet/Con. Call Updates (2026-03-27)/Sanofi Consumer Healthcare India Limited has informed the Exchange about the transcript of the Institutional Investor Meet held on Tuesday, 24th March 2026
[2639] Analysts/Institutional Investor Meet/Con. Call Updates (2026-03-27)/Sanofi Consumer Healthcare India Limited has informed the Exchange about the transcript of the Institutional Investor Meet held on Tuesday, 24th March 2026
[2640] Analysts/Institutional Investor Meet/Con. Call Updates (2026-03-27)/Sanofi Consumer Healthcare India Limited has informed the Exchange about the transcript of the Institutional Investor Meet held on Tuesday, 24th March 2026
[2641] Analysts/Institutional Investor Meet/Con. Call Updates (2026-03-27)/Sanofi Consumer Healthcare India Limited has informed the Exchange about the transcript of the Institutional Investor Meet held on Tuesday, 24th March 2026
[2642] Investor Presentation (2026-01-29)/BALAXI PHARMACEUTICALS LIMITED has informed the Exchange about Investor Presentation
[2643] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-14)/Divi's Laboratories Limited has informed the Exchange about Transcript
[2644] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-14)/Divi's Laboratories Limited has informed the Exchange about Transcript
[2645] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-17)/Sakar Healthcare Limited has informed the Exchange about Transcript
[2646] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-17)/Sakar Healthcare Limited has informed the Exchange about Transcript
[2647] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-14)/Divi's Laboratories Limited has informed the Exchange about Transcript
[2648] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-14)/Divi's Laboratories Limited has informed the Exchange about Transcript
[2649] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-14)/Divi's Laboratories Limited has informed the Exchange about Transcript
[2650] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-14)/Divi's Laboratories Limited has informed the Exchange about Transcript
[2651] Outcome of Board Meeting (2026-02-05)/Caplin Point Laboratories Limited has submitted to the Exchange, the financial results for the period ended December 31, 2025.
[2652] Outcome of Board Meeting (2026-02-05)/Caplin Point Laboratories Limited has submitted to the Exchange, the financial results for the period ended December 31, 2025.
[2653] Investor Presentation (2026-02-09)/Wanbury Limited has informed the Exchange about Investor Presentation
[2654] Investor Presentation (2026-01-29)/BALAXI PHARMACEUTICALS LIMITED has informed the Exchange about Investor Presentation
[2655] Investor Presentation (2026-01-29)/BALAXI PHARMACEUTICALS LIMITED has informed the Exchange about Investor Presentation
[2656] Outcome of Board Meeting (2026-02-05)/Caplin Point Laboratories Limited has submitted to the Exchange, the financial results for the period ended December 31, 2025.
[2657] Outcome of Board Meeting (2026-01-30)/Ajanta Pharma Limited has submitted to the Exchange, the financial results for the period ended December 31, 2025.
[2658] Press Release (2026-02-11)/Hikal Limited has informed the Exchange regarding a press release dated February 11, 2026, titled "Q3 FY26 Earnings Release".
[2659] Outcome of Board Meeting (2026-02-05)/Caplin Point Laboratories Limited has submitted to the Exchange, the financial results for the period ended December 31, 2025.